: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

Flying Publisher

The Angels Initiative

Stroke prevention

Vaccines

Free Subscription

Articles published in Vaccine
Retrieve available abstracts of 1747 articles:
HTML format

Single Articles

July 2022

NOWALK MP, D'Agostino H, Dauer K, Stiegler M, et al
Estimating the burden of adult hospitalized RSV infection including special populations.
Vaccine. 2022;40:4121-4127.
PubMed Abstract available

June 2022

MOGHNIEH R, Abdallah D, Sayegh MH, Rahman Bizri A, et al
Response to letter to the editor: Immunophenotyping of SARS-CoV-2 and vaccine design.
Vaccine. 2022;40:3987-3988.
PubMed

CIMOLAI N
Immunophenotyping of SARS-CoV-2 and vaccine design.
Vaccine. 2022;40:3985-3986.
PubMed

HU G, Jin WP, Yang ZH, Lv SY, et al
Efficacy of Coxsackievirus A2 vaccine candidates correlating to humoral immunity in mice challenged with a mouse-adapted strain.
Vaccine. 2022 Jun 24. pii: S0264-410X(22)00768.
PubMed Abstract available

AL-MUSTAPHA AI, Okechukwu O, Olayinka A, Muhammed OR, et al
A national survey of COVID-19 vaccine acceptance in Nigeria.
Vaccine. 2022 Jun 23. pii: S0264-410X(22)00818.
PubMed Abstract available

LOHMANN S, Albarracin D
Trust in the public health system as a source of information on vaccination matters most when environments are supportive.
Vaccine. 2022 Jun 23. pii: S0264-410X(22)00759.
PubMed Abstract available

HUANG L, Wasserman M, Grant L, Farkouh R, et al
Burden of pneumococcal disease due to serotypes covered by the 13-valent and new higher-valent pneumococcal conjugate vaccines in the United States.
Vaccine. 2022 Jun 23. pii: S0264-410X(22)00773.
PubMed Abstract available

ZHAO Z, Liao Y, Li Y, Jiang G, et al
Immunogenicity and safety of the inactivated enterovirus 71 vaccine administered concomitantly with the measles-rubella vaccine in infants aged 8 months in China: A noninferiority randomized controlled trial.
Vaccine. 2022 Jun 23. pii: S0264-410X(22)00776.
PubMed Abstract available

MAERTENS K, Leuridan E, Munoz FM, Zimmermann P, et al
Impact of vaccination during pregnancy on infants' immune responses to vaccinations- definitions and statistical approaches.
Vaccine. 2022 Jun 21. pii: S0264-410X(22)00811.
PubMed

BRAZ HMB, Silva MF, Carvalho TP, Silva LAD, et al
Pathogenesis of Brucella ovis in pregnant mice and protection induced by the candidate vaccine strain B. Ovis DeltaabcBA.
Vaccine. 2022 Jun 21. pii: S0264-410X(22)00812.
PubMed Abstract available

RONZANI P, Panizza F, Martini C, Savadori L, et al
Countering vaccine hesitancy through medical expert endorsement.
Vaccine. 2022 Jun 21. pii: S0264-410X(22)00780.
PubMed Abstract available

SOARES GH, Sethi S, Hedges J, Jamieson L, et al
Disparities in Human Papillomavirus vaccination coverage among adolescents in Australia: A geospatial analysis.
Vaccine. 2022 Jun 21. pii: S0264-410X(22)00777.
PubMed Abstract available

WANG L, Zhang J, Meng S, Ge L, et al
Safety and immunogenicity of human rabies vaccine for the Chinese population after PEP: A systematic review and meta-analysis.
Vaccine. 2022 Jun 21. pii: S0264-410X(22)00784.
PubMed Abstract available

HONDA-OKUBO Y, Cartee RT, Thanawastien A, Seung Yang J, et al
A typhoid fever protein capsular matrix vaccine candidate formulated with Advax-CpG adjuvant induces a robust and durable anti-typhoid Vi polysaccharide antibody response in mice, rabbits and nonhuman primates.
Vaccine. 2022 Jun 21. pii: S0264-410X(22)00809.
PubMed Abstract available

ULANOVA M, Huska B, Dubois S, McCready W, et al
Opsonophagocytic activity against Streptococcus pneumoniae in Indigenous and non-Indigenous patients with severe chronic kidney disease immunized with 13-valent pneumococcal conjugate vaccine.
Vaccine. 2022 Jun 20. pii: S0264-410X(22)00810.
PubMed Abstract available

DIONATO FAV, Jalalizadeh M, Buosi K, Visacri MB, et al
BCG vaccine safety in COVID-19 convalescent adults: BATTLE a randomized controlled trial.
Vaccine. 2022 Jun 20. pii: S0264-410X(22)00803.
PubMed Abstract available

KASAIJA PD, Contreras M, Kabi F, Mugerwa S, et al
Oral vaccine formulation combining tick Subolesin with heat inactivated mycobacteria provides control of cross-species cattle tick infestations.
Vaccine. 2022 Jun 18. pii: S0264-410X(22)00804.
PubMed Abstract available

CASAGRANDE TZ, Costa-Rocha IAD, Gavi MBRO, Miyamoto ST, et al
Previous biological therapy and impairment of the IFN-gamma/IL-10 axis are associated with low immune response to 17DD-YF vaccination in patients with spondyloarthritis.
Vaccine. 2022 Jun 18. pii: S0264-410X(22)00703.
PubMed Abstract available

UWAMINO Y, Kurafuji T, Takato K, Sakai A, et al
Dynamics of antibody titers and cellular immunity among Japanese healthcare workers during the 6 months after receiving two doses of BNT162b2 mRNA vaccine.
Vaccine. 2022 Jun 16. pii: S0264-410X(22)00763.
PubMed Abstract available

CANADAY LM, Resnick JD, Liu H, Powell H, et al
HA and M2 sequences alter the replication of 2013-16 H1 live attenuated influenza vaccine infection in human nasal epithelial cell cultures.
Vaccine. 2022 Jun 16. pii: S0264-410X(22)00733.
PubMed Abstract available

TAY S, Bowen AC, Blyth CC, Clifford P, et al
A quality improvement study: Optimizing pneumococcal vaccination rates in children with cochlear implants.
Vaccine. 2022 Jun 16. pii: S0264-410X(22)00769.
PubMed Abstract available

GAMBRELL A, Sundaram M, Bednarczyk RA
Estimating the number of US children susceptible to measles resulting from COVID-19-related vaccination coverage declines.
Vaccine. 2022 Jun 15. pii: S0264-410X(22)00782.
PubMed Abstract available

TSENG HF, Sy LS, Ackerson BK, Lee GS, et al
Safety of tetanus, diphtheria, acellular pertussis (Tdap) vaccination during pregnancy.
Vaccine. 2022 Jun 15. pii: S0264-410X(22)00756.
PubMed Abstract available

BRAUNFELD JB, Carson HN, Williams SR, Schwartz LM, et al
Clinical endpoints to inform vaccine policy: A systematic review of outcome measures from pediatric influenza vaccine efficacy trials.
Vaccine. 2022 Jun 15. pii: S0264-410X(22)00778.
PubMed Abstract available

ARAUJO BC, Simakawa R, Munhoz LG, Carmo FB, et al
Rubella antibodies in vertically and horizontally HIV-infected young adults vaccinated early in life and response to a booster dose in those with seronegative results.
Vaccine. 2022 Jun 15. pii: S0264-410X(22)00774.
PubMed Abstract available

FOLEGATTI PM, Jenkin D, Morris S, Gilbert S, et al
Vaccines based on the replication-deficient simian adenoviral vector ChAdOx1: Standardized template with key considerations for a risk/benefit assessment.
Vaccine. 2022 Jun 14. pii: S0264-410X(22)00755.
PubMed Abstract available

HERNANDEZ LM, Sumathy K, Sahastrabuddhe S, Excler JL, et al
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for an inactivated viral vaccine against Chikungunya virus.
Vaccine. 2022 Jun 14. pii: S0264-410X(22)00753.
PubMed Abstract available

CHUNG JR, Kim SS, Flannery B, Smith ME, et al
Vaccine-associated attenuation of subjective severity among outpatients with influenza.
Vaccine. 2022 Jun 14. pii: S0264-410X(22)00767.
PubMed Abstract available

RAZZAGHI H, Yankey D, Vashist K, Lu PJ, et al
COVID-19 vaccination coverage and intent among women aged 18-49 years by pregnancy status, United States, April-November 2021.
Vaccine. 2022 Jun 13. pii: S0264-410X(22)00779.
PubMed Abstract available

PHATARPHEKAR A, Vidyadhar Reddy GEC, Gokhale A, Karanam G, et al
RelCoVax(R), a two antigen subunit protein vaccine candidate against SARS-CoV-2 induces strong immune responses in mice.
Vaccine. 2022 Jun 13. pii: S0264-410X(22)00775.
PubMed Abstract available

SHOOTS-REINHARD B, Lawrence ER, Schulkin J, Peters E, et al
Excluding numeric side-effect information produces lower vaccine intentions.
Vaccine. 2022 Jun 10. pii: S0264-410X(22)00747.
PubMed Abstract available

ROLLIER CS, Dold C, Blackwell L, Linder A, et al
Immunogenicity of a single 4CMenB vaccine booster in adolescents 11 years after childhood immunisation.
Vaccine. 2022 Jun 10. pii: S0264-410X(22)00539.
PubMed Abstract available

HEININGER U
Referring to: Wilkinson K, Righolt CH, Elliott LJ, Fanella S, Mahmud SM. Pertussis vaccine effectiveness and duration of protection - a systematic review and meta-analysis. Vaccine. 2021 May 27;39(23):3120-3130.
Vaccine. 2022;40:3530.
PubMed

WIEMKEN TL, Salas J, Hoft DF, Jacobs C, et al
In response to: JVAC-D-21-02863, detection of a potential error in the results of the manuscript, dementia risk following influenza vaccination in a large veteran cohort, that could call into question the main conclusion.
Vaccine. 2022;40:3529.
PubMed

VUICHARD-GYSIN D, Schoenenberger A
Detection of a potential error in the results of the manuscript "Dementia risk following influenza vaccination in a large veteran cohort" that could eventually call into question the main conclusion.
Vaccine. 2022;40:3528.
PubMed

SCHENK J, Abrams S, Litzroth A, Cornelissen L, et al
Identifying immunity gaps for measles using Belgian serial serology data.
Vaccine. 2022;40:3676-3683.
PubMed Abstract available

POLLET J, Strych U, Chen WH, Versteeg L, et al
Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern.
Vaccine. 2022;40:3655-3663.
PubMed Abstract available

SPARROW E, Adetifa I, Chaiyakunapruk N, Cherian T, et al
WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants - Key considerations for global use.
Vaccine. 2022;40:3506-3510.
PubMed Abstract available

EVANS B, Jombart T
Worldwide routine immunisation coverage regressed during the first year of the COVID-19 pandemic.
Vaccine. 2022;40:3531-3535.
PubMed Abstract available

ZHAO FJ, Liu LT, Wang Z, Wang NX, et al
Development and immunogenicity evaluation of porcine deltacoronavirus inactivated vaccine with different adjuvants in mice.
Vaccine. 2022 Jun 9. pii: S0264-410X(22)00721.
PubMed Abstract available

HALME J, Syrjanen RK, Baum U, Palmu AA, et al
Effectiveness of trivalent influenza vaccines against hospitalizations due to laboratory-confirmed influenza a in the elderly: Comparison of test-negative design with register-based designs.
Vaccine. 2022 Jun 9. pii: S0264-410X(22)00716.
PubMed Abstract available

KUNASEKARAN MP, Chughtai AA, Heslop DJ, Poulos CJ, et al
Influenza cases in nine aged care facilities in Sydney, Australia over a three-year surveillance period, 2018-2020.
Vaccine. 2022 Jun 9. pii: S0264-410X(22)00476.
PubMed Abstract available

LEAV B, Straus W, White P, Leav A, et al
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Moderna COVID-19 Vaccine (mRNA-1273).
Vaccine. 2022 Jun 9. pii: S0264-410X(22)00752.
PubMed Abstract available

DIAZ-MENENDEZ M, de la Calle-Prieto F, Montejano R, Arsuaga M, et al
Clinical characteristics and outcome of hospitalized elderly patients with COVID- 19 after vaccine failure.
Vaccine. 2022 Jun 8. pii: S0264-410X(22)00751.
PubMed Abstract available

LIGHTOWLER MS, Manangazira P, Nackers F, Van Herp M, et al
Effectiveness of typhoid conjugate vaccine in Zimbabwe used in response to an outbreak among children and young adults: A matched case control study.
Vaccine. 2022 Jun 8. pii: S0264-410X(22)00552.
PubMed Abstract available

CHICHILI GR, Smulders R, Santos V, Cywin B, et al
Phase 1/2 study of a novel 24-valent pneumococcal vaccine in healthy adults aged 18 to 64 years and in older adults aged 65 to 85 years.
Vaccine. 2022 Jun 8. pii: S0264-410X(22)00715.
PubMed Abstract available

OKUNO H, Satoh H, Morino S, Arai S, et al
Characteristics and incidence of vaccine adverse events after Bacille Calmette-Guerin vaccination: A national surveillance study in Japan from 2013 to 2017.
Vaccine. 2022 Jun 8. pii: S0264-410X(22)00672.
PubMed Abstract available

LIN K, Liu M, Bao L, Lv Q, et al
Safety and protective capability of an inactivated SARS-CoV-2 vaccine on pregnancy, lactation and the growth of offspring in hACE2 mice.
Vaccine. 2022 Jun 8. pii: S0264-410X(22)00765.
PubMed Abstract available

ZHANG H, Li Y, Peng S, Jiang Y, et al
The effect of health literacy on COVID-19 vaccine hesitancy among community population in China: The moderating role of stress.
Vaccine. 2022 Jun 8. pii: S0264-410X(22)00762.
PubMed Abstract available

KOBAYASHI T, Nishina Y, Tomoi H, Harada K, et al
Corowa-kun: A messenger app chatbot delivers COVID-19 vaccine information, Japan 2021.
Vaccine. 2022 Jun 8. pii: S0264-410X(22)00754.
PubMed Abstract available

SMITH WJ, Ahl PL, Wang B, Hamm M, et al
Analytical technology development to monitor the stability of Polysaccharide-Protein conjugate vaccines.
Vaccine. 2022 Jun 7. pii: S0264-410X(22)00673.
PubMed Abstract available

SLOTTE P, Karlsson LC, Soveri A
Attitudes towards mandatory vaccination and sanctions for vaccination refusal.
Vaccine. 2022 Jun 7. pii: S0264-410X(22)00697.
PubMed Abstract available

WALKER JL, Schultze A, Tazare J, Tamborska A, et al
Safety of COVID-19 vaccination and acute neurological events: A self-controlled case series in England using the OpenSAFELY platform.
Vaccine. 2022 Jun 7. pii: S0264-410X(22)00757.
PubMed Abstract available

WYNBERG E, Han AX, Boyd A, van Willigen HDG, et al
The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): A prospective cohort study.
Vaccine. 2022 Jun 7. pii: S0264-410X(22)00748.
PubMed Abstract available

DAYTON L, Miller J, Strickland J, Davey-Rothwell M, et al
A socio-ecological perspective on parents' intentions to vaccinate their children against COVID-19.
Vaccine. 2022 Jun 6. pii: S0264-410X(22)00736.
PubMed Abstract available

EL-SHESHENY R, El Taweel A, Gomaa MR, Roshdy WH, et al
Induced humoral immunity of different types of vaccines against most common variants of SARS-CoV-2 in Egypt prior to Omicron outbreak.
Vaccine. 2022 Jun 6. pii: S0264-410X(22)00734.
PubMed Abstract available

SHANMUGARAJ B, Khorattanakulchai N, Panapitakkul C, Malla A, et al
Preclinical evaluation of a plant-derived SARS-CoV-2 subunit vaccine: Protective efficacy, immunogenicity, safety, and toxicity.
Vaccine. 2022 Jun 6. pii: S0264-410X(22)00735.
PubMed Abstract available

HASHIMOTO M, Nagata N, Homma T, Maeda H, et al
Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeys.
Vaccine. 2022 Jun 6. pii: S0264-410X(22)00718.
PubMed Abstract available

EUGENIA-TOLEDO-ROMANI M, Verdecia-Sanchez L, Rodriguez-Gonzalez M, Rodriguez-Noda L, et al
Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trials.
Vaccine. 2022 Jun 6. pii: S0264-410X(22)00717.
PubMed Abstract available

FLYNN JA, Weber T, Cejas PJ, Cox KS, et al
Characterization of humoral and cell-mediated immunity induced by mRNA vaccines expressing influenza hemagglutinin stem and nucleoprotein in mice and nonhuman primates.
Vaccine. 2022 Jun 6. pii: S0264-410X(22)00382.
PubMed Abstract available

SLARVE M, Holznecht N, Reza H, Gilkes A, et al
Recombinant Aspergillus fumigatus antigens Asp f 3 and Asp f 9 in liposomal vaccine protect mice against invasive pulmonary aspergillosis.
Vaccine. 2022 Jun 6. pii: S0264-410X(22)00674.
PubMed Abstract available

WATANABE A, Nishida S, Burcu T, Shibahara T, et al
Safety and immunogenicity of a quadrivalent seasonal influenza vaccine adjuvanted with hydroxypropyl-beta-cyclodextrin: A phase 1 clinical trial.
Vaccine. 2022 Jun 4. pii: S0264-410X(22)00677.
PubMed Abstract available

AB RAHMAN N, Lim MT, Lee FY, Lee SC, et al
Risk of serious adverse events after the BNT162b2, CoronaVac, and ChAdOx1 vaccines in Malaysia: A self-controlled case series study.
Vaccine. 2022 Jun 3. pii: S0264-410X(22)00700.
PubMed Abstract available

JANSSEN DF
A familiar species of Crank: Anti-Vaccinationists in medical history.
Vaccine. 2022 Jun 3. pii: S0264-410X(22)00665.
PubMed Abstract available

BILGIN GM, Lokuge K, Glass K
Modelling the impact of maternal pneumococcal vaccination on infant pneumococcal disease in low-income settings.
Vaccine. 2022 Jun 3. pii: S0264-410X(22)00684.
PubMed Abstract available

May 2022

AHMED S, Iqbal J, Sadiq K, Umrani F, et al
Association of Anti-Rotavirus IgA Seroconversion with Growth, Environmental Enteric Dysfunction and Enteropathogens in Rural Pakistani Infants.
Vaccine. 2022;40:3444-3451.
PubMed Abstract available

PILLSBURY M, Carias C, Samant S, Greenberg D, et al
Comparison of performance of varicella vaccines via infectious disease modeling.
Vaccine. 2022 May 31. pii: S0264-410X(22)00574.
PubMed Abstract available

HISYAM BIN ISMAIL CMK, Raihan Mohammad Shabani N, Chuah C, Hassan Z, et al
Shigella iron-binding proteins: An insight into molecular physiology, pathogenesis, and potential target vaccine development.
Vaccine. 2022 May 31. pii: S0264-410X(22)00679.
PubMed Abstract available

TOOR J, Li X, Jit M, Trotter CL, et al
COVID-19 impact on routine immunisations for vaccine-preventable diseases: Projecting the effect of different routes to recovery.
Vaccine. 2022 May 30. pii: S0264-410X(22)00698.
PubMed Abstract available

WOO EJ, Dimova RB
Thrombocytopenia after Ad.26.COV2.S COVID-19 vaccine: Reports to the vaccine adverse event reporting system.
Vaccine. 2022 May 30. pii: S0264-410X(22)00704.
PubMed Abstract available

MERRICK E, Weissman JP, Patel SJ
Utilizing Google trends to monitor coronavirus vaccine interest and hesitancies.
Vaccine. 2022 May 30. pii: S0264-410X(22)00699.
PubMed Abstract available

HEMMING-HARLO M, Gylling A, Herse F, Haavisto I, et al
Long-term surveillance of rotavirus vaccination after implementation of a national immunization program in Finland (2008-2018).
Vaccine. 2022 May 28. pii: S0264-410X(22)00584.
PubMed Abstract available

KLEINWAKS G, Schmit V, Morrison J
Corrigendum to "Considering human challenge trials for tuberculosis vaccine development" [Vaccine 40(2) (2022) 173-174].
Vaccine. 2022 May 28. pii: S0264-410X(22)00675.
PubMed

SHAPIRO BEN DAVID S, Mizrahi B, Rahamim-Cohen D, Supino-Rosin L, et al
Robust antibody response after a third BNT162b2 vaccine compared to the second among immunocompromised and healthy individuals, a prospective longitudinal cohort study.
Vaccine. 2022 May 28. pii: S0264-410X(22)00668.
PubMed Abstract available

SHIOHARA M, Suzuki S, Shichinohe S, Ishigaki H, et al
Inactivated whole influenza virus particle vaccines induce neutralizing antibodies with an increase in immunoglobulin gene subclones of B-lymphocytes in cynomolgus macaques.
Vaccine. 2022 May 28. pii: S0264-410X(22)00640.
PubMed Abstract available

RODES-SANCHEZ M, Spencer J, Tantri A, Mitrovich R, et al
Working towards a sustainable, healthy market for vaccines: A framework to support evidence-based policymaking.
Vaccine. 2022 May 27. pii: S0264-410X(22)00671.
PubMed

MACDONALD NE, Dube E, Comeau JL
Have vaccine hesitancy models oversimplified a complex problem to our detriment? The Adapted Royal Society of Canada vaccine uptake framework.
Vaccine. 2022 May 27. pii: S0264-410X(22)00669.
PubMed

SAVULESCU C, Krizova P, Valentiner-Branth P, Ladhani S, et al
Effectiveness of 10 and 13-valent pneumococcal conjugate vaccines against invasive pneumococcal disease in European children: SpIDnet observational multicentre study.
Vaccine. 2022 May 27. pii: S0264-410X(22)00581.
PubMed Abstract available

LAI X, Li M, Hou Z, Guo J, et al
Factors associated with caregivers' hesitancy to vaccinate children against influenza: A cross-sectional survey in China.
Vaccine. 2022 May 27. pii: S0264-410X(22)00606.
PubMed Abstract available

PATEL KM, Shafiq M, Malik AA, Cobanoglu A, et al
Relationship between the use of nonpharmaceutical interventions and COVID-19 vaccination among U.S. child care providers: A prospective cohort study.
Vaccine. 2022 May 27. pii: S0264-410X(22)00680.
PubMed Abstract available

SOEGIARTO G, Wulandari L, Purnomosari D, Dhia Fahmita K, et al
Hypertension is associated with antibody response and breakthrough infection in health care workers following vaccination with inactivated SARS-CoV-2.
Vaccine. 2022 May 27. pii: S0264-410X(22)00676.
PubMed Abstract available

DUBE C, Paris-Robidas S, Andreani G, Gutzeit C, et al
Broad neutralization against SARS-CoV-2 variants induced by ancestral and B.1.351 AS03-Adjuvanted recombinant Plant-Derived Virus-Like particle vaccines.
Vaccine. 2022 May 27. pii: S0264-410X(22)00641.
PubMed Abstract available

MOSS P, Berenbaum F, Curigliano G, Grupper A, et al
Benefit-risk evaluation of COVID-19 vaccination in special population groups of interest.
Vaccine. 2022 May 27. pii: S0264-410X(22)00682.
PubMed Abstract available

HALSTEAD IN, McKay RT, Lewis GJ
COVID-19 and seasonal flu vaccination hesitancy: Links to personality and general intelligence in a large, UK cohort.
Vaccine. 2022 May 27. pii: S0264-410X(22)00678.
PubMed Abstract available

MOUSSAOUI S, Combes S, Ibanez G, Gautier A, et al
Are immigrants living in France more reluctant to receive vaccines than native-born French citizens? findings from the national health Barometer study.
Vaccine. 2022 May 26. pii: S0264-410X(22)00636.
PubMed Abstract available

ILESANMI MM, Adeyinka DA, Olakunde BO
Sustainable Development Goals and childhood measles vaccination in Ekiti State, Nigeria: Results from spatial and interrupted time series analyses.
Vaccine. 2022 May 26. pii: S0264-410X(22)00632.
PubMed Abstract available

LARSEN L, Bistrup C, Sorensen SS, Boesby L, et al
Immunogenicity and safety of double dosage of pneumococcal vaccines in adult kidney transplant recipients and waiting list patients: A non-blinded, randomized clinical trial.
Vaccine. 2022 May 26. pii: S0264-410X(22)00635.
PubMed Abstract available

TAFURI S, Bianchi FP, Stefanizzi P
The public health and the question of the "best vaccine".
Vaccine. 2022 May 26. pii: S0264-410X(22)00639.
PubMed

HOFFMAN BL, Batra Hershey T, Chu KH, Sidani JE, et al
Moving vaccination beyond partisan politics.
Vaccine. 2022 May 26. pii: S0264-410X(22)00664.
PubMed

ZHOU Y, Hu X, Chen R, Wu J, et al
Impact of maternal and pre-existing antibodies on immunogenicity of inactivated rotavirus vaccines.
Vaccine. 2022 May 26. pii: S0264-410X(22)00620.
PubMed Abstract available

JANKO MM, Joffe J, Michael D, Earl L, et al
Cost-effectiveness of rotavirus vaccination in children under five years of age in 195 countries: A meta-regression analysis.
Vaccine. 2022 May 25. pii: S0264-410X(22)00637.
PubMed Abstract available

DUBE E, Gagnon D, MacDonald N
Between persuasion and compulsion: The case of COVID-19 vaccination in Canada.
Vaccine. 2022 May 25. pii: S0264-410X(22)00670.
PubMed

GAGHAN C, Adams D, Mohammed J, Crespo R, et al
Characterization of vaccine-induced immune responses against coccidiosis in broiler chickens.
Vaccine. 2022 May 25. pii: S0264-410X(22)00638.
PubMed Abstract available

ABRAHAM N, Spruin S, Rossi T, Fireman B, et al
Myocarditis and/or pericarditis risk after mRNA COVID-19 vaccination: A Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines.
Vaccine. 2022 May 25. pii: S0264-410X(22)00667.
PubMed Abstract available

BECK E, Biundo E, Devlin N, Doherty TM, et al
Capturing the value of vaccination within health technology assessment and health economics: Literature review and novel conceptual framework.
Vaccine. 2022 May 23. pii: S0264-410X(22)00490.
PubMed Abstract available

MALTER KB, Tugel ME, Gil-Rodriguez M, de la Guardia G, et al
Corrigendum to "Variability in non-core vaccination rates of dogs and cats in veterinary clinics across the United States" [Vaccine 40(7) (2022) 1001-1009].
Vaccine. 2022 May 23. pii: S0264-410X(22)00619.
PubMed

QUINN MK, Edmond KM, Fawzi WW, Hurt L, et al
Non-specific effects of BCG and DTP vaccination on infant mortality: An analysis of birth cohorts in Ghana and Tanzania.
Vaccine. 2022 May 23. pii: S0264-410X(22)00536.
PubMed Abstract available

CHANG CM, Awanye AM, Marsay L, Dold C, et al
Application of a Neisseria meningitidis antigen microarray to identify candidate vaccine proteins from a human Phase I clinical trial.
Vaccine. 2022 May 21. pii: S0264-410X(22)00616.
PubMed Abstract available

MOLLER A, Schwamborn K, Spillmann A, Hoogstraate J, et al
Travel vaccines are strongly associated to reduced mortality in prostate cancer patients - a real effect or residual confounding?
Vaccine. 2022 May 21. pii: S0264-410X(22)00611.
PubMed Abstract available

OSMAN S, Crowcroft N, McLachlan E, Hatchette T, et al
Population immunity to measles in Canada using Canadian Health Measures survey data - A Canadian Immunization Research Network (CIRN) study.
Vaccine. 2022;40:3228-3235.
PubMed Abstract available

LLAVE CL, Uy MEV, Lam HY, Aldaba JG, et al
The cost-effectiveness of human papillomavirus vaccination in the Philippines.
Vaccine. 2022 May 20. pii: S0264-410X(22)00609.
PubMed Abstract available

FOO D, Sarna M, Pereira G, Moore HC, et al
Maternal influenza vaccination and child mortality: Longitudinal, population-based linked cohort study.
Vaccine. 2022 May 20. pii: S0264-410X(22)00614.
PubMed Abstract available

KITCHEN M, Leierer G, Kistner O, Wodal W, et al
High seroprotection rates and geometric mean titre increases after repeated annual influenza vaccinations in a cohort of HIV-infected adults in Austria.
Vaccine. 2022 May 20. pii: S0264-410X(22)00575.
PubMed Abstract available

MCELFISH PA, Selig JP, Scott AJ, Rowland B, et al
Associations between 5-year influenza vaccination and sociodemographic factors and healthcare access among Arkansans.
Vaccine. 2022 May 20. pii: S0264-410X(22)00615.
PubMed Abstract available

SZANYI J, Wilson T, Scott N, Blakely T, et al
A log-odds system for waning and boosting of COVID-19 vaccine effectiveness.
Vaccine. 2022 May 20. pii: S0264-410X(22)00634.
PubMed Abstract available

SIQUEIRA PG, Duarte HO, Moura MDC
Risk-based cost-benefit analysis of alternative vaccines against COVID-19 in Brazil: Coronavac vs. Astrazeneca vs. Pfizer.
Vaccine. 2022 May 19. pii: S0264-410X(22)00633.
PubMed Abstract available

CARSON B, Isaacs J, Carilli T
Jabbing together? The complementarity between social capital, formal public health rules, and COVID-19 vaccine rates in the United States.
Vaccine. 2022 May 19. pii: S0264-410X(22)00612.
PubMed Abstract available

STEELFISHER GK, Caporello H, McIntosh R, Muhammad Safdar R, et al
Preventing erosion of oral polio vaccine acceptance: A role for vaccinator visits and social norms.
Vaccine. 2022 May 19. pii: S0264-410X(22)00567.
PubMed Abstract available

ZHANG Y, Lin L, Yang J, Lv Q, et al
Two Bordetella bronchiseptica attenuated vaccine candidates confer protection against lethal challenge with B. Bronchiseptica and Pasteurella multocida toxin in mouse models.
Vaccine. 2022 May 19. pii: S0264-410X(22)00604.
PubMed Abstract available

POSTMA M, Biundo E, Chicoye A, Devlin N, et al
Capturing the value of vaccination within health technology assessment and health economics: Country analysis and priority value concepts.
Vaccine. 2022 May 18. pii: S0264-410X(22)00442.
PubMed Abstract available

VESIKARI T, Saez-Llorens X, Blazevic V, Lopez P, et al
Immunogenicity of a bivalent virus-like particle norovirus vaccine in children from 1 to 8 years of age: A phase 2 randomized, double-blind study.
Vaccine. 2022 May 17. pii: S0264-410X(22)00550.
PubMed Abstract available

SALO-TUOMINEN K, Teros-Jaakkola T, Toivonen L, Ollila H, et al
Parental socioeconomic and psychological determinants of the 2009 pandemic influenza A(H1N1) vaccine uptake in children.
Vaccine. 2022 May 17. pii: S0264-410X(22)00582.
PubMed Abstract available

ROBERTSON DA, Mohr KS, Barjakova M, Lunn PD, et al
Experimental pre-tests of public health communications on the COVID-19 vaccine: A null finding for medical endorsement, risk and altruism.
Vaccine. 2022 May 16. pii: S0264-410X(22)00613.
PubMed Abstract available

NAZURDINOV A, Azizov Z, Mullojonova M, Sadykova U, et al
Impact and effectiveness of monovalent rotavirus vaccine in Tajik children.
Vaccine. 2022 May 14. pii: S0264-410X(22)00589.
PubMed Abstract available

SULIS G, Horn M, Borrow R, Basta NE, et al
A comparison of national vaccination policies to prevent serogroup B meningococcal disease.
Vaccine. 2022 May 14. pii: S0264-410X(22)00568.
PubMed Abstract available

POLAND GA, van Dijk N
John D. Bailey retiring after more than 20years of service to Vaccine.
Vaccine. 2022 May 13. pii: S0264-410X(22)00618.
PubMed

CHAMBERS C, Deeks SL, Sutradhar R, Cox J, et al
Increases in human papillomavirus vaccine coverage over 12 months among a community-recruited cohort of gay, bisexual, and other men who have sex with men in Canada.
Vaccine. 2022 May 13. pii: S0264-410X(22)00590.
PubMed Abstract available

KUMAR SURI R, Hayman B, Prasad SD, Makhoana M, et al
Vaccines: New challenges, new paradigms, new opportunities: Report of the 22nd DCVMN Annual General Meeting.
Vaccine. 2022 May 13. pii: S0264-410X(22)00576.
PubMed Abstract available

DUC DANG A, Dinh Vu T, Hai Vu H, Thanh Ta V, et al
Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam.
Vaccine. 2022 May 13. pii: S0264-410X(22)00526.
PubMed Abstract available

TSAI SY, Yeh TY, Chiu NC, Huang CT, et al
National safety surveillance of quadrivalent recombinant influenza vaccine in Taiwan during NH 20/21.
Vaccine. 2022 May 13. pii: S0264-410X(22)00588.
PubMed Abstract available

RUSKIN AC, Rice S, O'Connor M, Ruskin KJ, et al
Effects of vaccination status in the United States on willingness to undergo surgery during a pandemic: A prospective survey study.
Vaccine. 2022 May 13. pii: S0264-410X(22)00583.
PubMed Abstract available

LI F, Freed D, Heidecker G, Galli J, et al
A novel high throughput assay to quantify Epstein-Barr virus neutralizing antibody activity against B-cell and epithelial cell infections for vaccine and therapeutic developments.
Vaccine. 2022 May 13. pii: S0264-410X(22)00569.
PubMed Abstract available

IWATA S, Sonoyama T, Kamitani A, Shibata R, et al
Phase 1/2 clinical trial of COVID-19 vaccine in Japanese participants: A report of interim findings.
Vaccine. 2022 May 13. pii: S0264-410X(22)00494.
PubMed Abstract available

ALYA WA, Maraqa B, Nazzal Z, Odeh M, et al
COVID-19 vaccine uptake and its associated factors among Palestinian healthcare workers: Expectations beaten by reality.
Vaccine. 2022 May 13. pii: S0264-410X(22)00610.
PubMed Abstract available

MANCARELLA M, Natarelli F, Bertolini C, Zagari A, et al
Catch-up vaccination campaign in children between 6 and 8 years old during COVID-19 pandemic: The experience in a COVID hub in Milan, Italy.
Vaccine. 2022 May 12. pii: S0264-410X(22)00573.
PubMed Abstract available

CUMMINS NW, Badley AD
Could proteasome inhibition improve therapeutic vaccine response in HIV?
Vaccine. 2022 May 12. pii: S0264-410X(22)00578.
PubMed

CHONG-VALBUENA A, De-Jesus-Maria I, Agurto-Ramirez A, Puchades-Gimeno F, et al
Safety of Pfizer-BioNTech vaccine in a cohort of healthcare providers: Differences between naive and previously infected by SARS-CoV-2.
Vaccine. 2022 May 12. pii: S0264-410X(22)00586.
PubMed Abstract available

OSTER G, Bornheimer R, Ottino K, Stevenson C, et al
Adult immunization against hepatitis B: Does the number of jabs matter?
Vaccine. 2022 May 12. pii: S0264-410X(22)00534.
PubMed Abstract available

TEASDALE CA, Ratzan S, Stuart Lathan H, Rauh L, et al
Acceptability of COVID-19 vaccine mandates among New York City parents, November 2021.
Vaccine. 2022 May 11. pii: S0264-410X(22)00580.
PubMed Abstract available

SHAUM A, Mujuru HA, Takamiya M, Ticklay I, et al
Enhanced surveillance for adverse events following immunization during the 2019 typhoid conjugate vaccine campaign in Harare, Zimbabwe.
Vaccine. 2022 May 11. pii: S0264-410X(22)00551.
PubMed Abstract available

FERNANDES C, Alves J, Rodrigues A, Azevedo J, et al
Corrigendum to "Epidemiological impact of the human papillomavirus vaccination program on genital warts in Portugal: A retrospective, chart review study" [Vaccine 40(2) (2022) 275-281].
Vaccine. 2022 May 11. pii: S0264-410X(22)00537.
PubMed

ISLAM N, Xu C, Lau CL, Mills DJ, et al
Persistence of antibodies, boostability, and interchangeability of Japanese encephalitis vaccines: A systematic review and dose-response meta-analysis.
Vaccine. 2022 May 11. pii: S0264-410X(22)00535.
PubMed Abstract available

GUPTA C, Sachdeva A, Khamar J, Bu C, et al
Effectiveness of the influenza vaccine at reducing adverse events in patients with heart failure: A systematic review and meta-analysis.
Vaccine. 2022 May 10. pii: S0264-410X(22)00468.
PubMed Abstract available

KITRO A, Sirikul W, Thongkum W, Soponpong S, et al
Dynamic of anti-spike receptor binding domain (RBD) levels and short-term adverse events following a heterologous booster dose of BNT162b2 after two doses of CoronaVac in Thai health care workers.
Vaccine. 2022;40:2915-2924.
PubMed Abstract available

MARTIN J, Barrett ADT, Lei D, Minor P, et al
WHO working group meeting to amend WHO Recommendations to assure the quality, safety and efficacy of live attenuated yellow fever vaccines.
Vaccine. 2022 May 9. pii: S0264-410X(22)00548.
PubMed Abstract available

ZOLA MATUVANGA T, Lariviere Y, Lemey G, De Bie J, et al
Setting-up an Ebola vaccine trial in a remote area of the Democratic Republic of the Congo: Challenges, mitigations, and lessons learned.
Vaccine. 2022 May 9. pii: S0264-410X(22)00544.
PubMed Abstract available

YI S, Choe YJ, Lim DS, Lee HR, et al
Impact of national Covid-19 vaccination Campaign, South Korea.
Vaccine. 2022 May 8. pii: S0264-410X(22)00572.
PubMed Abstract available

BIFULCO M, Di Zazzo E, Pisanti S, Martini M, et al
The nineteenth-century experience of the kingdom of the two Sicilies on mandatory vaccination: An Italian phenomenon?
Vaccine. 2022 May 6. pii: S0264-410X(22)00492.
PubMed Abstract available

CROTHERS JW, Ross Colgate E, Cowan KJ, Dickson DM, et al
Corrigendum to "Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well-tolerated and augments a systemic immune response to all three poliovirus sero
Vaccine. 2022 May 6. pii: S0264-410X(22)00571.
PubMed

LUMBRERAS ARETA M, Valiton A, Diana A, Morales M, et al
Flu and pertussis vaccination during pregnancy in Geneva during the COVID-19 pandemic: A multicentric, prospective, survey-based study.
Vaccine. 2022 May 6. pii: S0264-410X(22)00533.
PubMed Abstract available

YU Y, Ma YL, Luo S, Wang S, et al
Prevalence and factors of influenza vaccination during the COVID-19 pandemic among university students in China.
Vaccine. 2022 May 5. pii: S0264-410X(22)00532.
PubMed Abstract available

COLE JW, Chen AMH, McGuire K, Berman S, et al
Erratum to "Motivational interviewing and vaccine acceptance in children: The MOTIVE study" [Vaccine 40(12) (2022) 1846-1854].
Vaccine. 2022 May 5. pii: S0264-410X(22)00538.
PubMed

VELICER C, Luxembourg A, Chen YT, Kohn M, et al
Using observational data to explore the hypothesis that a single dose of current HPV vaccines can provide durable protection.
Vaccine. 2022 May 5. pii: S0264-410X(22)00542.
PubMed

NAULT L, Marchitto L, Goyette G, Tremblay-Sher D, et al
Covid-19 vaccine immunogenicity in people living with HIV-1.
Vaccine. 2022 May 5. pii: S0264-410X(22)00543.
PubMed Abstract available

GASTEIGER N, Gasteiger C, Vedhara K, Broadbent E, et al
Characteristics associated with the willingness to receive a COVID-19 vaccine and an exploration of the general public's perceptions: A mixed-methods approach.
Vaccine. 2022 May 5. pii: S0264-410X(22)00547.
PubMed Abstract available

REES F, Geiger M, Lilleholt L, Zettler I, et al
Measuring parents' readiness to vaccinate themselves and their children against COVID-19.
Vaccine. 2022 May 5. pii: S0264-410X(22)00549.
PubMed Abstract available

LEIGH JP, Moss SJ, White TM, Picchio CA, et al
Factors affecting COVID-19 vaccine hesitancy among healthcare providers in 23 countries.
Vaccine. 2022 May 5. pii: S0264-410X(22)00545.
PubMed Abstract available

PERSSON U, Olofsson S, Althin R, Palmborg A, et al
Acceptance and application of a broad population health perspective when evaluating vaccine.
Vaccine. 2022 May 4. pii: S0264-410X(22)00425.
PubMed Abstract available

LIU W, Lien YH, Lee PI, Chan TC, et al
Impact of prior infection and repeated vaccination on post-vaccination antibody titers of the influenza A(H1N1)pdm09 strain in Taiwan schoolchildren: Implications for public health.
Vaccine. 2022 May 4. pii: S0264-410X(22)00358.
PubMed Abstract available

GUTIERREZ-TOBAR IF, Londono-Ruiz JP, Marino-Drews C, Beltran-Higuera S, et al
Epidemiological characteristics and serotype distribution of culture-confirmed pediatric pneumococcal pneumonia before and after PCV 10 introduction, a multicenter study in Bogota, Colombia, 2008-2019.
Vaccine. 2022;40:2875-2883.
PubMed Abstract available

BOTHUN LS, Feeder SE, Poland GA
Readability of COVID-19 vaccine information for the general public.
Vaccine. 2022 May 3. pii: S0264-410X(22)00546.
PubMed Abstract available

NANTANEE R, Aikphaibul P, Jaru-Ampornpan P, Sodsai P, et al
Immunogenicity and reactogenicity after booster dose with AZD1222 via intradermal route among adult who had received CoronaVac.
Vaccine. 2022 May 2. pii: S0264-410X(22)00521.
PubMed Abstract available

FEIKIN DR, Abu-Raddad LJ, Andrews N, Davies MA, et al
Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization.
Vaccine. 2022 May 2. pii: S0264-410X(22)00523.
PubMed Abstract available

April 2022

TOLL M, Li A
Vaccine mandates on childcare entry without conscientious objection exemptions: A quasi-experimental panel study.
Vaccine. 2022 Apr 29. pii: S0264-410X(22)00461.
PubMed Abstract available

GREYSON D, Carpiano RM, Bettinger JA
Support for a vaccination documentation mandate in British Columbia, Canada.
Vaccine. 2022 Apr 29. pii: S0264-410X(22)00247.
PubMed Abstract available

TAMURA K, Kohnoe M, Takashino A, Kobayashi K, et al
TAK - 021, an inactivated Enterovirus 71 vaccine candidate, provides cross-protection against heterologous sub-genogroups in human scavenger receptor B2 transgenic mice.
Vaccine. 2022 Apr 29. pii: S0264-410X(22)00518.
PubMed Abstract available

MASUDA T, Murakami K, Sugiura K, Sakui S, et al
Safety and immunogenicity of NVX-CoV2373 (TAK-019) vaccine in healthy Japanese adults: Interim report of a phase I/II randomized controlled trial.
Vaccine. 2022 Apr 29. pii: S0264-410X(22)00463.
PubMed Abstract available

HUSSAIN B, Latif A, Timmons S, Nkhoma K, et al
Overcoming COVID-19 vaccine hesitancy among ethnic minorities: A systematic review of UK studies.
Vaccine. 2022 Apr 28. pii: S0264-410X(22)00446.
PubMed Abstract available

DEMIR E, Dheir H, Safak S, Serra Artan A, et al
Differences in clinical outcomes of COVID-19 among vaccinated and unvaccinated kidney transplant recipients.
Vaccine. 2022 Apr 27. pii: S0264-410X(22)00519.
PubMed Abstract available

TAMURA K, Chang B, Shimbashi R, Watanabe H, et al
Dynamic changes in clinical characteristics and serotype distribution of invasive pneumococcal disease among adults in Japan after introduction of the pediatric 13-valent pneumococcal conjugate vaccine in 2013-2019.
Vaccine. 2022 Apr 27. pii: S0264-410X(22)00502.
PubMed Abstract available

NASREEN S, Calzavara A, Buchan SA, Thampi N, et al
Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance.
Vaccine. 2022 Apr 27. pii: S0264-410X(22)00520.
PubMed Abstract available

LV H, Wang S, Liang Z, Yu W, et al
Immunogenicity and safety of the 9-valent human papillomavirus vaccine in Chinese females 9-45 years of age: A phase 3 open-label study.
Vaccine. 2022 Apr 26. pii: S0264-410X(22)00205.
PubMed Abstract available

MARKOVITZ NH, Strome AL, Patel PK
Commentary: "The vaccine Selfie" and its influence on COVID-19 vaccine acceptance.
Vaccine. 2022 Apr 26. pii: S0264-410X(22)00503.
PubMed

JAFFLIN K, Deml MJ, Schwendener CL, Kiener L, et al
Parental and provider vaccine hesitancy and non-timely childhood vaccination in Switzerland.
Vaccine. 2022 Apr 26. pii: S0264-410X(22)00472.
PubMed Abstract available

KOULIDIATI JL, Kabore R, I Nebie E, Sidibe A, et al
Timely completion of childhood vaccination and its predictors in Burkina Faso.
Vaccine. 2022 Apr 26. pii: S0264-410X(22)00497.
PubMed Abstract available

MCCOSKER LK, El-Heneidy A, Seale H, Ware RS, et al
Strategies to improve vaccination rates in people who are homeless: A systematic review.
Vaccine. 2022 Apr 25. pii: S0264-410X(22)00436.
PubMed Abstract available

KRUPP K, Galea J, Madhivanan P, Gerald L, et al
Conversational artificial intelligence: A new approach for increasing influenza vaccination rates in children with asthma?
Vaccine. 2022 Apr 25. pii: S0264-410X(22)00496.
PubMed

YUKI Y, Nojima M, Kashima K, Sugiura K, et al
Oral MucoRice-CTB vaccine is safe and immunogenic in healthy US adults.
Vaccine. 2022 Apr 25. pii: S0264-410X(22)00491.
PubMed Abstract available

ZHU FC, Zeng H, Li JX, Wang B, et al
Evaluation of a recombinant five-antigen Staphylococcus aureus vaccine: The randomized, single-centre phase 1a/1b clinical trials.
Vaccine. 2022 Apr 23. pii: S0264-410X(22)00462.
PubMed Abstract available

PERCIACCANTE A, Asensi V, Cucu AI, Charlier P, et al
War, pandemic and vaccination - Upcoming health problems by the refugee wave in Europe?
Vaccine. 2022 Apr 23. pii: S0264-410X(22)00465.
PubMed

BEYER WEP, Palache AM, Boulfich M, Osterhaus ADME, et al
Clinical relevance of increased antibody titres in older adults upon vaccination with squalene-adjuvanted versus non-adjuvanted influenza vaccines.
Vaccine. 2022 Apr 23. pii: S0264-410X(22)00489.
PubMed Abstract available

STRECKENBACH B, Baldt J, Heidler F, Frahm N, et al
General vaccination willingness and current vaccination status in relation to clinical and psychological variables in patients with multiple sclerosis.
Vaccine. 2022 Apr 23. pii: S0264-410X(22)00428.
PubMed Abstract available

ONNIS V, Moriconi A, Paludi M, Giannini S, et al
Clinically proven specification setting for a meningococcal serogroup a conjugate vaccine.
Vaccine. 2022 Apr 23. pii: S0264-410X(22)00493.
PubMed Abstract available

ANTONOPOULOU T, Athanassakis I
SARS-CoV-2 immunogenicity: Is S protein the best target for vaccination?
Vaccine. 2022 Apr 22. pii: S0264-410X(22)00501.
PubMed

SHEA LL, Becker A, Lee BK, Miller KK, et al
Self-reported COVID-19 vaccination acceptance and hesitancy among autistic adults.
Vaccine. 2022 Apr 22. pii: S0264-410X(22)00500.
PubMed Abstract available

HAMID FA, Marker CL, Raleigh MD, Khaimraj A, et al
Pre-clinical safety and toxicology profile of a candidate vaccine to treat oxycodone use disorder.
Vaccine. 2022 Apr 22. pii: S0264-410X(22)00364.
PubMed Abstract available

SEPPALA E, Brathen Kristoffersen A, Boas H, Frimann Vestrheim D, et al
Pertussis epidemiology including direct and indirect effects of the childhood pertussis booster vaccinations, Norway, 1998-2019.
Vaccine. 2022 Apr 22. pii: S0264-410X(22)00466.
PubMed Abstract available

BEULENS C, Raven SFH, van Jaarsveld CHM, van Loo I, et al
Evaluation of a personalized, dose-sparing revaccination strategy in hepatitis B vaccine non-responders.
Vaccine. 2022 Apr 22. pii: S0264-410X(22)00470.
PubMed Abstract available

STALPERS CAL, Retmana IA, Pennings JLA, Vandebriel RJ, et al
Corrigendum to "Variability of in vivo potency tests of Diphtheria, Tetanus and acellular Pertussis (DTaP) vaccines" [Vaccine 39(18) (2021) 2506-2516].
Vaccine. 2022 Apr 22. pii: S0264-410X(22)00475.
PubMed

SALO H, Lehtonen T, Auranen K, Baum U, et al
Predictors of hospitalisation and death due to SARS-CoV-2 infection in Finland: A population-based register study with implications to vaccinations.
Vaccine. 2022 Apr 22. pii: S0264-410X(22)00495.
PubMed Abstract available

TAMANG ST, Dorji T
COVID-19 vaccinations in Bhutan - Mix-and-Match to Boosters: An experience.
Vaccine. 2022 Apr 22. pii: S0264-410X(22)00499.
PubMed Abstract available

ORTIZ JR, Spearman PW, Goepfert PA, Cross K, et al
Safety and immunogenicity of monovalent H7N9 influenza vaccine with AS03 adjuvant given sequentially or simultaneously with a seasonal influenza vaccine: A randomized clinical trial.
Vaccine. 2022 Apr 21. pii: S0264-410X(22)00366.
PubMed Abstract available

CAN G, Acar HC, Aydin SN, Balkan II, et al
Waning effectiveness of CoronaVac in real life: A retrospective cohort study in health care workers.
Vaccine. 2022;40:2574-2579.
PubMed Abstract available

LEBLANC JJ, ElSherif M, Ye L, MacKinnon-Cameron D, et al
Recalibrated estimates of non-bacteremic and bacteremic pneumococcal community acquired pneumonia in hospitalized Canadian adults from 2010 to 2017 with addition of an extended spectrum serotype-specific urine antigen detection assay.
Vaccine. 2022;40:2635-2646.
PubMed Abstract available

THOMPSON D, Metz SW, Abad C, Beaty S, et al
Immunological implications of diverse production approaches for Chikungunya virus-like particle vaccines.
Vaccine. 2022 Apr 19. pii: S0264-410X(22)00435.
PubMed Abstract available

GARTNER BC, Weinke T, Wahle K, Kwetkat A, et al
Importance and value of adjuvanted influenza vaccine in the care of older adults from a European perspective - A systematic review of recently published literature on real-world data.
Vaccine. 2022 Apr 19. pii: S0264-410X(22)00440.
PubMed Abstract available

LI L, Honda-Okubo Y, Baldwin J, Bowen R, et al
Covax-19/Spikogen(R) vaccine based on recombinant spike protein extracellular domain with Advax-CpG55.2 adjuvant provides single dose protection against SARS-CoV-2 infection in hamsters.
Vaccine. 2022 Apr 18. pii: S0264-410X(22)00469.
PubMed Abstract available

WANLAPAKORN N, Suntronwong N, Phowatthanasathian H, Yorsaeng R, et al
Immunogenicity of heterologous inactivated and adenoviral-vectored COVID-19 vaccine: Real-world data.
Vaccine. 2022 Apr 18. pii: S0264-410X(22)00471.
PubMed Abstract available

SAADE A, Cha L, Tadie E, Jurado B, et al
Delay between COVID-19 complete vaccination and SARS-CoV-2 infection among healthcare workers.
Vaccine. 2022 Apr 18. pii: S0264-410X(22)00473.
PubMed Abstract available

CHRISSIAN AA, Oyoyo UE, Patel P, Lawrence Beeson W, et al
Impact of COVID-19 vaccine-associated side effects on health care worker absenteeism and future booster vaccination.
Vaccine. 2022 Apr 18. pii: S0264-410X(22)00474.
PubMed Abstract available

XU S, Hong V, Sy LS, Glenn SC, et al
Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemic.
Vaccine. 2022 Apr 18. pii: S0264-410X(22)00464.
PubMed Abstract available

SINGH BK, Walker J, Paul P, Reddy S, et al
De-escalation of asymptomatic testing and potential of future COVID-19 outbreaks in US nursing homes amidst rising community vaccination coverage: A modeling study.
Vaccine. 2022 Apr 18. pii: S0264-410X(22)00467.
PubMed Abstract available

ANDERSON A
Attitudes towards vaccination and knowledge about antibiotics: Analysis of Wellcome Monitor survey data.
Vaccine. 2022 Apr 15. pii: S0264-410X(22)00429.
PubMed Abstract available

BAROUTSOU V, Wymann M, Zens K, Sinniger P, et al
National and regional variations in timely adherence to recommended measles vaccination scheme in 2-years old in Switzerland, 2005-2019.
Vaccine. 2022 Apr 15. pii: S0264-410X(22)00424.
PubMed Abstract available

KUSHNER T, Huang V, Janssen R
Safety and immunogenicity of HepB-CpG in women with documented pregnancies post-vaccination: A retrospective chart review.
Vaccine. 2022 Apr 13. pii: S0264-410X(22)00443.
PubMed Abstract available

FENOLLAR F, Thomas L, Raoult D, Gautret P, et al
Screening for SARS-CoV-2 antibodies to save vaccine doses.
Vaccine. 2022 Apr 12. pii: S0264-410X(22)00444.
PubMed

YAN Y, Naito T, Tabe Y, Ito K, et al
Increased delta variant SARS-CoV-2 infections in a highly vaccinated medical center in Japan.
Vaccine. 2022 Apr 12. pii: S0264-410X(22)00445.
PubMed Abstract available

BRAEYE T, Catteau L, Brondeel R, van Loenhout JAF, et al
Vaccine effectiveness against onward transmission of SARS-CoV2-infection by variant of concern and time since vaccination, Belgian contact tracing, 2021.
Vaccine. 2022 Apr 12. pii: S0264-410X(22)00441.
PubMed Abstract available

MORO PL, Olson CK, Clark E, Marquez P, et al
Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020 - October 2021.
Vaccine. 2022 Apr 12. pii: S0264-410X(22)00447.
PubMed Abstract available

ZHU XM, Yan W, Sun J, Liu L, et al
Patterns and influencing factors of COVID-19 vaccination willingness among college students in China.
Vaccine. 2022 Apr 11. pii: S0264-410X(22)00433.
PubMed Abstract available

SHINJOH M, Furuichi M, Kobayashi H, Yamaguchi Y, et al
Trends in effectiveness of inactivated influenza vaccine in children by age groups in seven seasons immediately before the COVID-19 era.
Vaccine. 2022 Apr 11. pii: S0264-410X(22)00449.
PubMed Abstract available

SPRINGER S, Kaatz M, Zieger M
Evaluation of weekly COVID-19 vaccination and case data supports negative correlation between incidence and vaccination in German federal states and cities during 4th wave.
Vaccine. 2022 Apr 11. pii: S0264-410X(22)00430.
PubMed Abstract available

CEYLAN ME, Onen Unsalver B, Donmez A, Kaya Yertutanol FD, et al
A case of myocarditis and isolated hypopotassemia after Biontech-Pfizer vaccine for Covid-19.
Vaccine. 2022 Apr 11. pii: S0264-410X(22)00432.
PubMed

LJUNG R, Feychting M, Burstrom B, Moller J, et al
Differences by region of birth in SARS-CoV-2 vaccine coverage and positive SARS-CoV-2 test among 400 000 healthcare workers and the general population in Sweden.
Vaccine. 2022 Apr 11. pii: S0264-410X(22)00431.
PubMed Abstract available

OKTARIA V, Bines JE, Murni IK, Dinari R, et al
Timeliness of routine childhood vaccinations in Indonesian infants in the first year of life.
Vaccine. 2022 Apr 11. pii: S0264-410X(22)00420.
PubMed Abstract available

BENINGER P
Need for a contingency dimension when planning vaccine development in a pandemic environment.
Vaccine. 2022 Apr 11. pii: S0264-410X(22)00401.
PubMed

PARK SJ, Kang YM, Cho HK, Kim DY, et al
Corrigendum to 'Cross-protective efficacy of inactivated whole influenza vaccines against Korean Y280 and Y439 lineage H9N2 viruses in mice' [Vaccine 39 (2021) 6213-6220].
Vaccine. 2022 Apr 9. pii: S0264-410X(22)00221.
PubMed

AINSLIE KEC, Riley S
Is annual vaccination best? A modelling study of influenza vaccination strategies in children.
Vaccine. 2022 Apr 8. pii: S0264-410X(22)00384.
PubMed Abstract available

TIANSHUO Z, Hanyu L, Bingfeng H, Bei L, et al
Evaluation of the reliability and validity of a vaccine hesitancy scale on knowledge, attitude, trust and vaccination environment (KATE-S) in Chinese parents.
Vaccine. 2022 Apr 8. pii: S0264-410X(22)00388.
PubMed Abstract available

MAYFIELD HJ, Lau CL, Sinclair JE, Brown SJ, et al
Designing an evidence-based Bayesian network for estimating the risk versus benefits of AstraZeneca COVID-19 vaccine.
Vaccine. 2022 Apr 8. pii: S0264-410X(22)00418.
PubMed Abstract available

BELDA F, Mora O, Lopez Martinez M, Torres N, et al
Seroconversion panels demonstrate anti-SARS-CoV-2 antibody development after administration of the mRNA-1273 vaccine.
Vaccine. 2022 Apr 8. pii: S0264-410X(22)00419.
PubMed Abstract available

ERFANI P, Sandoval RS, Rich KM, Ojo A, et al
Ask Me Anything": Lessons learned in implementing a COVID-19 vaccine information initiative in Massachusetts jails.
Vaccine. 2022 Apr 8. pii: S0264-410X(22)00439.
PubMed Abstract available

KENIGSBERG TA, Hause AM, McNeil MM, Nelson JC, et al
Dashboard development for near real-time visualization of COVID-19 vaccine safety surveillance data in the vaccine safety datalink.
Vaccine. 2022 Apr 8. pii: S0264-410X(22)00426.
PubMed Abstract available

LINKINS LA, Iorio A, Little J, Lavis J, et al
Extended reporting guidance for vaccine effectiveness studies for variants of concern for COVID-19.
Vaccine. 2022 Apr 7. pii: S0264-410X(22)00422.
PubMed

DE-LOS-RIOS-PINTO A, Fernandez-Guzman D, Soriano-Moreno DR, Sangster-Carrasco L, et al
Factors associated with the intention to participate in COVID-19 vaccine clinical trials: A cross-sectional study in Peru.
Vaccine. 2022 Apr 7. pii: S0264-410X(22)00421.
PubMed Abstract available

SHAH S, Gui H, Chua PEY, Tan JB, et al
Factors associated with COVID-19 vaccination intent in Singapore, Australia and Hong Kong.
Vaccine. 2022 Apr 5. pii: S0264-410X(22)00381.
PubMed Abstract available

HASSAN PM, Ali T, Saber E, Asghar A, et al
Potency, toxicity and protection evaluation of PastoCoAd candidate vaccines: Novel preclinical mix and match rAd5 S, rAd5 RBD-N and SOBERANA dimeric-RBD protein.
Vaccine. 2022 Apr 4. pii: S0264-410X(22)00385.
PubMed Abstract available

LEWIS RM, Markowitz LE
Disparities in human papillomavirus vaccination coverage in the United States, National Health and Nutrition Examination Survey, January 2017-March 2020.
Vaccine. 2022 Apr 4. pii: S0264-410X(22)00317.
PubMed Abstract available

WALTERS JN, Schouest B, Patel A, Reuschel EL, et al
Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates.
Vaccine. 2022 Apr 4. pii: S0264-410X(22)00368.
PubMed Abstract available

ENTRICAN G, Francis MJ
Applications of platform technologies in veterinary vaccinology and the benefits for one health.
Vaccine. 2022 Apr 2. pii: S0264-410X(22)00371.
PubMed Abstract available

FRISE R, Baillon L, Zhou J, Kugathasan R, et al
A self-amplifying RNA vaccine protects against SARS-CoV-2 (D614G) and Alpha variant of concern (B.1.1.7) in a transmission-challenge hamster model.
Vaccine. 2022 Apr 1. pii: S0264-410X(22)00383.
PubMed Abstract available

MA C, Sun W, Tang T, Jia M, et al
Effectiveness of adenovirus type 5 vectored and inactivated COVID-19 vaccines against symptomatic COVID-19, COVID-19 pneumonia, and severe COVID-19 caused by the B.1.617.2 (Delta) variant: Evidence from an outbreak in Yunnan, China, 2021.
Vaccine. 2022 Apr 1. pii: S0264-410X(22)00386.
PubMed Abstract available

SUGHAYER MA, Souan L, Abu Alhowr MM, Al Rimawi D, et al
Comparison of the effectiveness and duration of anti-RBD SARS-CoV-2 IgG antibody response between different types of vaccines: Implications for vaccine strategies.
Vaccine. 2022 Apr 1. pii: S0264-410X(22)00387.
PubMed Abstract available

March 2022

GERTOSIO C, Licari A, De Silvestri A, Rebuffi C, et al
Efficacy, immunogenicity, and safety of available vaccines in children on biologics: A systematic review and meta-analysis.
Vaccine. 2022 Mar 31. pii: S0264-410X(22)00341.
PubMed Abstract available

TEJADA RA, Malagon T, Franco EL
Cost-effectiveness of human papillomavirus vaccination in girls living in Latin American countries: A systematic review and meta-analysis.
Vaccine. 2022 Mar 31. pii: S0264-410X(22)00357.
PubMed Abstract available

VANDOORN E, Parys A, Chepkwony S, Chiers K, et al
Efficacy of the NS1-truncated live attenuated influenza virus vaccine for swine against infection with viruses of major North American and European H3N2 lineages.
Vaccine. 2022 Mar 30. pii: S0264-410X(22)00362.
PubMed Abstract available

BURNY W, Herve C, Caubet M, Yarzabal JP, et al
Utility of urinary cytokine levels as predictors of the immunogenicity and reactogenicity of AS01-adjuvanted hepatitis B vaccine in healthy adults.
Vaccine. 2022 Mar 30. pii: S0264-410X(22)00361.
PubMed Abstract available

CROTHERS JW, Ross Colgate E, Cowan KJ, Dickson DM, et al
Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well-tolerated and augments a systemic immune response to all three poliovirus serotypes in a rando
Vaccine. 2022 Mar 30. pii: S0264-410X(22)00367.
PubMed Abstract available

EFUA SACKEY M, Markey K, Grealish A
Healthcare professional's promotional strategies in improving Human papillomavirus (HPV) vaccination uptake in adolescents: A systematic review.
Vaccine. 2022 Mar 30. pii: S0264-410X(22)00365.
PubMed Abstract available

TADDIO A, Gudzak V, Jantzi M, Logeman C, et al
Impact of the CARD (Comfort Ask Relax Distract) system on school-based vaccinations: A cluster randomized trial.
Vaccine. 2022 Mar 29. pii: S0264-410X(22)00224.
PubMed Abstract available

MCRAE J, Blyth CC, Cheng AC, Quinn HE, et al
Preventing severe influenza in Australian infants: Maternal influenza vaccine effectiveness in the PAEDS-FluCAN networks using the test-negative design.
Vaccine. 2022 Mar 29. pii: S0264-410X(22)00353.
PubMed

ESTIVARIZ CF, Kovacs SD, Mach O
Review of use of inactivated poliovirus vaccine in campaigns to control type 2 circulating vaccine derived poliovirus (cVDPV) outbreaks.
Vaccine. 2022 Mar 29. pii: S0264-410X(22)00304.
PubMed Abstract available

ISITT C, Sjoholm D, Hergens MP, Granath F, et al
The early impact of vaccination against SARS-CoV-2 in Region Stockholm, Sweden.
Vaccine. 2022 Mar 29. pii: S0264-410X(22)00372.
PubMed Abstract available

KATO H, Miyakawa K, Ohtake N, Yamaoka Y, et al
Vaccine-induced humoral response against SARS-CoV-2 dramatically declined but cellular immunity possibly remained at 6 months post BNT162b2 vaccination.
Vaccine. 2022 Mar 29. pii: S0264-410X(22)00369.
PubMed Abstract available

LI K, Yu T, Seabury SA, Dor A, et al
Trends and disparities in the utilization of influenza vaccines among commercially insured US adults during the COVID-19 pandemic.
Vaccine. 2022 Mar 29. pii: S0264-410X(22)00370.
PubMed Abstract available

JUDDOO V, Juddoo S, Megarbane B
Erythema nodosum triggered by BNT162b2 mRNA COVID-19 vaccine.
Vaccine. 2022 Mar 28. pii: S0264-410X(22)00363.
PubMed

BREAKWELL L, Marke D, Kaiser R, Tejada-Strop A, et al
Assessing the impact of the routine childhood hepatitis B immunization program and the need for hepatitis B vaccine birth dose in Sierra Leone, 2018.
Vaccine. 2022 Mar 28. pii: S0264-410X(22)00360.
PubMed Abstract available

FUNK PR, Yogurtcu ON, Forshee RA, Anderson SA, et al
Benefit-risk assessment of COVID-19 vaccine, mRNA (Comirnaty) for age 16-29 years.
Vaccine. 2022 Mar 28. pii: S0264-410X(22)00329.
PubMed Abstract available

WELLS K, Moore KL, Bednarczyk R
Supporting immunization programs to address COVID-19 vaccine hesitancy: Recommendations for national and community-based stakeholders.
Vaccine. 2022 Mar 28. pii: S0264-410X(22)00339.
PubMed

RICKETSON LJ, Bettinger JA, Sadarangani M, Halperin SA, et al
Vaccine effectiveness of the 7-valent and 13-valent pneumococcal conjugate vaccines in Canada: An IMPACT study.
Vaccine. 2022 Mar 26. pii: S0264-410X(22)00359.
PubMed Abstract available

SIMMONS LA, Whipps MDM, Phipps JE, Satish NS, et al
Understanding COVID-19 vaccine uptake during pregnancy: 'Hesitance', knowledge, and evidence-based decision-making.
Vaccine. 2022 Mar 25. pii: S0264-410X(22)00355.
PubMed Abstract available

FARAH W, Breeher L, Shah V, Hainy C, et al
Disparities in COVID-19 vaccine uptake among health care workers.
Vaccine. 2022 Mar 25. pii: S0264-410X(22)00356.
PubMed Abstract available

NOMURA Y, Noda K, Oohashi Y, Okuda S, et al
Proposal for the revision of the guidelines for Non-clinical studies of vaccines for the prevention of infectious diseases in Japan.
Vaccine. 2022 Mar 24. pii: S0264-410X(22)00354.
PubMed Abstract available

NANTHAPISAL S, Puthanakit T, Jaru-Ampornpan P, Nantanee R, et al
A randomized clinical trial of a booster dose with low versus standard dose of AZD1222 in adult after 2 doses of inactivated vaccines.
Vaccine. 2022 Mar 24. pii: S0264-410X(22)00336.
PubMed Abstract available

ST JEAN DT, Rogawski McQuade ET, Edwards JK, Thompson P, et al
Effect of early life antibiotic use on serologic responses to oral rotavirus vaccine in the MAL-ED birth cohort study.
Vaccine. 2022 Mar 24. pii: S0264-410X(22)00300.
PubMed Abstract available

LEACH K, Checchi F
The utilisation of vaccines in humanitarian crises, 2015-2019: A review of practice.
Vaccine. 2022 Mar 24. pii: S0264-410X(22)00335.
PubMed Abstract available

VOORMAN A, Lyons H, Bennette C, Kovacs S, et al
Analysis of population immunity to poliovirus following cessation of trivalent oral polio vaccine.
Vaccine. 2022 Mar 23. pii: S0264-410X(22)00277.
PubMed Abstract available

LIU X, Yu W, Yin Z, Rodewald L, et al
Vaccine events raising public concern and associated immunization program policy and practice changes, China, 2005-2021.
Vaccine. 2022 Mar 23. pii: S0264-410X(22)00334.
PubMed Abstract available

ABDEL-QADER DH, Hazza Alkhatatbeh I, Hayajneh W, Annab H, et al
IgA nephropathy in a pediatric patient after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine.
Vaccine. 2022 Mar 23. pii: S0264-410X(22)00265.
PubMed

SNIDER CJ, Boualam L, Tallis G, Takashima Y, et al
Concurrent outbreaks of circulating vaccine-derived poliovirus types 1 and 2 affecting the Republic of the Philippines and Malaysia, 2019-2021.
Vaccine. 2022 Mar 22. pii: S0264-410X(22)00145.
PubMed Abstract available

MALTEZOU HC, Medic S, Cassimos DC, Effraimidou E, et al
Decreasing routine vaccination rates in children in the COVID-19 era.
Vaccine. 2022 Mar 22. pii: S0264-410X(22)00333.
PubMed

FANO V, Crielesi A, Coviello E, Fabiani M, et al
Effectiveness of the Comirnaty and the Vaxzevria vaccines in preventing SARS-CoV-2 infection among residents in Lazio region (Italy).
Vaccine. 2022 Mar 22. pii: S0264-410X(22)00208.
PubMed Abstract available

FERDINANDS JM, Patel M
Influence of disease attenuation on relative influenza vaccine effectiveness by vaccine type.
Vaccine. 2022 Mar 21. pii: S0264-410X(22)00274.
PubMed Abstract available

JIAN-BIN L, Lau EYH, Chan DKC
Why do Hong Kong parents have low intention to vaccinate their children against COVID-19? testing health belief model and theory of planned behavior in a large-scale survey.
Vaccine. 2022 Mar 21. pii: S0264-410X(22)00340.
PubMed Abstract available

YUEN WLP, Loh SYJ, Wang DB
SIRVA (Shoulder Injury Related to Vaccine Administration) following mRNA COVID-19 Vaccination: Case discussion and literature review.
Vaccine. 2022 Mar 21. pii: S0264-410X(22)00337.
PubMed Abstract available

ZERBO O, Modaressi S, Goddard K, Lewis E, et al
Safety of measles and pertussis-containing vaccines in children with autism spectrum disorders.
Vaccine. 2022 Mar 18. pii: S0264-410X(22)00331.
PubMed Abstract available

CALLAGHAN T, Washburn D, Goidel K, Nuzhath T, et al
Imperfect messengers? An analysis of vaccine confidence among primary care physicians.
Vaccine. 2022 Mar 18. pii: S0264-410X(22)00302.
PubMed Abstract available

ESPOSITO S, Nauta J, Lapini G, Montomoli E, et al
Efficacy and safety of a quadrivalent influenza vaccine in children aged 6-35 months: A global, multiseasonal, controlled, randomized Phase III study.
Vaccine. 2022 Mar 18. pii: S0264-410X(22)00263.
PubMed Abstract available

BILGIN H, Marku M, Yilmaz SS, Karahasan Yagci A, et al
The effect of immunization with inactivated SARS-CoV-2 vaccine (CoronaVac) and/or SARS-CoV-2 infection on antibody levels, plasmablasts, long-lived-plasma-cells, and IFN-gamma release by natural killer cells.
Vaccine. 2022 Mar 18. pii: S0264-410X(22)00264.
PubMed Abstract available

GRUHN S, Witte J, Greiner W, Damm O, et al
Epidemiology and economic burden of meningococcal disease in Germany: A systematic review.
Vaccine. 2022;40:1932-1947.
PubMed Abstract available

WANG H, Ypma E, Nicolay U
Managing multiplicity in clinical vaccine studies - A case study using a gatekeeping testing strategy.
Vaccine. 2022 Mar 17. pii: S0264-410X(22)00244.
PubMed Abstract available

GRAFFIGNA G, Palamenghi L, Barello S, Boccia S, et al
Erratum to ""Cultivating" acceptance of a COVID-19 vaccination program: Lessons from Italy" [Vaccine 38(48) (2020) 7585-7586].
Vaccine. 2022 Mar 17. pii: S0264-410X(22)00295.
PubMed

BATOOL R, Yousafzai MT, Qureshi S, Ali M, et al
Corrigendum to "Effectiveness of typhoid conjugate vaccine against culture-confirmed typhoid in a peri-urban setting in Karachi: A case-control study". [Vaccine 39 (2021) 5858-5865].
Vaccine. 2022 Mar 17. pii: S0264-410X(22)00294.
PubMed

MACKLIN G, Peak C, Eisenhawer M, Kurji F, et al
Enabling accelerated vaccine roll-out for Public Health Emergencies of International Concern (PHEICs): Novel Oral Polio Vaccine type 2 (nOPV2) experience.
Vaccine. 2022 Mar 17. pii: S0264-410X(22)00195.
PubMed Abstract available

SADIGH K, Fox G, Khetsuriani N, Gao H, et al
Policy and practice of checking vaccination status at school in 2018, a global overview.
Vaccine. 2022 Mar 17. pii: S0264-410X(22)00266.
PubMed Abstract available

GAO Z, Chen L, Song T, Pan X, et al
A candidate multi-epitope vaccine against porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae induces robust humoral and cellular response in mice.
Vaccine. 2022 Mar 17. pii: S0264-410X(22)00296.
PubMed Abstract available

GUL A, Doskaya M, Can H, Karakavuk M, et al
Immunogenicity of a xenogeneic multi-epitope HER2(+) breast cancer DNA vaccine targeting the dendritic cell restricted antigen-uptake receptor DEC205.
Vaccine. 2022 Mar 16. pii: S0264-410X(22)00279.
PubMed Abstract available

BEESLAAR J, Mather S, Absalon J, Eiden JJ, et al
Safety data from the MenB-FHbp clinical development program in healthy individuals aged 10 years and older.
Vaccine. 2022;40:1872-1878.
PubMed Abstract available

KHETSURIANI N, Zaika O, Slobodianyk L, Scobie HM, et al
Diphtheria and tetanus seroepidemiology among children in Ukraine, 2017.
Vaccine. 2022;40:1810-1820.
PubMed Abstract available

CAMARA J, Gonzalez-Diaz A, Barrabeig I, Fernandez-Huerta M, et al
SARS-CoV-2 outbreak in a nursing home after vaccination with BNT162b2: A role for the quantification of circulating antibodies.
Vaccine. 2022 Mar 15. pii: S0264-410X(22)00303.
PubMed Abstract available

ROTOLO B, Dube E, Vivion M, MacDonald SE, et al
Hesitancy towards COVID-19 vaccines on social media in Canada.
Vaccine. 2022 Mar 15. pii: S0264-410X(22)00301.
PubMed Abstract available

MOSCARDINO U, Musso P, Inguglia C, Ceccon C, et al
Sociodemographic and psychological correlates of COVID-19 vaccine hesitancy and resistance in the young adult population in Italy.
Vaccine. 2022 Mar 14. pii: S0264-410X(22)00293.
PubMed Abstract available

MORGA A, Kimura T, Feng Q, Rozario N, et al
Compliance to Advisory Committee on Immunization Practices recommendations for pneumococcal vaccination.
Vaccine. 2022 Mar 12. pii: S0264-410X(22)00269.
PubMed Abstract available

LAMORI J, Feng X, Pericone CD, Mesa-Frias M, et al
Real-world evidence on adherence and completion of the two-dose recombinant zoster vaccine and associated factors in U.S. adults, 2017-2021.
Vaccine. 2022 Mar 12. pii: S0264-410X(22)00268.
PubMed Abstract available

HUANG HJ, Yang M, Chen HW, Wang S, et al
A novel chimeric dengue vaccine candidate composed of consensus envelope protein domain III fused to C-terminal-modified NS1 protein.
Vaccine. 2022 Mar 11. pii: S0264-410X(22)00225.
PubMed Abstract available

GU YOON J, Jang AY, Ja Kim M, Bin Seo Y, et al
Persistent serotype 3 and 19A invasive pneumococcal diseases in adults in vaccine era: Serotype-dependent difference in ceftriaxone susceptibility.
Vaccine. 2022 Mar 10. pii: S0264-410X(22)00267.
PubMed Abstract available

KAKATSAKI I, Vergadi E, Paraskakis E, Galanakis E, et al
Attitudes of junior healthcare professionals towards mandatory vaccination.
Vaccine. 2022 Mar 10. pii: S0264-410X(22)00275.
PubMed Abstract available

HARUTYUNYAN V, Quddus A, Pallansch M, Zipursky S, et al
Global oral poliovirus vaccine stockpile management as an essential preparedness and response mechanism for type 2 poliovirus outbreaks following global oral poliovirus vaccine type 2 withdrawal.
Vaccine. 2022 Mar 10. pii: S0264-410X(22)00204.
PubMed Abstract available

VAN DEN HOOGEN LL, Smits G, van Hagen CCE, Wong D, et al
Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination?
Vaccine. 2022 Mar 9. pii: S0264-410X(22)00272.
PubMed Abstract available

THOMAS CM, Searle K, Galvan A, Liebman AK, et al
Healthcare worker perspectives on COVID-19 vaccines: Implications for increasing vaccine acceptance among healthcare workers and patients.
Vaccine. 2022 Mar 9. pii: S0264-410X(22)00276.
PubMed Abstract available

WILKINSON K, Righolt CH, Kwong JC, Schwartz KL, et al
Corrigendum to "A nested case-control study measuring pertussis vaccine effectiveness and duration of protection in Manitoba, Canada, 1992-2015: A Canadian Immunization Research Network Study" [Vaccine 37(48) (2019) 7132-7137].
Vaccine. 2022 Mar 7. pii: S0264-410X(22)00240.
PubMed

YUEN VWH
Political attitudes and efficacy of health expert communication on the support for COVID-19 vaccination program: Findings from a survey in Hong Kong.
Vaccine. 2022 Mar 7. pii: S0264-410X(22)00261.
PubMed Abstract available

BANSAL P, Raj A, Mani Shukla D, Sunder N, et al
COVID-19 vaccine preferences in India.
Vaccine. 2022 Mar 7. pii: S0264-410X(22)00241.
PubMed Abstract available

ULRICH AK, Sundaram ME, Basta NE
Supporting individual vaccine decision-making: A role for vaccination counselors.
Vaccine. 2022 Mar 4. pii: S0264-410X(22)00135.
PubMed

MASCHERINI M, Nivakoski S
Social media use and vaccine hesitancy in the European Union.
Vaccine. 2022 Mar 3. pii: S0264-410X(22)00206.
PubMed Abstract available

KLUMPP M, Monfared IG, Vollmer S
Public opinion on global distribution of COVID-19 vaccines: Evidence from two nationally representative surveys in Germany and the United States.
Vaccine. 2022 Mar 3. pii: S0264-410X(22)00259.
PubMed Abstract available

COULAUD PJ, Ablona A, Bolduc N, Fast D, et al
COVID-19 vaccine intention among young adults: Comparative results from a cross-sectional study in Canada and France.
Vaccine. 2022 Mar 3. pii: S0264-410X(22)00260.
PubMed Abstract available

ROBERTSON LJ, Price R, Moore JS, Curry G, et al
IgG antibody production and persistence to 6 months following SARS-CoV-2 vaccination: A Northern Ireland observational study.
Vaccine. 2022 Mar 3. pii: S0264-410X(22)00262.
PubMed Abstract available

KREPS SE, Kriner DL
How do COVID-19 vaccine mandates affect attitudes toward the vaccine and participation in mandate-affected activities? Evidence from the United States.
Vaccine. 2022 Mar 2. pii: S0264-410X(22)00258.
PubMed Abstract available

WONDIMU A, Postma MJ, van Hulst M
Cost-effectiveness analysis of quadrivalent and nonavalent human papillomavirus vaccines in Ethiopia.
Vaccine. 2022 Mar 2. pii: S0264-410X(22)00245.
PubMed Abstract available

YU M, Yao X, Liu G, Wu J, et al
Barriers and facilitators to uptake and promotion of influenza vaccination among health care workers in the community in Beijing, China: A qualitative study.
Vaccine. 2022 Mar 2. pii: S0264-410X(22)00207.
PubMed Abstract available

POINTON L, Howe AS, Hobbs M, Paynter J, et al
Evidence of suboptimal maternal vaccination coverage in pregnant New Zealand women and increasing inequity over time: A nationwide retrospective cohort study.
Vaccine. 2022 Mar 2. pii: S0264-410X(22)00243.
PubMed Abstract available

LAI FTT, Leung MTY, Chan EWW, Huang L, et al
Self-reported reactogenicity of CoronaVac (Sinovac) compared with Comirnaty (Pfizer-BioNTech): A prospective cohort study with intensive monitoring.
Vaccine. 2022;40:1390-1396.
PubMed Abstract available

DENNY L
HPV vaccine introduction and implementation in LMICs.
Vaccine. 2022 Mar 1. pii: S0264-410X(22)00227.
PubMed

GU J, Dor A, Li K, Broniatowski DA, et al
The impact of Facebook's vaccine misinformation policy on user endorsements of vaccine content: An interrupted time series analysis.
Vaccine. 2022 Mar 1. pii: S0264-410X(22)00209.
PubMed Abstract available

SEXSON TEJTEL SK, Munoz FM, Al-Ammouri I, Savorgnan F, et al
Myocarditis and pericarditis: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
Vaccine. 2022;40:1499-1511.
PubMed Abstract available

MOURA C, Truche P, Sousa Salgado L, Meireles T, et al
The impact of COVID-19 on routine pediatric vaccination delivery in Brazil.
Vaccine. 2022 Mar 1. pii: S0264-410X(22)00242.
PubMed Abstract available

February 2022

SINGH JA, Kochhar S, Wolff J, Atuire C, et al
WHO guidance on COVID-19 vaccine trial designs in the context of authorized COVID-19 vaccines and expanding global access: Ethical considerations.
Vaccine. 2022 Feb 28. pii: S0264-410X(22)00175.
PubMed Abstract available

MCANDREW T, Cambeiro J, Besiroglu T
Aggregating human judgment probabilistic predictions of the safety, efficacy, and timing of a COVID-19 vaccine.
Vaccine. 2022 Feb 28. pii: S0264-410X(22)00200.
PubMed Abstract available

LAU YL, Fan Leung T, Sirvan Cetin B, Cagri Dinleyici E, et al
Safety and reactogenicity of a liquid formulation of human rotavirus vaccine (porcine circovirus-free): A phase III, observer-blind, randomized, multi-country study.
Vaccine. 2022 Feb 26. pii: S0264-410X(22)00218.
PubMed Abstract available

SALIOU P, Duteil Q, Plotkin SA, Gentilini M, et al
The scourge of vaccine falsification.
Vaccine. 2022 Feb 26. pii: S0264-410X(22)00119.
PubMed Abstract available

SCHAFER W, Reinders T, Schink T
Second dose of measles-mumps-rubella-varicella vaccine (MMRV) and the risk of febrile convulsions.
Vaccine. 2022 Feb 26. pii: S0264-410X(22)00222.
PubMed Abstract available

DANIELS V, Saxena K, Patterson-Lomba O, Gomez-Lievano A, et al
Modeling the health and economic implications of adopting a 1-dose 9-valent human papillomavirus vaccination regimen in a high-income country setting: An analysis in the United Kingdom.
Vaccine. 2022 Feb 26. pii: S0264-410X(22)00220.
PubMed Abstract available

KAGEYAMA T, Tanaka S, Etori K, Hattori K, et al
Immunological features that associate with the strength of antibody responses to BNT162b2 mRNA vaccine against SARS-CoV-2.
Vaccine. 2022 Feb 25. pii: S0264-410X(22)00192.
PubMed Abstract available

MULLER KE, Dohos D, Sipos Z, Kiss S, et al
Immune response to influenza and pneumococcal vaccines in adults with inflammatory bowel disease: A systematic review and meta-analysis of 1429 patients.
Vaccine. 2022 Feb 25. pii: S0264-410X(22)00163.
PubMed Abstract available

MCGOLDRICK M, Gastineau T, Wilkinson D, Campa C, et al
How to accelerate the supply of vaccines to all populations worldwide? Part II: Initial industry lessons learned and detailed technical reflections leveraging the COVID-19 situation.
Vaccine. 2022;40:1223-1230.
PubMed Abstract available

MCGOLDRICK M, Gastineau T, Wilkinson D, Campa C, et al
How to accelerate the supply of vaccines to all populations worldwide? Part I: Initial industry lessons learned and practical overarching proposals leveraging the COVID-19 situation.
Vaccine. 2022;40:1215-1222.
PubMed Abstract available

DIXON MG, Tapia MD, Wannemuehler K, Luce R, et al
Measles susceptibility in maternal-infant dyads-Bamako, Mali.
Vaccine. 2022;40:1316-1322.
PubMed Abstract available

HAO F, Shao W
Understanding the influence of political orientation, social network, and economic recovery on COVID-19 vaccine uptake among Americans.
Vaccine. 2022 Feb 22. pii: S0264-410X(22)00219.
PubMed Abstract available

NIE J, Sun Y, Feng K, Huang L, et al
The efficient development of a novel recombinant adenovirus zoster vaccine perfusion production process.
Vaccine. 2022 Feb 22. pii: S0264-410X(22)00159.
PubMed Abstract available

EL-HENEIDY A, Grimwood K, Lambert SB, Sarna M, et al
Association between vaccination status, symptom identification and healthcare use: Implications for test negative design observational studies.
Vaccine. 2022 Feb 22. pii: S0264-410X(22)00198.
PubMed Abstract available

ABBATECOLA AM, Incalzi RA, Malara A, Palmieri A, et al
Monitoring COVID-19 vaccine use in Italian long term care centers: The GeroCovid VAX study.
Vaccine. 2022 Feb 22. pii: S0264-410X(22)00217.
PubMed Abstract available

CHOOI WH, Ng PW, Hussain Z, Ming LC, et al
Vaccine contamination: Causes and control.
Vaccine. 2022 Feb 21. pii: S0264-410X(22)00169.
PubMed

TAWINPRAI K, Siripongboonsitti T, Porntharukchareon T, Wittayasak K, et al
Immunogenicity and safety of an intradermal fractional third dose of ChAdOx1 nCoV-19/AZD1222 vaccine compared with those of a standard intramuscular third dose in volunteers who previously received two doses of CoronaVac: A randomized controlled trial
Vaccine. 2022 Feb 21. pii: S0264-410X(22)00143.
PubMed Abstract available

ISMAIL ALHOSANI F, Eduardo Stanciole A, Aden B, Timoshkin A, et al
Impact of the Sinopharm's BBIBP-CorV vaccine in preventing hospital admissions and death in infected vaccinees: Results from a retrospective study in the emirate of Abu Dhabi, United Arab Emirates (UAE).
Vaccine. 2022 Feb 19. pii: S0264-410X(22)00174.
PubMed Abstract available

FILIA A, Rota MC, Grossi A, Martinelli D, et al
Are vaccine shortages a relevant public health issue in Europe? Results from a survey conducted in the framework of the EU Joint Action on Vaccination.
Vaccine. 2022 Feb 19. pii: S0264-410X(22)00187.
PubMed Abstract available

WINTER T, Riordan BC, Scarf D, Jose PE, et al
Conspiracy beliefs and distrust of science predicts reluctance of vaccine uptake of politically right-wing citizens.
Vaccine. 2022 Feb 18. pii: S0264-410X(22)00074.
PubMed Abstract available

STANDAERT B, Strens D, Raes M, Benninghoff B, et al
Explaining the formation of a plateau in rotavirus vaccine impact on rotavirus hospitalisations in Belgium.
Vaccine. 2022 Feb 18. pii: S0264-410X(22)00199.
PubMed Abstract available

LEE GY, Inthasorn P, Laowahutanont P, Lawpoolsri S, et al
Long-term effectiveness of human papillomavirus vaccines among adult women: A real-world scenario.
Vaccine. 2022 Feb 18. pii: S0264-410X(22)00188.
PubMed Abstract available

SCHMALING KB
Couples and COVID-19 vaccination: Frequency and reasons for discordance.
Vaccine. 2022 Feb 18. pii: S0264-410X(22)00202.
PubMed Abstract available

TRUMP BD, Golan MS, Keisler JM, Cegan JC, et al
Vaccine supply chain: Resilience-by-design and resilience-by-intervention.
Vaccine. 2022 Feb 17. pii: S0264-410X(22)00172.
PubMed

HENSCHKE N, Bergman H, Hungerford D, Cunliffe NA, et al
The efficacy and safety of rotavirus vaccines in countries in Africa and Asia with high child mortality.
Vaccine. 2022 Feb 17. pii: S0264-410X(22)00125.
PubMed Abstract available

KASSTAN B, Mounier-Jack S, Letley L, Gaskell KM, et al
Localising vaccination services: Qualitative insights on public health and minority group collaborations to co-deliver coronavirus vaccines.
Vaccine. 2022 Feb 17. pii: S0264-410X(22)00201.
PubMed Abstract available

MERKLEY E, Loewen PJ
The correlates and dynamics of COVID-19 vaccine-specific hesitancy.
Vaccine. 2022 Feb 17. pii: S0264-410X(22)00168.
PubMed Abstract available

LAZO L, Bequet-Romero M, Lemos G, Musacchio A, et al
A recombinant SARS-CoV-2 receptor-binding domain expressed in an engineered fungal strain of Thermothelomyces heterothallica induces a functional immune response in mice.
Vaccine. 2022;40:1162-1169.
PubMed Abstract available

JOG P, Memon IA, Thisyakorn U, Hozbor D, et al
Pertussis in Asia: Recent country-specific data and recommendations.
Vaccine. 2022;40:1170-1179.
PubMed Abstract available

STEFANIZZI P, Larocca AMV, Martinelli A, Soldano S, et al
Immune response to one dose of BNT162b2 mRNA Covid-19 vaccine followed by SARS-CoV-2 infection: An Italian prospective observational study.
Vaccine. 2022 Feb 16. pii: S0264-410X(22)00124.
PubMed Abstract available

KALASKA B, Miklosz J, Swieton J, Jakimczuk A, et al
The effect of ChAdOx1 nCov-19 vaccine on arterial thrombosis development and platelet aggregation in female rats.
Vaccine. 2022 Feb 16. pii: S0264-410X(22)00173.
PubMed Abstract available

BUCKLEY A, Lager K
Efficacy of an inactivated Senecavirus A vaccine in weaned pigs and mature sows.
Vaccine. 2022 Feb 16. pii: S0264-410X(22)00142.
PubMed Abstract available

ANUGULRUENGKITT S, Angsuwatcharakon P, Puthanakit T, Bunjoungmanee P, et al
Seroprevalence of mumps among children and adolescents in Thailand, 2020.
Vaccine. 2022;40:1061-1064.
PubMed Abstract available

HUSKA B, Kubinec C, Sadarangani M, Ulanova M, et al
Seroprevalence of IgG and IgM antibodies to Haemophilus influenzae type a in Canadian children.
Vaccine. 2022;40:1128-1134.
PubMed Abstract available

ARAKELIAN T, Oosterhuis K, Tondini E, Los M, et al
Pyroptosis-inducing active caspase-1 as a genetic adjuvant in anti-cancer DNA vaccination.
Vaccine. 2022 Feb 15. pii: S0264-410X(22)00162.
PubMed Abstract available

SALEH OA, Halperin O
Influenza virus vaccine compliance among pregnant women during the COVID-19 pandemic (pre-vaccine era) in Israel and future intention to uptake BNT162b2 mRNA COVID-19 vaccine.
Vaccine. 2022 Feb 15. pii: S0264-410X(22)00160.
PubMed Abstract available

HIDLE A, Brennan T, Garon J, An Q, et al
Cost of human papillomavirus vaccine delivery at district and health facility levels in Zimbabwe: A school-based vaccination program targeting multiple cohorts.
Vaccine. 2022 Feb 15. pii: S0264-410X(22)00047.
PubMed Abstract available

QUITIAN LM, Rodriguez-Martinez CE, Sossa-Briceno MP, Cortes JA, et al
Disease burden and vaccination priorities in Colombia.
Vaccine. 2022 Feb 15. pii: S0264-410X(22)00029.
PubMed Abstract available

TANI N, Chong Y, Kurata Y, Gondo K, et al
Relation of fever intensity and antipyretic use with specific antibody response after two doses of the BNT162b2 mRNA vaccine.
Vaccine. 2022 Feb 14. pii: S0264-410X(22)00158.
PubMed Abstract available

AMMETER T, Lang P, Czock A
Overview of the influenza vaccination activities and legal frameworks in 26 Swiss cantons during the influenza season 2019/20.
Vaccine. 2022 Feb 14. pii: S0264-410X(22)00132.
PubMed Abstract available

MUCHIRI SK, Muthee R, Kiarie H, Sitienei J, et al
Unmet need for COVID-19 vaccination coverage in Kenya.
Vaccine. 2022 Feb 14. pii: S0264-410X(22)00167.
PubMed Abstract available

GAFFNEY KK, Jana Broadhurst M, Brett-Major DM
Mumps to COVID-19: Vaccinated persons remain vulnerable when community uptake is low.
Vaccine. 2022 Feb 14. pii: S0264-410X(22)00193.
PubMed Abstract available

YAMAMOTO S, Fukunaga A, Tanaka A, Takeuchi JS, et al
Association between reactogenicity and SARS-CoV-2 antibodies after the second dose of the BNT162b2 COVID-19 vaccine.
Vaccine. 2022 Feb 14. pii: S0264-410X(22)00196.
PubMed Abstract available

UWAMINO Y, Yokoyama T, Shimura T, Nishimura T, et al
The effect of the E484K mutation of SARS-CoV-2 on the neutralizing activity of antibodies from BNT162b2 vaccinated individuals.
Vaccine. 2022 Feb 14. pii: S0264-410X(22)00191.
PubMed Abstract available

GAO F, An C, Bian L, Wang Y, et al
Establishment of the first Chinese national standard for protein subunit SARS-CoV-2 vaccine.
Vaccine. 2022 Feb 14. pii: S0264-410X(22)00194.
PubMed Abstract available

CHAN IL, Mowson R, Alonso JP, Roberti J, et al
Promoting immunization equity in Latin America and the Caribbean: Case studies, lessons learned, and their implication for COVID-19 vaccine equity.
Vaccine. 2022 Feb 14. pii: S0264-410X(22)00197.
PubMed Abstract available

CHRYSI P, Stella M, Marios K, Despo C, et al
Exploring vaccination coverage and attitudes of health care workers towards influenza vaccine in Cyprus.
Vaccine. 2022 Feb 12. pii: S0264-410X(22)00141.
PubMed Abstract available

HELLER O, Chun Y, Shlomo Y, Gewirtz-Meydan A, et al
Public perceptions and the willingness to get vaccinated against COVID-19: Lessons from Israel.
Vaccine. 2022 Feb 11. pii: S0264-410X(22)00165.
PubMed Abstract available

KOCHHAR S, Barreira D, Beattie P, Cavaleri M, et al
Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test case.
Vaccine. 2022 Feb 11. pii: S0264-410X(21)01395.
PubMed Abstract available

DIETRICH LG, Luthy A, Lucas Ramanathan P, Baldesberger N, et al
Healthcare professional and professional stakeholders' perspectives on vaccine mandates in Switzerland: A mixed-methods study.
Vaccine. 2022 Feb 11. pii: S0264-410X(22)00007.
PubMed Abstract available

TIBBELS NJ, Dosso A, Fordham C, Benie W, et al
"On the last day of the last month, I will go": A qualitative exploration of COVID-19 vaccine confidence among Ivoirian adults.
Vaccine. 2022 Feb 11. pii: S0264-410X(22)00166.
PubMed Abstract available

KAPLONEK P, Yao L, Reppe K, Voss F, et al
A semisynthetic glycoconjugate provides expanded cross-serotype protection against Streptococcus pneumoniae.
Vaccine. 2022;40:1038-1046.
PubMed Abstract available

ABHILASH KPP, Mathiyalagan P, Krishnaraj VRK, Selvan S, et al
Impact of prior vaccination with Covishield(TM) and Covaxin(R) on mortality among symptomatic COVID-19 patients during the second wave of the pandemic in South India during April and May 2021: a cohort study.
Vaccine. 2022 Feb 10. pii: S0264-410X(22)00157.
PubMed Abstract available

DEBELLUT F, Mkisi R, Masoo V, Chisema M, et al
Projecting the cost of introducing typhoid conjugate vaccine (TCV) in the national immunization program in Malawi using a standardized costing framework.
Vaccine. 2022 Feb 10. pii: S0264-410X(22)00139.
PubMed Abstract available

COLE JW, M H Chen A, McGuire K, Berman S, et al
Motivational interviewing and vaccine acceptance in children: The MOTIVE study.
Vaccine. 2022 Feb 10. pii: S0264-410X(22)00114.
PubMed Abstract available

PAOLINO KM, Regules JA, Moon JE, Ruck RC, et al
Safety and immunogenicity of a plant-derived recombinant protective antigen (rPA)-based vaccine against Bacillus anthracis: A Phase 1 dose-escalation study in healthy adults.
Vaccine. 2022 Feb 10. pii: S0264-410X(22)00093.
PubMed Abstract available

BERGMANN ESTEVES S, Moreira Santos C, Ferreira Salgado F, Paldes Goncales A, et al
Efficacy of commercially available vaccines against canine leptospirosis: A systematic review and meta-analysis.
Vaccine. 2022 Feb 10. pii: S0264-410X(22)00144.
PubMed Abstract available

DREYER N, Reynolds MW, Albert L, Brinkley E, et al
How frequent are acute reactions to COVID-19 vaccination and who is at risk?
Vaccine. 2022 Feb 9. pii: S0264-410X(22)00103.
PubMed Abstract available

PRAMOD S, Govindan D, Ramasubramani P, Kar SS, et al
Effectiveness of Covishield vaccine in preventing Covid-19 - A test-negative case-control study.
Vaccine. 2022 Feb 9. pii: S0264-410X(22)00138.
PubMed Abstract available

DE LUCA C, Schachner A, Heidl S, Hess M, et al
Vaccination with a fowl adenovirus chimeric fiber protein (crecFib-4/11) simultaneously protects chickens against hepatitis-hydropericardium syndrome (HHS) and inclusion body hepatitis (IBH).
Vaccine. 2022 Feb 9. pii: S0264-410X(22)00116.
PubMed Abstract available

SCHALTZ-BUCHHOLZER F, Toldi G
The association between parental and neonatal BCG vaccination and neonatal T helper 17 cell expansion.
Vaccine. 2022 Feb 9. pii: S0264-410X(22)00128.
PubMed Abstract available

CARLOW DA, Lai JCY, Kollmann TR, Sadarangani M, et al
Cutaneous CpG adjuvant conditioning to enhance vaccine responses.
Vaccine. 2022 Feb 8. pii: S0264-410X(21)01668.
PubMed Abstract available

MASUDA T, Murakami K, Sugiura K, Sakui S, et al
A phase 1/2 randomised placebo-controlled study of the COVID-19 vaccine mRNA-1273 in healthy Japanese adults: An interim report.
Vaccine. 2022 Feb 8. pii: S0264-410X(22)00164.
PubMed Abstract available

PEREZ-RODRIGUEZ S, de la Caridad Rodriguez-Gonzalez M, Ochoa-Azze R, Climent-Ruiz Y, et al
A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: Safety, reactogenicity and immunogenicity.
Vaccine. 2022 Feb 8. pii: S0264-410X(22)00161.
PubMed Abstract available

LADHANI SN, Campbell H, Amin-Chowdhury Z, Lucidarme J, et al
Timing of meningococcal vaccination with 4CMenB (Bexsero(R)) in children with invasive meningococcal group B (MenB) disease in England.
Vaccine. 2022 Feb 8. pii: S0264-410X(21)01618.
PubMed Abstract available

CORNISH MJ, Hedrick JA, Gabrielsen AA, Johnson AD, et al
Safety and immunogenicity of an investigational quadrivalent meningococcal tetanus toxoid conjugate vaccine (MenACYW-TT) co-administered with routine pediatric vaccines in infants and toddlers: A Phase II study.
Vaccine. 2022 Feb 7. pii: S0264-410X(22)00096.
PubMed Abstract available

DENG JZ, Lancaster C, Winters MA, Phillips KM, et al
Multi-attribute characterization of pneumococcal conjugate vaccine by Size-exclusion chromatography coupled with UV-MALS-RI detections.
Vaccine. 2022 Feb 7. pii: S0264-410X(22)00076.
PubMed Abstract available

WALKER B, Anderson A, Stoecker C, Shao Y, et al
COVID-19 and Routine Childhood and Adolescent Immunizations: Evidence from Louisiana Medicaid.
Vaccine. 2022;40:837-840.
PubMed Abstract available

CRUVINEL E, P Richter K, S Scheuermann T, M Machado N, et al
The impact of COVID-19 on income and employment and willingness to become vaccinated among African Americans enrolled in a smoking cessation randomized trial.
Vaccine. 2022 Feb 7. pii: S0264-410X(22)00120.
PubMed Abstract available

MEWHIRTER J, Sagir M, Sanders R
Towards a predictive model of COVID-19 vaccine hesitancy among American adults.
Vaccine. 2022 Feb 7. pii: S0264-410X(22)00134.
PubMed Abstract available

DOMNICH A, Orsi A, Sticchi L, Panatto D, et al
Effect of the 2020/21 season influenza vaccine on SARS-CoV-2 infection in a cohort of Italian healthcare workers.
Vaccine. 2022 Feb 7. pii: S0264-410X(22)00137.
PubMed Abstract available

BELLOS I, Karageorgiou V, Viskin D
Myocarditis following mRNA Covid-19 vaccination: A pooled analysis.
Vaccine. 2022 Feb 7. pii: S0264-410X(22)00140.
PubMed Abstract available

SPRENGHOLZ P, Korn L, Eitze S, Felgendreff L, et al
Attitude toward a mandatory COVID-19 vaccination policy and its determinants: Evidence from serial cross-sectional surveys conducted throughout the pandemic in Germany.
Vaccine. 2022 Feb 7. pii: S0264-410X(22)00130.
PubMed Abstract available

WONODI C, Obi-Jeff C, Adewumi F, Keluo-Udeke SC, et al
Conspiracy theories and misinformation about COVID-19 in Nigeria: Implications for vaccine demand generation communications.
Vaccine. 2022 Feb 7. pii: S0264-410X(22)00126.
PubMed Abstract available

WALKER J, Paul P, Dooling K, Oliver S, et al
Modeling strategies for the allocation of SARS-CoV-2 vaccines in the United States.
Vaccine. 2022 Feb 7. pii: S0264-410X(22)00136.
PubMed Abstract available

HU S, Logan N, Puenpa J, Wanlapakorn N, et al
Evaluation of the effect of maternally derived antibody on response to MMR vaccine in Thai infants.
Vaccine. 2022 Feb 5. pii: S0264-410X(22)00095.
PubMed Abstract available

AKGUN O, Kayaalp GK, Demirkan FG, Cakmak F, et al
Exploring the attitudes, concerns, and knowledge regarding COVID-19 vaccine by the parents of children with rheumatic disease: Cross-sectional online survey.
Vaccine. 2022 Feb 4. pii: S0264-410X(22)00117.
PubMed Abstract available

NONVIGNON J, Owusu R, Asare B, Adjagba A, et al
Estimating the cost of COVID-19 vaccine deployment and introduction in Ghana using the CVIC tool.
Vaccine. 2022 Feb 4. pii: S0264-410X(22)00070.
PubMed Abstract available

OLIANI F, Savoia A, Gallo G, Tiwana N, et al
Italy's rollout of COVID-19 vaccinations: The crucial contribution of the first experimental mass vaccination site in Lombardy.
Vaccine. 2022 Feb 3. pii: S0264-410X(22)00115.
PubMed Abstract available

GORSE GJ, Grimes S, Buck H, Mulla H, et al
MAS-1, a novel water-in-oil adjuvant/delivery system, with reduced seasonal influenza vaccine hemagglutinin dose may enhance potency, durability and cross-reactivity of antibody responses in the elderly.
Vaccine. 2022 Feb 3. pii: S0264-410X(22)00059.
PubMed Abstract available

IRVING SA, Groom HC, Dandamudi P, Daley MF, et al
A decade of data: Adolescent vaccination in the vaccine safety datalink, 2007 through 2016.
Vaccine. 2022 Feb 3. pii: S0264-410X(22)00091.
PubMed Abstract available

TAKESHITA K, Ishiwada N, Takeuchi N, Ohkusu M, et al
Immunogenicity and safety of routine 13-valent pneumococcal conjugate vaccination outside recommended age range in patients with hematological malignancies and solid tumors.
Vaccine. 2022 Feb 3. pii: S0264-410X(22)00102.
PubMed Abstract available

GORSE GJ, Grimes S, Buck H, Mulla H, et al
A phase 1 dose-sparing, randomized clinical trial of seasonal trivalent inactivated influenza vaccine combined with MAS-1, a novel water-in-oil adjuvant/delivery system.
Vaccine. 2022 Feb 3. pii: S0264-410X(22)00058.
PubMed Abstract available

ELLITHORPE ME, Alade F, Adams RB, Nowak GJ, et al
Looking ahead: Caregivers' COVID-19 vaccination intention for children 5 years old and younger using the health belief model.
Vaccine. 2022 Feb 1. pii: S0264-410X(22)00097.
PubMed Abstract available

HEYERDAHL LW, Vray M, Lana B, Tvardik N, et al
Conditionality of COVID-19 vaccine acceptance in European countries.
Vaccine. 2022 Feb 1. pii: S0264-410X(22)00099.
PubMed Abstract available

SHAW J, Anderson KB, Fabi RE, Thompson CA, et al
COVID-19 vaccination intention and behavior in a large, diverse, U.S. refugee population.
Vaccine. 2022 Feb 1. pii: S0264-410X(22)00100.
PubMed Abstract available

YOUSAF M, Hassan Raza S, Mahmood N, Core R, et al
Immunity debt or vaccination crisis? A multi-method evidence on vaccine acceptance and media framing for emerging COVID-19 variants.
Vaccine. 2022 Feb 1. pii: S0264-410X(22)00101.
PubMed Abstract available

January 2022

YANG YL, Kim J, Jeong Y, Jang YS, et al
Intranasal immunization with a Middle East respiratory syndrome-coronavirus antigen conjugated to the M-cell targeting ligand Co4B enhances antigen-specific mucosal and systemic immunity and protects against infection.
Vaccine. 2022;40:714-725.
PubMed Abstract available

JANSSEN YF, Feitsma EA, Boersma HH, Alleva DG, et al
Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452.
Vaccine. 2022 Jan 31. pii: S0264-410X(22)00077.
PubMed Abstract available

PANWAR K, Godi A, Cocuzza CE, Andrews N, et al
Binding antibody levels to vaccine (HPV6/11/16/18) and non-vaccine (HPV31/33/45/52/58) HPV antigens up to 7 years following immunization with either Cervarix(R) or Gardasil(R) vaccine.
Vaccine. 2022 Jan 31. pii: S0264-410X(22)00075.
PubMed Abstract available

SANDMANN FG, van Leeuwen E, Bernard-Stoecklin S, Casado I, et al
Health and economic impact of seasonal influenza mass vaccination strategies in European settings: A mathematical modelling and cost-effectiveness analysis.
Vaccine. 2022 Jan 31. pii: S0264-410X(22)00039.
PubMed Abstract available

PITTET LF, Cox L, Freyne B, Germano S, et al
Hepatitis B vaccine co-administration influences the heterologous effects of neonatal BCG vaccination in a sex-differential manner.
Vaccine. 2022 Jan 29. pii: S0264-410X(22)00020.
PubMed Abstract available

MORGAN C, Giattas MR, Holroyd T, Pfitzer A, et al
Integration of other services with human papillomavirus vaccination; lessons from earlier in the life course highlight the need for new policy and implementation evidence.
Vaccine. 2022 Jan 29. pii: S0264-410X(21)01674.
PubMed Abstract available

SHERIDAN S, McIntyre P, Liu B, Fathima P, et al
Pertussis burden and acellular pertussis vaccine effectiveness in high risk children.
Vaccine. 2022 Jan 28. pii: S0264-410X(21)01322.
PubMed Abstract available

MSUSA KP, Rogalski-Salter T, Mandi H, Clemens R, et al
Critical success factors for conducting human challenge trials for vaccine development in low- and middle-income countries.
Vaccine. 2022 Jan 28. pii: S0264-410X(22)00072.
PubMed Abstract available

KANTELE A, Rombo L, Vene S, Kundi M, et al
Three-dose versus four-dose primary schedules for tick-borne encephalitis (TBE) vaccine FSME-immun for those aged 50 years or older: A single-centre, open-label, randomized controlled trial.
Vaccine. 2022 Jan 28. pii: S0264-410X(22)00048.
PubMed Abstract available

KALNIN KV, Plitnik T, Kishko M, Huang D, et al
Pan-SARS neutralizing responses after third boost vaccination in non-human primate immunogenicity model.
Vaccine. 2022 Jan 28. pii: S0264-410X(22)00045.
PubMed Abstract available

WHITE AA, Neelon B, Martin RH, Cartmell KB, et al
Spatial patterns of HPV and Tdap vaccine dose administration and the association of health department clinic access in Georgia counties.
Vaccine. 2022 Jan 28. pii: S0264-410X(21)01647.
PubMed Abstract available

DING H, Huang J, Ngai CH, Sun Q, et al
The cost-effectiveness of starting 23-valent pneumococcal polysaccharide vaccine and influenza vaccination at 50 vs. 65 years: A comparative modelling study.
Vaccine. 2022 Jan 28. pii: S0264-410X(22)00057.
PubMed Abstract available

STEPPERT P, Mosor M, Stanek L, Burgstaller D, et al
A scalable, integrated downstream process for production of a recombinant measles virus-vectored vaccine.
Vaccine. 2022 Jan 27. pii: S0264-410X(22)00019.
PubMed Abstract available

HE Q, Xiao J, Liu M, Li Z, et al
Immunogenicity of meningococcal polysaccharide conjugate vaccine as a replacement for meningococcal polysaccharide vaccine in children in Guangzhou, China.
Vaccine. 2022 Jan 27. pii: S0264-410X(21)01200.
PubMed Abstract available

JAFFE AE, Graupensperger S, Blayney JA, Duckworth JC, et al
The role of perceived social norms in college student vaccine hesitancy: Implications for COVID-19 prevention strategies.
Vaccine. 2022 Jan 26. pii: S0264-410X(22)00073.
PubMed Abstract available

KARAFILLAKIS E, Peretti-Watel P, Verger P, Chantler T, et al
'I trust them because my mum trusts them': Exploring the role of trust in HPV vaccination decision-making among adolescent girls and their mothers in France.
Vaccine. 2022 Jan 25. pii: S0264-410X(22)00046.
PubMed Abstract available

IANNINO F, Uriza PJ, Duarte CM, Pepe MV, et al
Development of a Salmonella-based oral vaccine to control intestinal colonization of Shiga-toxin-producing Escherichia coli (STEC) in animals.
Vaccine. 2022 Jan 24. pii: S0264-410X(22)00056.
PubMed Abstract available

OGUTI B, Ali A, Andrews N, Barug D, et al
The half-life of maternal transplacental antibodies against diphtheria, tetanus, and pertussis in infants: an individual participant data meta-analysis.
Vaccine. 2022;40:450-458.
PubMed Abstract available

ZINTGRAFF J, Gagetti P, Napoli D, Sanchez Eluchans N, et al
Invasive Streptococcus pneumoniae isolates from pediatric population in Argentina for the period 2006-2019. Temporal progression of serotypes distribution and antibiotic resistance.
Vaccine. 2022;40:459-470.
PubMed Abstract available

BLUNCK BN, Aideyan L, Ye X, Avadhanula V, et al
Antibody responses of healthy adults to the p27 peptide of respiratory syncytial virus fusion protein.
Vaccine. 2022;40:536-543.
PubMed Abstract available

KIMOTO T
Development of a safe and effective novel synthetic mucosal adjuvant SF-10 derived from physiological metabolic pathways and function of human pulmonary surfactant.
Vaccine. 2022;40:544-553.
PubMed Abstract available

TANGUAY M, Boutin M, Laumaea A, Salaciak M, et al
B-cell cytopenia and time to last B-cell-depleting therapy predict response to SARS-COV-2 vaccines in patients with lymphoproliferative disorders.
Vaccine. 2022 Jan 24. pii: S0264-410X(22)00071.
PubMed Abstract available

TRICOU V, Gottardo R, Egan MA, Clement F, et al
Characterization of the cell-mediated immune response to Takeda's live-attenuated tetravalent dengue vaccine in adolescents participating in a phase 2 randomized controlled trial conducted in a dengue-endemic setting.
Vaccine. 2022 Jan 22. pii: S0264-410X(22)00040.
PubMed Abstract available

HIDALGO-RUIZ M, Mejia-Lopez S, Perez-Serrano RM, Zaldivar-Lelo de Larrea G, et al
Babesia bovis AMA-1, MSA-2c and RAP-1 contain conserved B and T-cell epitopes, which generate neutralizing antibodies and a long-lasting Th1 immune response in vaccinated cattle.
Vaccine. 2022 Jan 22. pii: S0264-410X(22)00049.
PubMed Abstract available

GHASWALLA PK, Bengtson LGS, Marshall GS, Buikema AR, et al
Corrigendum to 'Meningococcal vaccination in patients with newly diagnosed asplenia in the United States' [Vaccine 39 (2021) 272-281].
Vaccine. 2022 Jan 22. pii: S0264-410X(21)00994.
PubMed

TRENT MJ, Salmon DA, MacIntyre CR
Predictors of pneumococcal vaccination among Australian adults at high risk of pneumococcal disease.
Vaccine. 2022 Jan 22. pii: S0264-410X(22)00026.
PubMed Abstract available

STEBBINGS R, Armour G, Pettis V, Goodman J, et al
AZD1222 (ChAdOx1 nCov-19): A Single-Dose biodistribution study in mice.
Vaccine. 2022;40:192-195.
PubMed Abstract available

DRAZAN D, Czajka H, Maguire JD, Pregaldien JL, et al
A phase 3 study to assess the immunogenicity, safety, and tolerability of MenB-FHbp administered as a 2-dose schedule in adolescents and young adults.
Vaccine. 2022;40:351-358.
PubMed Abstract available

RUSTANDI RR, Xu Q
Reactivity characterization of bromoacetyl derivatized polyribosylribitol polysaccharide in Haemophilus influenzae type b for PedvaxHIB(R) by NMR spectroscopy.
Vaccine. 2022;40:187-191.
PubMed Abstract available

TUN ZM, Ring Z, Tam CC
Factors associated with maternal tetanus vaccination in Myanmar: An analysis of demographic and health survey data.
Vaccine. 2022 Jan 20. pii: S0264-410X(22)00042.
PubMed Abstract available

LIU F, Feng C, Xu S, Wu Q, et al
An AAV vaccine targeting the RBD of the SARS-CoV-2 S protein induces effective neutralizing antibody titers in mice and canines.
Vaccine. 2022 Jan 20. pii: S0264-410X(22)00054.
PubMed Abstract available

LIAO Q, Cowling BJ, Xiao J, Yuan J, et al
Priming with social benefit information of vaccination to increase acceptance of COVID-19 vaccines.
Vaccine. 2022 Jan 20. pii: S0264-410X(22)00055.
PubMed Abstract available

LI LL, Zheng C, La J, Do NV, et al
Impact of prior SARS-CoV-2 infection on incidence of hospitalization and adverse events following mRNA SARS-CoV-2 vaccination: A nationwide, retrospective cohort study.
Vaccine. 2022 Jan 19. pii: S0264-410X(22)00051.
PubMed Abstract available

PITCOVSKI J, Gruzdev N, Abzach A, Katz C, et al
Oral subunit SARS-CoV-2 vaccine induces systemic neutralizing IgG, IgA and cellular immune responses and can boost neutralizing antibody responses primed by an injected vaccine.
Vaccine. 2022 Jan 19. pii: S0264-410X(22)00050.
PubMed Abstract available

ZHU D, Lv M, Bai Y, Wu J, et al
Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in Beijing: A modeling analysis.
Vaccine. 2022 Jan 19. pii: S0264-410X(22)00024.
PubMed Abstract available

PASSARETTI CL, Priem JS, Agner TG, McCurdy L, et al
Reducing the rates of household transmission: The impact of COVID-19 vaccination in healthcare workers with a known household exposure.
Vaccine. 2022 Jan 19. pii: S0264-410X(22)00044.
PubMed Abstract available

TUSE D, Malm M, Tamminen K, Diessner A, et al
Safety and immunogenicity studies in animal models support clinical development of a bivalent norovirus-like particle vaccine produced in plants.
Vaccine. 2022 Jan 18. pii: S0264-410X(22)00022.
PubMed Abstract available

ROLFES L, Harmark L, Kant A, van Balveren L, et al
COVID-19 vaccine reactogenicity - A cohort event monitoring study in the Netherlands using patient reported outcomes.
Vaccine. 2022 Jan 17. pii: S0264-410X(22)00028.
PubMed Abstract available

OHFUJI S, Tanaka T, Nakano T, Kase T, et al
Annual trends in adverse events following mumps vaccination in Japan: A retrospective study.
Vaccine. 2022 Jan 17. pii: S0264-410X(22)00023.
PubMed Abstract available

BEDSTON S, Akbari A, Jarvis CI, Lowthian E, et al
COVID-19 vaccine uptake, effectiveness, and waning in 82,959 health care workers: A national prospective cohort study in Wales.
Vaccine. 2022 Jan 15. pii: S0264-410X(21)01535.
PubMed Abstract available

TANAKA M, Okubo R, Hoshi SL, Ishikawa N, et al
Cost-effectiveness of pertussis booster vaccination for preschool children in Japan.
Vaccine. 2022 Jan 13. pii: S0264-410X(22)00003.
PubMed Abstract available

SIMON JK, Staerke NB, Hemming-Harlo M, Layle S, et al
Lot-to-lot consistency, safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in healthy adults aged >/=50 years: A randomized phase 3 trial (PNEU-TRUE).
Vaccine. 2022 Jan 13. pii: S0264-410X(21)01675.
PubMed Abstract available

MALTER KB, Tugel ME, Gil-Rodriguez M, Guardia G, et al
Variability in non-core vaccination rates of dogs and cats in veterinary clinics across the United States.
Vaccine. 2022 Jan 13. pii: S0264-410X(22)00006.
PubMed Abstract available

WARNER EL, Barbati JL, Duncan KL, Yan K, et al
Vaccine misinformation types and properties in Russian troll tweets.
Vaccine. 2022 Jan 13. pii: S0264-410X(21)01648.
PubMed Abstract available

MOYO P, Bosco E, Bardenheier BH, Rivera-Hernandez M, et al
Variation in influenza vaccine assessment, receipt, and refusal by the concentration of Medicare Advantage enrollees in U.S. nursing homes.
Vaccine. 2022 Jan 13. pii: S0264-410X(21)01688.
PubMed Abstract available

WONG WHS, Leung D, Chua GT, Duque JSR, et al
Adolescents' attitudes to the COVID-19 vaccination.
Vaccine. 2022 Jan 12. pii: S0264-410X(22)00025.
PubMed Abstract available

WOO EJ, Moro PL
Postmarketing safety surveillance of high-dose quadrivalent influenza vaccine: Reports to the Vaccine Adverse Event Reporting System.
Vaccine. 2022 Jan 11. pii: S0264-410X(22)00001.
PubMed Abstract available

SHIMIZU S, Tanaka R, Itoh E, Maekawa-Matsuura M, et al
Performance and usability evaluation of novel intradermal injection device Immucise and reanalysis of intradermal administration trials of influenza vaccine for the elderly.
Vaccine. 2022 Jan 11. pii: S0264-410X(21)01669.
PubMed Abstract available

BLYTH DM, Liang Z, Williams M, Murray CK, et al
Immune interference revisited: Impact of live-attenuated influenza vaccine prior to yellow fever vaccination.
Vaccine. 2022 Jan 11. pii: S0264-410X(21)01637.
PubMed Abstract available

DANIEL CL, Williams J, Legg R, McGowen C, et al
Factors associated with COVID-19 vaccination intentions among adults in the deep South.
Vaccine. 2022 Jan 10. pii: S0264-410X(21)01667.
PubMed Abstract available

PENG KW, Carey T, Lech P, Vandergaast R, et al
Boosting of SARS-CoV-2 immunity in nonhuman primates using an oral rhabdoviral vaccine.
Vaccine. 2022 Jan 10. pii: S0264-410X(21)01671.
PubMed Abstract available

OMER I, Rosenberg A, Sefty H, Pando R, et al
Lineage-matched versus mismatched influenza B vaccine effectiveness following seasons of marginal influenza B circulation.
Vaccine. 2022 Jan 8. pii: S0264-410X(21)01664.
PubMed Abstract available

VADLAMUDI NK, Patrick DM, Rose C, Sadatsafavi M, et al
A population-based analysis to determine the impact of the 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in British Columbia, Canada.
Vaccine. 2022 Jan 7. pii: S0264-410X(21)01673.
PubMed Abstract available

FOO D, Sarna M, Pereira G, Moore HC, et al
Longitudinal, population-based cohort study of prenatal influenza vaccination and influenza infection in childhood.
Vaccine. 2022 Jan 7. pii: S0264-410X(21)01556.
PubMed Abstract available

UWAMINO Y, Kurafuji T, Sato Y, Tomita Y, et al
Young age, female sex, and presence of systemic adverse reactions are associated with high post-vaccination antibody titer after two doses of BNT162b2 mRNA SARS-CoV-2 vaccination: An observational study of 646 Japanese healthcare workers and universit
Vaccine. 2022 Jan 7. pii: S0264-410X(22)00002.
PubMed Abstract available

HSIAO A, Hansen J, Nunley KV, Lewis N, et al
Safety of recombinant quadrivalent influenza vaccine compared to inactivated influenza vaccine in Chinese adults: An observational study.
Vaccine. 2022 Jan 6. pii: S0264-410X(21)01641.
PubMed Abstract available

EUSER S, Kroese FM, Derks M, de Bruin M, et al
Understanding COVID-19 vaccination willingness among youth: A survey study in the Netherlands.
Vaccine. 2022 Jan 5. pii: S0264-410X(21)01670.
PubMed Abstract available

HUANG Z, Ji M, Ren J, Sun X, et al
Effect of the framing of HPV vaccination on parents' willingness to accept an HPV vaccine.
Vaccine. 2022 Jan 4. pii: S0264-410X(21)01659.
PubMed Abstract available

GLADSTONE RA, Siira L, Brynildsrud OB, Vestrheim DF, et al
International links between Streptococcus pneumoniae vaccine serotype 4 sequence type (ST) 801 in Northern European shipyard outbreaks of invasive pneumococcal disease.
Vaccine. 2022 Jan 4. pii: S0264-410X(21)01377.
PubMed Abstract available

LEDLIE S, Ricci C, Pan C, Rojas A, et al
Yellow fever vaccine usage in the United States and risk of neurotropic and viscerotropic disease: A retrospective cohort study using three healthcare databases.
Vaccine. 2022 Jan 4. pii: S0264-410X(21)01655.
PubMed Abstract available

VILLENA R, Valenzuela MT, Bastias M, Santolaya ME, et al
Invasive meningococcal disease in Chile seven years after ACWY conjugate vaccine introduction.
Vaccine. 2022 Jan 4. pii: S0264-410X(21)01549.
PubMed Abstract available

PENLINGTON M, Goulet P, Metcalfe B
Improving knowledge and trust in vaccines: A survey-based assessment of the potential of the European Union Clinical Trial Regulation No 536/2014 plain language summary to increase health literacy.
Vaccine. 2022 Jan 4. pii: S0264-410X(21)01653.
PubMed Abstract available

ZHANG J, Ji Y, Wang Z, Jia Y, et al
Effective improvements to the live-attenuated Newcastle disease virus vaccine by polyethylenimine-based biomimetic silicification.
Vaccine. 2022 Jan 3. pii: S0264-410X(21)01662.
PubMed Abstract available

KUZNETSOVA A, Ceregido MA, Jourquin A, Campora L, et al
Fourteen years of the Pregnancy Registry on maternal immunisation with a reduced-antigen-content tetanus-diphtheria-acellular pertussis (Tdap) vaccine.
Vaccine. 2022 Jan 3. pii: S0264-410X(21)01658.
PubMed Abstract available

OHM M, Knol MJ, Vos ERA, Bogaard MJM, et al
Seroprevalence of meningococcal ACWY antibodies across the population in the Netherlands: Two consecutive surveys in 2016/17 and 2020.
Vaccine. 2022;40:59-66.
PubMed Abstract available

KUJAWSKI SA, Yao L, Wang HE, Carias C, et al
Impact of the COVID-19 pandemic on pediatric and adolescent vaccinations and well child visits in the United States: A database analysis.
Vaccine. 2022 Jan 1. pii: S0264-410X(21)01672.
PubMed Abstract available

December 2021

PASCHALL AV, Ozdilek A, Briner SL, Brindley MA, et al
Modulation of immunosuppressant drug treatment to improve SARS-CoV-2 vaccine efficacy in mice.
Vaccine. 2021 Dec 31. pii: S0264-410X(21)01666.
PubMed Abstract available

GROOM HC, Crane B, Naleway AL, Weintraub E, et al
Monitoring vaccine safety using the vaccine safety Datalink: Assessing capacity to integrate data from Immunization Information systems.
Vaccine. 2021 Dec 31. pii: S0264-410X(21)01656.
PubMed Abstract available

LUBLIN A, Katz C, Gruzdev N, Yadid I, et al
Protection against avian coronavirus conferred by oral vaccination with live bacteria secreting LTB-fused viral proteins.
Vaccine. 2021 Dec 30. pii: S0264-410X(21)01661.
PubMed Abstract available

SAELAND E, van der Fits L, Bolder R, Heemskerk-van der Meer M, et al
Immunogenicity and protective efficacy of adenoviral and subunit RSV vaccines based on stabilized prefusion F protein in pre-clinical models.
Vaccine. 2021 Dec 29. pii: S0264-410X(21)01651.
PubMed Abstract available

FAINGELERNT Y, Dagan R, Givon-Lavi N, van der Beek BA, et al
The impact of the pneumococcal conjugate vaccines on the incidence of community-acquired alveolar pneumonia in premature compared with in term-born infants.
Vaccine. 2021 Dec 29. pii: S0264-410X(21)01636.
PubMed Abstract available

ASOGWA OA, de Hoog MLA, Bruijning-Verhagen PCJI
Impact of 7-valent versus 10-valent pneumococcal conjugate vaccines on primary care consultations across various age groups in the Netherlands, 5 years after the switch: A time-series analysis.
Vaccine. 2021 Dec 27. pii: S0264-410X(21)01533.
PubMed Abstract available

REIS LR, Costa-Rocha IAD, Campi-Azevedo AC, Peruhype-Magalhaes V, et al
Exploratory study of humoral and cellular immunity to 17DD Yellow Fever vaccination in children and adults residents of areas without circulation of Yellow Fever Virus.
Vaccine. 2021 Dec 27. pii: S0264-410X(21)01638.
PubMed Abstract available

KUSI KA, Ofori EA, Akyea-Mensah K, Kyei-Baafour E, et al
Towards large-scale identification of HLA-restricted T cell epitopes from four vaccine candidate antigens in a malaria endemic community in Ghana.
Vaccine. 2021 Dec 27. pii: S0264-410X(21)01650.
PubMed Abstract available

CHOWDHURY F, Akter A, Bhuiyan TR, Tauheed I, et al
A non-inferiority trial comparing two killed, whole cell, oral cholera vaccines (Cholvax vs. Shanchol) in Dhaka, Bangladesh.
Vaccine. 2021 Dec 27. pii: S0264-410X(21)01623.
PubMed Abstract available

SHUKLA S, Fressin F, Un M, Coetzer H, et al
Optimizing vaccine distribution via mobile clinics: a case study on COVID-19 vaccine distribution to long-term care facilities.
Vaccine. 2021 Dec 27. pii: S0264-410X(21)01657.
PubMed Abstract available

RIBEIRO SP, De Moura Mattaraia VG, Almeida RR, Valentine EJG, et al
A promiscuous T cell epitope-based HIV vaccine providing redundant population coverage of the HLA class II elicits broad, polyfunctional T cell responses in nonhuman primates.
Vaccine. 2021 Dec 24. pii: S0264-410X(21)01550.
PubMed Abstract available

DE KOFF EM, van Houten MA, de Heij F, Berbers GAM, et al
Salivary antibody responses to ten-valent pneumococcal conjugate vaccination following two different immunization schedules in a healthy birth cohort.
Vaccine. 2021 Dec 24. pii: S0264-410X(21)01622.
PubMed Abstract available

FREEMAN RE, Thaker J, Daley MF, Glanz JM, et al
Vaccine timeliness and prevalence of undervaccination patterns in children ages 0-19 months, U.S., National immunization Survey-Child 2017.
Vaccine. 2021 Dec 24. pii: S0264-410X(21)01645.
PubMed Abstract available

JUNE CHOE Y, Yi S, Hwang I, Kim J, et al
Safety and effectiveness of BNT162b2 mRNA Covid-19 vaccine in adolescents.
Vaccine. 2021 Dec 24. pii: S0264-410X(21)01654.
PubMed Abstract available

THOMAS SJ, Perez JL, Lockhart SP, Hariharan S, et al
Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trial.
Vaccine. 2021 Dec 24. pii: S0264-410X(21)01652.
PubMed Abstract available

LACY J, Tessier E, Andrews N, White J, et al
Impact of an accelerated measles-mumps-rubella (MMR) vaccine schedule on vaccine coverage: An ecological study among London children, 2012-2018.
Vaccine. 2021 Dec 23. pii: S0264-410X(21)01619.
PubMed Abstract available

BRENNAN T, Hidle A, Doshi RH, An Q, et al
Cost of human papillomavirus vaccine delivery in a single-age cohort, routine-based vaccination program in Senegal.
Vaccine. 2021 Dec 23. pii: S0264-410X(21)01531.
PubMed Abstract available

RAHIM S, Ahmad Z, Abdul-Ghafar J
The polio vaccination story of Pakistan.
Vaccine. 2021 Dec 23. pii: S0264-410X(21)01595.
PubMed Abstract available

FERNANDES C, Alves J, Rodrigues A, Azevedo J, et al
Epidemiological impact of the human papillomavirus vaccination program on genital warts in Portugal: A retrospective, chart review study.
Vaccine. 2021 Dec 22. pii: S0264-410X(21)01544.
PubMed Abstract available

KIM HJ, Yun HJ, Kim J, Kym S, et al
Antibody response to second dose of the BNT162b2 mRNA vaccine in the first 12 weeks in South Korea: A prospective longitudinal study.
Vaccine. 2021 Dec 22. pii: S0264-410X(21)01620.
PubMed Abstract available

ROMAIN-SCELLE N, Elias C, Vanhems P
COVID-19 vaccine is correlated with favourable epidemiological indicators in the Auvergne-Rhone-Alpes region (France): An ecological study.
Vaccine. 2021 Dec 22. pii: S0264-410X(21)01644.
PubMed Abstract available

MANOMAIPIBOON A, Phumisantiphong U, Maneerit J, Chalearmchai Y, et al
Immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 with 12-dose vials: An interim analysis.
Vaccine. 2021 Dec 22. pii: S0264-410X(21)01632.
PubMed Abstract available

KENNEDY RB, Ovsyannikova IG, Haralambieva IH, Grill DE, et al
Proteomic assessment of humoral immune responses in smallpox vaccine recipients.
Vaccine. 2021 Dec 21. pii: S0264-410X(21)01642.
PubMed Abstract available

PORTH JM, Wagner AL, Treleaven E, Fleischer NL, et al
Childhood vaccination timeliness following maternal migration to an informal urban settlement in Kenya.
Vaccine. 2021 Dec 21. pii: S0264-410X(21)01625.
PubMed Abstract available

TADAKUMA K, Maruyama T, Mori K, Fujiki N, et al
Effectiveness of seasonal influenza vaccine in adult Japanese workers, 2017-2020.
Vaccine. 2021 Dec 21. pii: S0264-410X(21)01624.
PubMed Abstract available

ERBER W, Khan F, Zavadska D, Freimane Z, et al
Effectiveness of TBE vaccination in southern Germany and Latvia.
Vaccine. 2021 Dec 21. pii: S0264-410X(21)01639.
PubMed Abstract available

PETERSEN MB, Jorgensen F, Lindholt MF
Did the European suspension of the AstraZeneca vaccine decrease vaccine acceptance during the COVID-19 pandemic?
Vaccine. 2021 Dec 21. pii: S0264-410X(21)01631.
PubMed Abstract available

WILLIAMS KV, Zhai B, Alcorn JF, Patricia Nowalk M, et al
A randomized controlled trial of antibody response to 2019-20 cell-based inactivated and egg-based live attenuated influenza vaccines in children and young adults.
Vaccine. 2021 Dec 21. pii: S0264-410X(21)01643.
PubMed Abstract available

SHAPIRO GK, Gottfredson N, Leask J, Wiley K, et al
COVID-19 and missed or delayed vaccination in 26 middle- and high-income countries: An observational survey.
Vaccine. 2021 Dec 21. pii: S0264-410X(21)01649.
PubMed Abstract available

BLANCO S, Salome Konigheim B, Diaz A, Spinsanti L, et al
Evaluation of the Gam-COVID-Vac and vaccine-induced neutralizing response against SARS-CoV-2 lineage P.1 variant in an Argentinean cohort.
Vaccine. 2021 Dec 20. pii: S0264-410X(21)01634.
PubMed Abstract available

NASREEN S, Wang J, Kwong JC, Crowcroft NS, et al
Population-based incidence of invasive pneumococcal disease in children and adults in Ontario and British Columbia, 2002-2018: A Canadian Immunization Research Network (CIRN) study.
Vaccine. 2021;39:7545-7553.
PubMed Abstract available

IVANOVA-MARKOVA Y, Gonzalez-Dominguez A, Hidalgo A, Sanchez R, et al
Cost of illness of invasive meningococcal disease caused by serogroup B Neisseria meningitidis in Spain.
Vaccine. 2021;39:7646-7654.
PubMed Abstract available

RANADE D, Jena R, Sancheti S, Deore V, et al
Rapid, high throughput protein estimation method for saponin and alhydrogel adjuvanted R21 VLP Malaria vaccine based on intrinsic fluorescence.
Vaccine. 2021 Dec 18. pii: S0264-410X(21)01627.
PubMed Abstract available

HERRING WL, Zhang Y, Shinde V, Stoddard J, et al
Clinical and economic outcomes associated with respiratory syncytial virus vaccination in older adults in the United States.
Vaccine. 2021 Dec 18. pii: S0264-410X(21)01609.
PubMed Abstract available

POUKKA E, Baum U, Palmu AA, Lehtonen TO, et al
Cohort study of Covid-19 vaccine effectiveness among healthcare workers in Finland, December 2020 - October 2021.
Vaccine. 2021 Dec 18. pii: S0264-410X(21)01640.
PubMed Abstract available

WIDGREN K, Tomba GS, Leung KY, Giesecke J, et al
Modelling varicella vaccination - What does a lack of surge in herpes zoster incidence tell us about exogenous boosting?
Vaccine. 2021 Dec 17. pii: S0264-410X(21)01537.
PubMed Abstract available

CHUNG NH, Chen YC, Yang SJ, Lin YC, et al
Induction of Th1 and Th2 in the protection against SARS-CoV-2 through mucosal delivery of an adenovirus vaccine expressing an engineered spike protein.
Vaccine. 2021 Dec 17. pii: S0264-410X(21)01635.
PubMed Abstract available

CARLSON SJ, McKenzie L, Roberts L, Blyth CC, et al
Does a major change to a COVID-19 vaccine program alter vaccine intention? A qualitative investigation.
Vaccine. 2021 Dec 16. pii: S0264-410X(21)01629.
PubMed Abstract available

GOLDBLATT D, Fiore-Gartland A, Johnson M, Hunt A, et al
Towards a population-based threshold of protection for COVID-19 vaccines.
Vaccine. 2021 Dec 15. pii: S0264-410X(21)01615.
PubMed Abstract available

YU Y, Jia W, Lau MMC, Lau JTF, et al
Levels and factors derived from the Health Action Process Approach of behavioral intentions to take up COVID-19 vaccination: A random population-based study.
Vaccine. 2021 Dec 15. pii: S0264-410X(21)01628.
PubMed Abstract available

CHEN X, Wang H
On the rise of the new B.1.1.529 variant: Five dimensions of access to a COVID-19 vaccine.
Vaccine. 2021 Dec 14. pii: S0264-410X(21)01596.
PubMed Abstract available

ALMOHAYA AM, Alsubie H, Alqarni B, Alzayad B, et al
Acute unsolicited adverse events following BNT162b2 vaccine in Saudi Arabia, a real-world data.
Vaccine. 2021 Dec 13. pii: S0264-410X(21)01610.
PubMed Abstract available

KURANI S, MacLaughlin KL, Jacobson RM, St Sauver JL, et al
Socioeconomic disadvantage and human papillomavirus (HPV) vaccination uptake.
Vaccine. 2021 Dec 13. pii: S0264-410X(21)01611.
PubMed Abstract available

BOTTON J, Dray-Spira R, Baricault B, Drouin J, et al
Reduced risk of severe COVID-19 in more than 1.4 million elderly people aged 75 years and older vaccinated with mRNA-based vaccines.
Vaccine. 2021 Dec 11. pii: S0264-410X(21)01617.
PubMed Abstract available

COSSU D, Ruberto S, Yokoyama K, Hattori N, et al
Efficacy of BCG vaccine in animal models of neurological disorders.
Vaccine. 2021 Dec 11. pii: S0264-410X(21)01613.
PubMed Abstract available

LUTRICK K, Groom H, Fowlkes AL, Groover KD, et al
COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers.
Vaccine. 2021 Dec 11. pii: S0264-410X(21)01593.
PubMed Abstract available

HSIEH YL, Rak S, SteelFisher GK, Bauhoff S, et al
Effect of the suspension of the J&J COVID-19 vaccine on vaccine hesitancy in the United States.
Vaccine. 2021 Dec 11. pii: S0264-410X(21)01559.
PubMed Abstract available

OLIVEIRA-SILVA J, Reis T, Lopes C, Batista-Silva R, et al
Humoral response to the SARS-CoV-2 BNT162b2 mRNA vaccine: Real-world data from a large cohort of healthcare workers.
Vaccine. 2021 Dec 11. pii: S0264-410X(21)01621.
PubMed Abstract available

ZHAO AR, Bishai DM
Public health spending, primary care, and perceived risk promoted vaccination against H1N1.
Vaccine. 2021 Dec 10. pii: S0264-410X(21)01538.
PubMed Abstract available

KATZ MA, Harlev EB, Chazan B, Chowers M, et al
Early effectiveness of BNT162b2 Covid-19 vaccine in preventing SARS-CoV-2 infection in healthcare personnel in six Israeli hospitals (CoVEHPI).
Vaccine. 2021 Dec 10. pii: S0264-410X(21)01580.
PubMed Abstract available

AVILA-AGUERO ML, Camacho-Badilla K, Ulloa-Gutierrez R, Espinal-Tejada C, et al
Epidemiology of pertussis in Costa Rica and the impact of vaccination: A 58-year experience (1961-2018).
Vaccine. 2021 Dec 10. pii: S0264-410X(21)01552.
PubMed Abstract available

KADKHODA K
Post RNA-based COVID vaccines myocarditis: Proposed mechanisms.
Vaccine. 2021 Dec 9. pii: S0264-410X(21)01594.
PubMed

ZHAO H, Li Y, Wang Z
Adverse event of Sinovac Coronavirus vaccine: Deafness.
Vaccine. 2021 Dec 9. pii: S0264-410X(21)01576.
PubMed Abstract available

HOOK SA, Hansen AP, Niesobecki SA, Meek JI, et al
Evaluating public acceptability of a potential Lyme disease vaccine using a population-based, cross-sectional survey in high incidence areas of the United States.
Vaccine. 2021 Dec 8. pii: S0264-410X(21)01540.
PubMed Abstract available

PEPIN J, Labbe AC, Carignan A, Parent ME, et al
Does BCG provide long-term protection against SARS-CoV-2 infection? A case-control study in Quebec, Canada.
Vaccine. 2021;39:7300-7307.
PubMed Abstract available

VON REYN CF
BCG versus rBCG: What is the way forward?
Vaccine. 2021;39:7319-7320.
PubMed

VAN HOOIJ A, van den Eeden SJF, Khatun M, Soren S, et al
BCG-induced immunity profiles in household contacts of leprosy patients differentiate between protection and disease.
Vaccine. 2021;39:7230-7237.
PubMed Abstract available

HEIJMENBERG I, Husain A, Sathkumara HD, Muruganandah V, et al
ESX-5-targeted export of ESAT-6 in BCG combines enhanced immunogenicity & efficacy against murine tuberculosis with low virulence and reduced persistence.
Vaccine. 2021;39:7265-7276.
PubMed Abstract available

KOWALEWICZ-KULBAT M, Locht C
BCG for the prevention and treatment of allergic asthma.
Vaccine. 2021;39:7341-7352.
PubMed Abstract available

LENNON RP, Block R Jr, Schneider EC, Zephrin L, et al
Underserved population acceptance of combination influenza-COVID-19 booster vaccines.
Vaccine. 2021 Dec 7. pii: S0264-410X(21)01597.
PubMed Abstract available

MA J, Casadei E, Bruce TJ, Sepahi A, et al
Long-term efficacy of nasal vaccination against enteric red mouth (ERM) disease and infectious hematopoietic necrosis (IHN) in juvenile rainbow trout (Oncorhynchus mykiss).
Vaccine. 2021 Dec 7. pii: S0264-410X(21)01551.
PubMed Abstract available

MARGOLIS MA, Brewer NT, Boynton MH, Lafata JE, et al
Provider response and follow-up to parental declination of HPV vaccination.
Vaccine. 2021 Dec 6. pii: S0264-410X(21)01529.
PubMed Abstract available

PEREZ-VILAR S, Dores GM, Marquez PL, Ng CS, et al
Safety surveillance of meningococcal group B vaccine (Bexsero(R)), Vaccine Adverse Event Reporting System, 2015-2018.
Vaccine. 2021 Dec 6. pii: S0264-410X(21)01545.
PubMed Abstract available

SULIS G, Basta NE, Wolfson C, Kirkland SA, et al
Influenza vaccination uptake among Canadian adults before and during the COVID-19 pandemic: An analysis of the Canadian Longitudinal study on Aging (CLSA).
Vaccine. 2021 Dec 4. pii: S0264-410X(21)01579.
PubMed Abstract available

RAW RK, Rees J, Kelly CA, Wroe C, et al
Prior COVID-19 infection is associated with increased Adverse Events (AEs) after the first, but not the second, dose of the BNT162b2/Pfizer vaccine.
Vaccine. 2021 Dec 4. pii: S0264-410X(21)01577.
PubMed Abstract available

BRONSTEIN MV, Kummerfeld E, MacDonald A 3rd, Vinogradov S, et al
Willingness to vaccinate against SARS-CoV-2: The role of reasoning biases and conspiracist ideation.
Vaccine. 2021 Dec 4. pii: S0264-410X(21)01553.
PubMed Abstract available

FACK C, Wood R, Hatherill M, Cobelens F, et al
The impact of a change in infant BCG vaccination policy on adolescent TB incidence rates: A South African population-level cohort study.
Vaccine. 2021 Dec 3. pii: S0264-410X(21)01488.
PubMed Abstract available

NGUYEN AT, Arnold BF, Kennedy CJ, Mishra K, et al
Evaluation of a city-wide school-located influenza vaccination program in Oakland, California with respect to race and ethnicity: A matched cohort study.
Vaccine. 2021 Dec 3. pii: S0264-410X(21)01547.
PubMed Abstract available

IZAK M, Stoyanov E, Dezuraev K, Shinar E, et al
Correlation of Anti-SARS-CoV-2 S1-specificIgG antibody levels and adverse events following vaccination with BNT162b2 mRNA COVID-19 vaccine in healthcare workers.
Vaccine. 2021 Dec 3. pii: S0264-410X(21)01557.
PubMed Abstract available

HERZBERG J, Vollmer T, Fischer B, Becher H, et al
SARS-CoV-2-antibody response in health care workers after vaccination or natural infection in a longitudinal observational study.
Vaccine. 2021 Dec 3. pii: S0264-410X(21)01555.
PubMed Abstract available

YORSAENG R, Suntronwong N, Phowatthanasathian H, Assawakosri S, et al
Immunogenicity of a third dose viral-vectored COVID-19 vaccine after receiving two-dose inactivated vaccines in healthy adults.
Vaccine. 2021 Dec 3. pii: S0264-410X(21)01560.
PubMed Abstract available

HELLE F, Moyet J, Demey B, Francois C, et al
Humoral anti-SARS-CoV-2 immune response after two doses of Comirnaty vaccine in nursing home residents by previous infection status.
Vaccine. 2021 Dec 3. pii: S0264-410X(21)01558.
PubMed Abstract available

LI S, Chen W, Shen Y, Xia J, et al
Molecular characterization of infectious bronchitis virus in Southwestern China for the protective efficacy evaluation of four live vaccine strains.
Vaccine. 2021 Dec 2. pii: S0264-410X(21)01546.
PubMed Abstract available

DUONG CH, Mueller JE, Tubert-Bitter P, Escolano S, et al
Estimation of mid-and long-term benefits and hypothetical risk of Guillain-Barre syndrome after human papillomavirus vaccination among boys in France: A simulation study.
Vaccine. 2021 Dec 2. pii: S0264-410X(21)01502.
PubMed Abstract available

WANG CH, Kung WJ, Lee CH, Lee CF, et al
High rates of colonization and antimicrobial resistance of group B streptococcus highlight the need for vaccination even after implementation of guidelines for intrapartum antibiotic prophylaxis.
Vaccine. 2021 Dec 2. pii: S0264-410X(21)01543.
PubMed Abstract available

MUNOZ-QUILES C, Lopez-Lacort M, Diez-Domingo J, Rodrigo-Casares V, et al
Human papillomavirus vaccines effectiveness to prevent genital warts: A population-based study using health system integrated databases, 2009-2017.
Vaccine. 2021 Dec 2. pii: S0264-410X(21)01536.
PubMed Abstract available

NEWALL AT, Beutels P, Tuffaha HW, Hall PS, et al
How can early stage economic evaluation help guide research for future vaccines?
Vaccine. 2021 Dec 2. pii: S0264-410X(21)01462.
PubMed

PRICE J, Mooney J, Bain C, Bawa JT, et al
National stakeholder preferences for next-generation rotavirus vaccines: Results from a six-country study.
Vaccine. 2021 Dec 2. pii: S0264-410X(21)01443.
PubMed Abstract available

VALCKX S, Crevecoeur J, Verelst F, Vranckx M, et al
Individual factors influencing COVID-19 vaccine acceptance in between and during pandemic waves (July-December 2020).
Vaccine. 2021 Dec 1. pii: S0264-410X(21)01414.
PubMed Abstract available

EZE P, Aniebo CL, Agu UJ, Agu SA, et al
Validity of maternal recall for estimating childhood vaccination coverage - Evidence from Nigeria.
Vaccine. 2021 Dec 1. pii: S0264-410X(21)01534.
PubMed Abstract available

WIRTZ C, Mohamed Y, Engel D, Sidibe A, et al
Integrating HPV vaccination programs with enhanced cervical cancer screening and treatment, a systematic review.
Vaccine. 2021 Dec 1. pii: S0264-410X(21)01447.
PubMed Abstract available

November 2021

ATTWELL K, Rizzi M, McKenzie L, Carlson SJ, et al
COVID-19 vaccine Mandates: An Australian attitudinal study.
Vaccine. 2021 Nov 30. pii: S0264-410X(21)01530.
PubMed Abstract available

SUGISHITA Y, Sugawara T
Effectiveness and cost-effectiveness of influenza vaccination for elderly people.
Vaccine. 2021 Nov 29. pii: S0264-410X(21)01257.
PubMed Abstract available

PORRAS C, Sampson JN, Herrero R, Gail MH, et al
Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trial.
Vaccine. 2021 Nov 29. pii: S0264-410X(21)01486.
PubMed Abstract available

ZOU X, He J, Zheng J, Liang M, et al
Evaluation of effectiveness, safety and cost-benefit of the 23- valent pneumococcal capsular polysaccharide vaccine for HIV-Infected patients.
Vaccine. 2021 Nov 29. pii: S0264-410X(21)01532.
PubMed Abstract available

LAURENZ M, von Eiff C, Borchert K, Jacob C, et al
Vaccination rates and adherence in premature infants before and after pneumococcal conjugate vaccine schedule change for term infants - A claims database analysis in Germany.
Vaccine. 2021 Nov 28. pii: S0264-410X(21)01437.
PubMed Abstract available

LI H, Monslow MA, Freed DC, Chang D, et al
Novel adjuvants enhance immune responses elicited by a replication-defective human cytomegalovirus vaccine in nonhuman primates.
Vaccine. 2021 Nov 28. pii: S0264-410X(21)01416.
PubMed Abstract available

MALTEZOU HC, Anastassopoulou C, Hatziantoniou S, Poland GA, et al
Anaphylaxis rates associated with COVID-19 vaccines are comparable to those of other vaccines.
Vaccine. 2021 Nov 27. pii: S0264-410X(21)01539.
PubMed Abstract available

CASTRO F, Pascale JM, Slocum Hewitt I, Calvo A, et al
Mass vaccination campaign during the 2016 influenza outbreak in Panama: Challenges and implications for COVID-19 vaccination efforts.
Vaccine. 2021 Nov 27. pii: S0264-410X(21)01504.
PubMed

SCHMITZ M, Luminet O, Klein O, Morbee S, et al
Predicting vaccine uptake during COVID-19 crisis: A motivational approach.
Vaccine. 2021 Nov 27. pii: S0264-410X(21)01542.
PubMed Abstract available

JIN P, Sun F, Liu Q, Wang Q, et al
An oral vaccine based on chitosan/aluminum adjuvant induces both local and systemic immune responses in turbot (Scophthalmus maximus).
Vaccine. 2021 Nov 26. pii: S0264-410X(21)01396.
PubMed Abstract available

GULPINAR G, Uzun MB
Examining community pharmacists' intention to provide pharmacist-driven vaccination services: A structural equation modelling.
Vaccine. 2021 Nov 26. pii: S0264-410X(21)01499.
PubMed Abstract available

ROBERTSON JS, Loizides U, Adisa A, Lopez de la Rica Manjavacas A, et al
International Nonproprietary Names (INN) for novel vaccine substances: A matter of safety.
Vaccine. 2021 Nov 26. pii: S0264-410X(21)01528.
PubMed Abstract available

ENGEL D, Afeli ADJ, Morgan C, Zeck W, et al
Promoting adolescent health through integrated human papillomavirus vaccination programs: The experience of Togo.
Vaccine. 2021 Nov 26. pii: S0264-410X(21)01466.
PubMed Abstract available

AHMED S, Dorin F, Satter SM, Sarker AR, et al
The economic burden of rotavirus hospitalization among children < 5 years of age in selected hospitals in Bangladesh.
Vaccine. 2021;39:7082-7090.
PubMed Abstract available

CANNON K, Elder C, Young M, Scott DA, et al
A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults >/=65 years of age with different prior pneumococcal vaccination.
Vaccine. 2021 Nov 25. pii: S0264-410X(21)01352.
PubMed Abstract available

KLEINWAKS G, Schmit V, Morrison J
Considering human challenge trials for tuberculosis vaccine development.
Vaccine. 2021 Nov 25. pii: S0264-410X(21)01469.
PubMed Abstract available

URUENA A, Badano MN, Bare P, Gonzalez J, et al
Humoral and cellular immune memory response 12 years following single dose vaccination against hepatitis A in Argentinian children.
Vaccine. 2021 Nov 24. pii: S0264-410X(21)01482.
PubMed Abstract available

BUCHMAN TG, Simpson SQ, Sciarretta KL, Finne KP, et al
Seasonal influenza vaccination is associated with reduced risk of death among Medicare beneficiaries().
Vaccine. 2021 Nov 23. pii: S0264-410X(21)01461.
PubMed Abstract available

BETTENCOURT PJG, Joosten SA, Lindestam Arlehamn CS, Behr MA, et al
100 years of the Bacillus Calmette-Guerin vaccine.
Vaccine. 2021 Nov 22. pii: S0264-410X(21)01483.
PubMed

SUN P, Jani V, Johnson A, Cheng Y, et al
T cell and memory B cell responses in tetravalent DNA, tetravalent inactivated and tetravalent live-attenuated prime-boost dengue vaccines in rhesus macaques.
Vaccine. 2021 Nov 22. pii: S0264-410X(21)01325.
PubMed Abstract available

DINC HO, Saltoglu N, Can G, Balkan II, et al
Inactive SARS-CoV-2 vaccine generates high antibody responses in healthcare workers with and without prior infection.
Vaccine. 2021 Nov 22. pii: S0264-410X(21)01507.
PubMed Abstract available

LENTZEN MP, Huebenthal V, Kaiser R, Kreppel M, et al
A retrospective analysis of social media posts pertaining to COVID-19 vaccination side effects.
Vaccine. 2021 Nov 22. pii: S0264-410X(21)01526.
PubMed Abstract available

AREGA SM, Knobel DL, Toka FN, Conan A, et al
Non-specific effects of veterinary vaccines: a systematic review.
Vaccine. 2021 Nov 20. pii: S0264-410X(21)01479.
PubMed Abstract available

HARA M, Koshida R, Nakano T
Parents' views on mumps, mumps vaccine, and the factors associated with vaccination in Japan.
Vaccine. 2021 Nov 20. pii: S0264-410X(21)01449.
PubMed Abstract available

YE K, Shi D, Zhang Z, Bian L, et al
A chemiluminescence immunoassay for precise automatic quality control of glycoprotein in human rabies vaccine.
Vaccine. 2021 Nov 20. pii: S0264-410X(21)01393.
PubMed Abstract available

LIN C, Tu P, Terry TC
Moving the needle on racial disparity: COVID-19 vaccine trust and hesitancy.
Vaccine. 2021 Nov 20. pii: S0264-410X(21)01444.
PubMed Abstract available

CHEN T, Dai M, Xia S
Perceived facilitators and barriers to intentions of receiving the COVID-19 vaccines among elderly Chinese adults.
Vaccine. 2021 Nov 19. pii: S0264-410X(21)01484.
PubMed Abstract available

CAMBON L, Schwarzinger M, Alla F
Increasing acceptance of a vaccination program for coronavirus disease 2019 in France: A challenge for one of the world's most vaccine-hesitant countries.
Vaccine. 2021 Nov 19. pii: S0264-410X(21)01467.
PubMed Abstract available

MUSCATELLO DJ, Nazareno AL, Turner RM, Newall AT, et al
Influenza-associated mortality in Australia, 2010 through 2019: High modelled estimates in 2017.
Vaccine. 2021 Nov 19. pii: S0264-410X(21)01464.
PubMed Abstract available

BELLIZZI S, Aidyralieva C, Al-Shaikh A, Muthu N, et al
Inclusiveness of prisons in COVID-19 vaccination deployment: Evidence from Jordan.
Vaccine. 2021 Nov 18. pii: S0264-410X(21)01468.
PubMed

ORTEGA-SANCHEZ IR, Mott JA, Kittikraisak W, Khanthamaly V, et al
Cost-effectiveness of seasonal influenza vaccination in pregnant women, healthcare workers and adults >= 60 years of age in Lao People's Democratic Republic.
Vaccine. 2021 Nov 18. pii: S0264-410X(21)01445.
PubMed Abstract available

IRVING SA, Ball SW, Booth SM, Regan AK, et al
A multi-country investigation of influenza vaccine coverage in pregnant individuals, 2010-2016.
Vaccine. 2021 Nov 18. pii: S0264-410X(21)01463.
PubMed Abstract available

HAFNER-GIESSAUF H, Horn S, Schwantzer G, Sprenger-Mahr H, et al
Cholecalciferol supplementation to improve the hepatitis B vaccination response in hemodialysis patients: A first randomized open label pilot study (DeVitaHep).
Vaccine. 2021 Nov 18. pii: S0264-410X(21)01474.
PubMed Abstract available

BLAIN AE, Reese HE, Marjuki H, Topaz N, et al
Serogroup A, C, W, and Y meningococcal disease in persons previously vaccinated with a serogroup ACWY meningococcal vaccine - United States, 2014-2018.
Vaccine. 2021 Nov 18. pii: S0264-410X(21)01480.
PubMed Abstract available

WANG W, Wang Y, Wang Y, Yan F, et al
Vaccine bidding, procurement and distribution management practices in mainland China: A nationwide study.
Vaccine. 2021 Nov 18. pii: S0264-410X(21)01465.
PubMed Abstract available

NGUYEN KH, Anneser E, Toppo A, Allen JD, et al
Disparities in national and state estimates of COVID-19 vaccination receipt and intent to vaccinate by race/ethnicity, income, and age group among adults >/= 18 years, United States.
Vaccine. 2021 Nov 18. pii: S0264-410X(21)01485.
PubMed Abstract available

KITRO A, Sirikul W, Piankusol C, Rirermsoonthorn P, et al
Acceptance, attitude, and factors affecting the intention to accept COVID-19 vaccine among Thai people and expatriates living in Thailand.
Vaccine. 2021 Nov 17. pii: S0264-410X(21)01476.
PubMed Abstract available

JEAN BAPTISTE AE, Bawa S, Oteri AJ, Dieng B, et al
Nationwide measles supplementary immunization activities to increase immunity levels in Nigeria.
Vaccine. 2021;39 Suppl 3:C1-C2.
PubMed

KORAVE J, Bawa S, Ageda B, Ucho A, et al
Internal displacement; an impediment to the successful implementation of planned measles supplemental activities in Nigeria, a case study of Benue State.
Vaccine. 2021;39 Suppl 3:C76-C81.
PubMed Abstract available

HOFF NA, Bratcher A, Mukadi P, Ahuka S, et al
Increasing Ebola transmission behaviors 6 months post-vaccination: Comparing vaccinated and unvaccinated populations near 2018 Mbandaka Ebola outbreak in the Democratic Republic of Congo.
Vaccine. 2021 Nov 16. pii: S0264-410X(21)01404.
PubMed Abstract available

VOSS G, Jacquet JM, Tornieporth N, Kampmann B, et al
Meeting report: CEPI consultation on accelerating access to novel vaccines against emerging infectious diseases for pregnant and lactating women, London, 12-13 February 2020.
Vaccine. 2021 Nov 16. pii: S0264-410X(21)01382.
PubMed Abstract available

VOHRA P, Chintoan-Uta C, Bremner A, Mauri M, et al
Evaluation of a Campylobacter jejuni N-glycan-ExoA glycoconjugate vaccine to reduce C. jejuni colonisation in chickens.
Vaccine. 2021 Nov 16. pii: S0264-410X(21)01434.
PubMed Abstract available

LIANG Q, Li H, Chang X, Zhang H, et al
A phase 3 clinical trial of MINHAI PCV13 in Chinese children aged from 7 months to 5 years old.
Vaccine. 2021;39:6947-6955.
PubMed Abstract available

BRAKEL KA, Binjawadagi B, French-Kim K, Watts M, et al
Coexpression of respiratory syncytial virus (RSV) fusion (F) protein and attachment glycoprotein (G) in a vesicular stomatitis virus (VSV) vector system provides synergistic effects against RSV infection in a cotton rat model.
Vaccine. 2021;39:6817-6828.
PubMed Abstract available

BOBO FT, Asante A, Woldie M, Dawson A, et al
Child vaccination in sub-Saharan Africa: Increasing coverage addresses inequalities.
Vaccine. 2021 Nov 15. pii: S0264-410X(21)01439.
PubMed Abstract available

ESPARZA J, Damaso CR
Searching for the origin of the smallpox vaccine: Edward Jenner and his little-known horsepox hypothesis.
Vaccine. 2021 Nov 15. pii: S0264-410X(21)01441.
PubMed

AMEND KL, Turnbull B, Zhou L, Marks MA, et al
Vaccine initiation and 3-dose series completion of 4vHPV vaccine among US insured males 2012-2016.
Vaccine. 2021 Nov 15. pii: S0264-410X(21)01403.
PubMed Abstract available

SILAS J, Jones A, Weiss-Cohen L, Ayton P, et al
The seductive allure of technical language and its effect on covid-19 vaccine beliefs and intentions.
Vaccine. 2021 Nov 15. pii: S0264-410X(21)01472.
PubMed Abstract available

MURPHY RP, Taaffe C, Ahern E, McMahon G, et al
A meta-analysis of influenza vaccination following correspondence: Considerations for COVID-19.
Vaccine. 2021 Nov 15. pii: S0264-410X(21)01470.
PubMed Abstract available

ROGERS JH, Cox SN, Hughes JP, Link AC, et al
Trends in COVID-19 vaccination intent and factors associated with deliberation and reluctance among adult homeless shelter residents and staff, 1 November 2020 to 28 February 2021 - King County, Washington.
Vaccine. 2021 Nov 15. pii: S0264-410X(21)01471.
PubMed Abstract available

CHOKEPHAIBULKIT K, Puthanakit T, Bhat N, Mansouri S, et al
A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in women of childbearing age.
Vaccine. 2021 Nov 14. pii: S0264-410X(21)01425.
PubMed Abstract available

BURKE RM, Shih S, Hsiung CA, Yen C, et al
Impact of rotavirus vaccination on rotavirus hospitalizations in Taiwanese children.
Vaccine. 2021 Nov 14. pii: S0264-410X(21)01397.
PubMed Abstract available

REESE HE, McNamara LA, Vianzon V, Blain A, et al
Serogroup B meningococcal disease in persons previously vaccinated with a serogroup B meningococcal vaccine - United States, 2014-2019.
Vaccine. 2021 Nov 13. pii: S0264-410X(21)01438.
PubMed Abstract available

ROSENTHAL S, Cummings CL
Influence of rapid COVID-19 vaccine development on vaccine hesitancy.
Vaccine. 2021 Nov 13. pii: S0264-410X(21)01448.
PubMed Abstract available

HARMON SHE, Faour DE, MacDonald NE
Mandatory immunization and vaccine injury support programs: A survey of 28 GNN countries.
Vaccine. 2021 Nov 12. pii: S0264-410X(21)01390.
PubMed Abstract available

CHHABRIA S, Stanford FC
A long shot: The importance of needle length in vaccinating patients with obesity against COVID-19.
Vaccine. 2021 Nov 11. pii: S0264-410X(21)01442.
PubMed

VIZCARRA P, Haemmerle J, Velasco H, Velasco T, et al
BNT162b2 mRNA COVID-19 vaccine Reactogenicity: The key role of immunity.
Vaccine. 2021 Nov 11. pii: S0264-410X(21)01417.
PubMed Abstract available

AW R, Ashik MR, Islam AAZM, Khan I, et al
Production and purification of an active CRM197 in Pichia pastoris and its immunological characterization using a Vi-typhoid antigen vaccine.
Vaccine. 2021 Nov 10. pii: S0264-410X(21)01432.
PubMed Abstract available

COLOMBATTI OLIVIERI MA, Moyano RD, Mon ML, Gravisaco MJ, et al
Evaluation of a virulent strain of Mycobacterium avium subsp. Paratuberculosis used as a heat-killed vaccine.
Vaccine. 2021 Nov 10. pii: S0264-410X(21)01433.
PubMed Abstract available

MCLEAN HQ, Levine MZ, King JP, Flannery B, et al
Serologic response to sequential vaccination with enhanced influenza vaccines: Open label randomized trial among adults aged 65-74 years.
Vaccine. 2021 Nov 10. pii: S0264-410X(21)01415.
PubMed Abstract available

BABUADZE GG, Echanove J, Lamarre C, deLaVega MA, et al
A novel DNA platform designed for vaccine use with high transgene expression and immunogenicity.
Vaccine. 2021 Nov 10. pii: S0264-410X(21)01315.
PubMed Abstract available

RODRIGUES CMC, Plotkin SA
The influence of interval between doses on response to vaccines.
Vaccine. 2021 Nov 10. pii: S0264-410X(21)01381.
PubMed

RADWAN NF, Abu-Sheasha GA, Bedwani RN, Yassine OG, et al
Vaccine wastage and cost saving after multi-dose vial policy implementation in Egypt: A success story.
Vaccine. 2021 Nov 9. pii: S0264-410X(21)01400.
PubMed Abstract available

SHAH SFA, Ginossar T, Bentley JM, Zimet G, et al
Using the Theory of Planned behavior to identify correlates of HPV vaccination uptake among college students attending a rural university in Alabama.
Vaccine. 2021 Nov 9. pii: S0264-410X(21)01431.
PubMed Abstract available

SVENNERHOLM AM, Qadri F, Lundgren A, Kaim J, et al
Induction of mucosal and systemic immune responses against the common O78 antigen of an oral inactivated ETEC vaccine in Bangladeshi children and infants.
Vaccine. 2021 Nov 9. pii: S0264-410X(21)01389.
PubMed Abstract available

THULUVA S, Matur R, Tsa K, Gv SR, et al
A single blind randomized phase 3 study to evaluate safety and immunogenicity of inactivated hepatitis A vaccine (HAPIBEV(TM)) in 1-15 years-old healthy hepatitis A vaccine-naive children.
Vaccine. 2021 Nov 8. pii: S0264-410X(21)01326.
PubMed Abstract available

HOSANGADI D, Martin EK, Watson M, Bruns R, et al
Supporting use of thermostable vaccines during public health emergencies: Considerations and recommendations for the future.
Vaccine. 2021 Nov 8. pii: S0264-410X(21)01398.
PubMed

MCKINNON B, Quach C, Dube E, Tuong Nguyen C, et al
Social inequalities in COVID-19 vaccine acceptance and uptake for children and adolescents in Montreal, Canada.
Vaccine. 2021 Nov 8. pii: S0264-410X(21)01426.
PubMed Abstract available

WU K, Choi A, Koch M, Elbashir S, et al
Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice.
Vaccine. 2021 Nov 8. pii: S0264-410X(21)01435.
PubMed Abstract available

VILLANUEVA-UY MET, Lam HY, Aldaba JG, Uy TMZ, et al
Cost-effectiveness of rotavirus vaccination in the Philippines: A modeling study.
Vaccine. 2021 Nov 6. pii: S0264-410X(21)01290.
PubMed Abstract available

CUEVAS-JUAREZ E, Pando-Robles V, Palomares LA
Flavivirus vaccines: Virus-like particles and single-round infectious particles as promising alternatives.
Vaccine. 2021 Nov 6. pii: S0264-410X(21)01383.
PubMed Abstract available

SHARUN K, Tiwari R, Saied AA, Dhama K, et al
SARS-CoV-2 vaccine for domestic and captive animals: An effort to counter COVID-19 pandemic at the human-animal interface.
Vaccine. 2021 Nov 6. pii: S0264-410X(21)01386.
PubMed Abstract available

GOODE JR, Cook P, Cuttino S, Gatewood SBS, et al
Early experience with COVID-19 vaccine in a Federally-Qualified Healthcare Center for the homeless.
Vaccine. 2021 Nov 6. pii: S0264-410X(21)01388.
PubMed

DE HAAS TDJ, Yeung KHT, Hutubessy R, van der Putten IM, et al
Programme costs for introducing age/gestation-based universal influenza vaccine schedules for young children and pregnant women in Hong Kong.
Vaccine. 2021;39:6762-6780.
PubMed Abstract available

LAU CL, Mayfield HJ, Sinclair JE, Brown SJ, et al
Risk-benefit analysis of the AstraZeneca COVID-19 vaccine in Australia using a Bayesian network modelling framework.
Vaccine. 2021 Nov 4. pii: S0264-410X(21)01428.
PubMed Abstract available

SANZ-ROJO S, Jimenez-Garcia R, Lopez-de-Andres A, de Miguel-Diez J, et al
Influenza vaccination uptake among high-risk target groups and health care workers in Spain and change from 2017 to 2020.
Vaccine. 2021 Nov 3. pii: S0264-410X(21)01392.
PubMed Abstract available

VASUDEVAN L, Ostermann J, Wang Y, Harrison SE, et al
Predictors of HPV vaccination in the southern US: A survey of caregivers from 13 states.
Vaccine. 2021 Nov 3. pii: S0264-410X(21)01356.
PubMed Abstract available

RIBERA-CANO A, Dupont M, Houze-Cerfon CH, Houze-Cerfon V, et al
Evaluation of a prototype decontamination mobile unit (UMDEO) for COVID-19 vaccination: A cross-sectional survey in France.
Vaccine. 2021 Nov 3. pii: S0264-410X(21)01429.
PubMed Abstract available

MIYA TV, Groome MJ, de Assis Rosa D
TLR genetic variation is associated with Rotavirus-specific IgA seroconversion in South African Black infants after two doses of Rotarix vaccine.
Vaccine. 2021 Nov 2. pii: S0264-410X(21)01384.
PubMed Abstract available

PIERRON A, Bozon F, Berceanu A, Fontan J, et al
Vaccination coverage in hematological patients undergoing chemotherapy: Should we move towards personalized vaccination?
Vaccine. 2021 Nov 2. pii: S0264-410X(21)01369.
PubMed Abstract available

MALTEZOU HC
Vaccination of healthcare personnel in the COVID-19 era: A call for actions.
Vaccine. 2021 Nov 2. pii: S0264-410X(21)01427.
PubMed

CASSONE A, Cauda R
Multicomponent vaccines to fight SARS-CoV-2 variants of concern.
Vaccine. 2021 Nov 1. pii: S0264-410X(21)01402.
PubMed

WAGNER A, Jasinska J, Tomosel E, Zielinski CC, et al
Absent antibody production following COVID19 vaccination with mRNA in patients under immunosuppressive treatments.
Vaccine. 2021 Nov 1. pii: S0264-410X(21)01401.
PubMed Abstract available

October 2021

LIU H, Zhou C, An J, Song Y, et al
Development of recombinant COVID-19 vaccine based on CHO-produced, prefusion spike trimer and alum/CpG adjuvants.
Vaccine. 2021 Oct 30. pii: S0264-410X(21)01399.
PubMed Abstract available

MALTEZOU HC, Panagopoulos P, Sourri F, Giannouchos TV, et al
COVID-19 vaccination significantly reduces morbidity and absenteeism among healthcare personnel: A prospective multicenter study.
Vaccine. 2021 Oct 30. pii: S0264-410X(21)01387.
PubMed Abstract available

KHOURY J, Najjar-Debbiny R, Hanna A, Jabbour A, et al
COVID-19 vaccine - Long term immune decline and breakthrough infections.
Vaccine. 2021 Oct 30. pii: S0264-410X(21)01370.
PubMed Abstract available

GORDON SF, Clothier HJ, Morgan H, Buttery JP, et al
Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia.
Vaccine. 2021 Oct 29. pii: S0264-410X(21)01350.
PubMed Abstract available

GARCIA-GRIMSHAW M, Ceballos-Liceaga SE, Michel-Chavez A, Garcia-Alanis M, et al
Transient sensory symptoms among first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine: A case-control study.
Vaccine. 2021 Oct 29. pii: S0264-410X(21)01391.
PubMed Abstract available

MAZUR A, Benitez S, Chuffart-Finsterwald S, La Rotta R, et al
COVAX no fault compensation program for COVID-19 vaccine injuries in 92 low and middle income countries.
Vaccine. 2021 Oct 28. pii: S0264-410X(21)01380.
PubMed

MARTIN S, Vanderslott S
"Any idea how fast 'It's just a mask!' can turn into 'It's just a vaccine!'": From mask mandates to vaccine mandates during the COVID-19 pandemic.
Vaccine. 2021 Oct 28. pii: S0264-410X(21)01351.
PubMed Abstract available

NOWALK MP, D'Agostino HEA, Zimmerman RK, Saul SG, et al
Agreement among sources of adult influenza vaccination in the age of immunization information systems.
Vaccine. 2021 Oct 26. pii: S0264-410X(21)01372.
PubMed Abstract available

JEON S, Kelly M, Yun J, Lee B, et al
Scalable production and immunogenicity of a cholera conjugate vaccine.
Vaccine. 2021 Oct 26. pii: S0264-410X(21)01312.
PubMed Abstract available

CAPPOZZO F, Dal Zotto A, Scollo M, Bernardini D, et al
dTap vaccination uptake during pregnancy: Pregnant women-focused and health professionals-focused predictors in the Veneto Region (Italy).
Vaccine. 2021 Oct 25. pii: S0264-410X(21)01321.
PubMed Abstract available

HUANG J, Bai Y, Ding H, Wang B, et al
Acceptance of pneumococcal vaccination in older adults: A general population-based survey.
Vaccine. 2021 Oct 25. pii: S0264-410X(21)01344.
PubMed Abstract available

CHANTHAVANICH P, Versage E, Van Twuijver E, Hohenboken M, et al
Antibody responses against heterologous A/H5N1 strains for an MF59-adjuvanted cell culture-derived A/H5N1 (aH5N1c) influenza vaccine in healthy pediatric subjects.
Vaccine. 2021 Oct 25. pii: S0264-410X(21)01317.
PubMed Abstract available

OLANIPEKUN T, Abe T, Effoe V, Westney G, et al
Changes in COVID-19 vaccine acceptance rate among recovered critically Ill patients: A 12-month follow-up study.
Vaccine. 2021 Oct 25. pii: S0264-410X(21)01324.
PubMed Abstract available

OPRIESSNIG T, Rawal G, McKeen L, Filippsen Favaro P, et al
Evaluation of the intranasal route for porcine reproductive and respiratory disease modified-live virus vaccination.
Vaccine. 2021 Oct 24. pii: S0264-410X(21)01353.
PubMed Abstract available

LOEB M, Russell ML, Kelly-Stradiotto C, Fuller N, et al
Adjuvanted trivalent influenza vaccine versus quadrivalent inactivated influenza vaccine in Hutterite Children: A randomized clinical trial.
Vaccine. 2021 Oct 23. pii: S0264-410X(21)01355.
PubMed Abstract available

MYAT TW, Thu HM, Tate JE, Burnett E, et al
Rotavirus infection among children under five years of age hospitalized with acute gastroenteritis in Myanmar during 2018-2020 - Multicentre surveillance before rotavirus vaccine introduction.
Vaccine. 2021 Oct 23. pii: S0264-410X(21)01323.
PubMed Abstract available

FAN X, Li X, Wan K, Zhao X, et al
Construction and immunogenicity of a T cell epitope-based subunit vaccine candidate against Mycobacterium tuberculosis.
Vaccine. 2021 Oct 23. pii: S0264-410X(21)01354.
PubMed Abstract available

SHACHOR-MEYOUHAS Y, Hussein K, Szwarcwort-Cohen M, Weissman A, et al
Single BNT162b2 vaccine dose produces seroconversion in under 60 s cohort.
Vaccine. 2021 Oct 23. pii: S0264-410X(21)01327.
PubMed Abstract available

TRAN VN, Nguyen HA, Le TTA, Truong TT, et al
Factors influencing adverse events following immunization with AZD1222 in Vietnamese adults during first half of 2021.
Vaccine. 2021;39:6485-6491.
PubMed Abstract available

ANDRADE G
Covid-19 vaccine hesitancy, conspiracist beliefs, paranoid ideation and perceived ethnic discrimination in a sample of University students in Venezuela.
Vaccine. 2021 Oct 22. pii: S0264-410X(21)01371.
PubMed Abstract available

SHUBITZ LF, Robb EJ, Powell DA, Bowen RA, et al
Deltacps1 vaccine protects dogs against experimentally induced coccidioidomycosis.
Vaccine. 2021 Oct 22. pii: S0264-410X(21)01349.
PubMed Abstract available

VAN BEEK LF, Langereis JD, van den Berg van Saparoea HB, Gillard J, et al
Intranasal vaccination with protein bodies elicit strong protection against Streptococcus pneumoniae colonization.
Vaccine. 2021 Oct 22. pii: S0264-410X(21)01313.
PubMed Abstract available

DAR SA, Kole S, Shin SM, Jeong HJ, et al
Comparative study on antigen persistence and immunoprotective efficacy of intramuscular and intraperitoneal injections of squalene - aluminium hydroxide (Sq + Al) adjuvanted viral hemorrhagic septicaemia virus vaccine in olive flounder (Paralichthys o
Vaccine. 2021 Oct 22. pii: S0264-410X(21)01345.
PubMed Abstract available

ABU-RAYA B, Maertens K, Munoz FM, Zimmermann P, et al
Factors affecting antibody responses to immunizations in infants born to women immunized against pertussis in pregnancy and unimmunized women: Individual-Participant Data Meta-analysis.
Vaccine. 2021;39:6545-6552.
PubMed Abstract available

FAN S, Li D, Zhao H, Yu L, et al
Ameliorated immunity elicited by intradermal inoculation in individuals vaccinated with inactivated SARS-CoV-2 vaccine.
Vaccine. 2021 Oct 22. pii: S0264-410X(21)01375.
PubMed Abstract available

MAKOVITZKI A, Lerer E, Kafri Y, Adar Y, et al
Evaluation of a downstream process for the recovery and concentration of a Cell-Culture-Derived rVSV-Spike COVID-19 vaccine candidate.
Vaccine. 2021 Oct 22. pii: S0264-410X(21)01376.
PubMed Abstract available

WANG J, Wagner AL, Chen Y, Jaime E, et al
Would COVID-19 vaccination willingness increase if mobile technologies prohibit unvaccinated individuals from public spaces? A nationwide discrete choice experiment from China.
Vaccine. 2021 Oct 22. pii: S0264-410X(21)01340.
PubMed Abstract available

JAMES EK, Bokemper SE, Gerber AS, Omer SB, et al
Persuasive messaging to increase COVID-19 vaccine uptake intentions.
Vaccine. 2021 Oct 22. pii: S0264-410X(21)01368.
PubMed Abstract available

NETANEL C, Ben-Aharon O, Ben-Ari Z, Chodick G, et al
Evaluation of a universal hepatitis B vaccination program and antenatal screening for hepatitis B surface antigen: Results from a real-world study 2015-2016.
Vaccine. 2021 Oct 20. pii: S0264-410X(21)01287.
PubMed Abstract available

DANKWA EA, Donnelly CA, Brouwer AF, Zhao R, et al
Estimating vaccination threshold and impact in the 2017-2019 hepatitis A virus outbreak among persons experiencing homelessness or who use drugs in Louisville, Kentucky, United states.
Vaccine. 2021 Oct 19. pii: S0264-410X(21)01308.
PubMed Abstract available

KIM D, Pekgun P, Yildirim I, Keskinocak P, et al
Resource allocation for different types of vaccines against COVID-19: Tradeoffs and synergies between efficacy and reach.
Vaccine. 2021 Oct 18. pii: S0264-410X(21)01346.
PubMed Abstract available

DANG TKNS, Rivero Cabrera R, Yeung KHT, van der Putten IM, et al
Feasibility of age- and gestation-based routine universal influenza vaccines schedules for children aged 6 months - 2 years and pregnant women.
Vaccine. 2021 Oct 18. pii: S0264-410X(21)01291.
PubMed Abstract available

CHEN AT, Stacey HD, Marzok A, Singh P, et al
Effect of inactivated influenza vaccination on human coronavirus infection: Secondary analysis of a randomized trial in Hutterite colonies.
Vaccine. 2021 Oct 18. pii: S0264-410X(21)01341.
PubMed Abstract available

MAKI Y, Kashiwagi S, Kimizuka Y
Laser vaccine adjuvants: Light-augmented immune responses.
Vaccine. 2021 Oct 16. pii: S0264-410X(21)01233.
PubMed Abstract available

CHAPIN-BARDALES J, Myers T, Gee J, Shay DK, et al
Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance system.
Vaccine. 2021 Oct 16. pii: S0264-410X(21)01339.
PubMed Abstract available

ALI SAHRAIAN M, Ghadiri F, Azimi A, Naser Moghadasi A, et al
Adverse events reported by Iranian patients with multiple sclerosis after the first dose of Sinopharm BBIBP-CorV.
Vaccine. 2021;39:6347-6350.
PubMed Abstract available

AYAZ S, Dibben O, Chapman D
Presence of defective viral genes in H1N1 live attenuated influenza vaccine strains is not associated with reduced human cell fitness or vaccine effectiveness.
Vaccine. 2021 Oct 15. pii: S0264-410X(21)01320.
PubMed Abstract available

SILVER MC, Neumann PJ, Ma S, Kim DD, et al
Frequency and impact of the inclusion of broader measures of value in economic evaluations of vaccines.
Vaccine. 2021 Oct 13. pii: S0264-410X(21)01285.
PubMed Abstract available

MOGHNIEH R, Mekdashi R, El-Hassan S, Abdallah D, et al
Immunogenicity and reactogenicity of BNT162b2 booster in BBIBP-CorV-vaccinated individuals compared with homologous BNT162b2 vaccination: Results of a pilot prospective cohort study from Lebanon.
Vaccine. 2021 Oct 13. pii: S0264-410X(21)01314.
PubMed Abstract available

LALWANI SK, Ramanan PV, Sapru A, Sundaram B, et al
Safety and immunogenicity of a multidose vial formulation of 13-valent pneumococcal conjugate vaccine administered with routine pediatric vaccines in healthy infants in India: A phase 4, randomized, open-label study.
Vaccine. 2021 Oct 13. pii: S0264-410X(21)01208.
PubMed Abstract available

BUUS M, da Silva I, Nielsen S, Thysen SM, et al
Coverage and factors associated with receiving campaign polio vaccines in an urban population in Guinea-Bissau.
Vaccine. 2021 Oct 12. pii: S0264-410X(21)01150.
PubMed Abstract available

PARK WJ, Yoon YK, Kim Y, Park JS, et al
Development of a bivalent conjugate vaccine candidate against rotaviral diarrhea and tuberculosis using polysaccharide from Mycobacterium tuberculosis conjugated to DeltaVP8* protein from rotavirus.
Vaccine. 2021 Oct 9. pii: S0264-410X(21)01282.
PubMed Abstract available

MCNAY LA, Arnoczy G, Martell M, Mock P, et al
Community-based hospitals: New partners for government-sponsored clinical research during public health emergencies.
Vaccine. 2021;39:6183-6185.
PubMed Abstract available

HART P, Farrar J
The influenza vaccines roadmap - A better future through improved influenza vaccines.
Vaccine. 2021 Oct 8. pii: S0264-410X(21)01286.
PubMed

VERBERK JDM, van Dongen JAP, van de Kassteele J, Andrews NJ, et al
Impact analysis of rotavirus vaccination in various geographic regions in Western Europe.
Vaccine. 2021 Oct 8. pii: S0264-410X(21)01262.
PubMed Abstract available

BRYDEN GM, Rockloff M, Browne M, Unsworth C, et al
Effect of contamination and purity priming on attitudes to vaccination and other health interventions: A randomised controlled experiment.
Vaccine. 2021 Oct 8. pii: S0264-410X(21)01278.
PubMed Abstract available

VANDERMEULEN C, Leroux-Roels I, Vandeleur J, Staniscia T, et al
A new fully liquid presentation of MenACWY-CRM conjugate vaccine: Results from a multicentre, randomised, controlled, observer-blind study.
Vaccine. 2021 Oct 8. pii: S0264-410X(21)01283.
PubMed Abstract available

FU LY, Torres R, Caleb S, Cheng YI, et al
Vaccination coverage among young homeless children compared to US national immunization survey data.
Vaccine. 2021 Oct 8. pii: S0264-410X(21)01288.
PubMed Abstract available

MOTTELSON A, Vandeweerdt C, Atchapero M, Luong T, et al
A self-administered virtual reality intervention increases COVID-19 vaccination intention.
Vaccine. 2021 Oct 8. pii: S0264-410X(21)01311.
PubMed Abstract available

HUMBLE RM, Sell H, Dube E, MacDonald NE, et al
Canadian parents' perceptions of COVID-19 vaccination and intention to vaccinate their children: Results from a cross-sectional national survey.
Vaccine. 2021 Oct 8. pii: S0264-410X(21)01309.
PubMed Abstract available

BYRNE T, Patel P, Shrotri M, Beale S, et al
Trends, patterns and psychological influences on COVID-19 vaccination intention: Findings from a large prospective community cohort study in England and Wales (Virus Watch).
Vaccine. 2021 Oct 8. pii: S0264-410X(21)01281.
PubMed Abstract available

MULLER-PEBODY B, Sinnathamby MA, Warburton F, Rooney G, et al
Impact of the childhood influenza vaccine programme on antibiotic prescribing rates in primary care in England.
Vaccine. 2021 Oct 6. pii: S0264-410X(21)01284.
PubMed Abstract available

GIERSING B, Shah N, Kristensen D, Amorij JP, et al
Strategies for vaccine-product innovation: Creating an enabling environment for product development to uptake in low- and middle-income countries.
Vaccine. 2021 Oct 6. pii: S0264-410X(21)00996.
PubMed Abstract available

REIDENBERG BE, Hirsch K, Costello CM, Russo M, et al
Drive through COVID19 vaccination for developmentally disabled persons.
Vaccine. 2021 Oct 6. pii: S0264-410X(21)01279.
PubMed

MUKHERJEE N, Julian E, Torrelles JB, Svatek RS, et al
Effects of Mycobacterium bovis Calmette et Guerin (BCG) in oncotherapy: Bladder cancer and beyond.
Vaccine. 2021 Oct 6. pii: S0264-410X(21)01256.
PubMed Abstract available

ALLEVA DG, Delpero AR, Scully MM, Murikipudi S, et al
Development of an IgG-Fc fusion COVID-19 subunit vaccine, AKS-452.
Vaccine. 2021 Oct 5. pii: S0264-410X(21)01294.
PubMed Abstract available

LAZAROS G, Anastassopoulou C, Hatziantoniou S, Kalos T, et al
A case series of acute pericarditis following COVID-19 vaccination in the context of recent reports from Europe and the United States.
Vaccine. 2021 Oct 5. pii: S0264-410X(21)01295.
PubMed Abstract available

DRAPER M, Stergiopoulos S
Shingles vaccination uptake in Massachusetts adults aged 50 years and older.
Vaccine. 2021 Oct 5. pii: S0264-410X(21)01223.
PubMed Abstract available

BRUCE YU Y, Taraban MB, Briggs KT
All vials are not the same: Potential role of vaccine quality in vaccine adverse reactions.
Vaccine. 2021 Oct 5. pii: S0264-410X(21)01280.
PubMed

VADREVU KM, Raju D, Rani S, Reddy S, et al
Persisting antibody responses to Vi polysaccharide-tetanus toxoid conjugate (Typbar TCV(R)) vaccine up to 7years following primary vaccination of children<2years of age with, or without, a booster vaccination.
Vaccine. 2021 Oct 5. pii: S0264-410X(21)00966.
PubMed Abstract available

CORCORAN KE, Scheitle CP, DiGregorio BD
Christian nationalism and COVID-19 vaccine hesitancy and uptake.
Vaccine. 2021 Oct 2. pii: S0264-410X(21)01289.
PubMed Abstract available

SRICHAN P, Thohinung U, Kodyee S, Apidechkul T, et al
Vaccine serocoverage under the expanded program on immunization among hill tribe children in Thailand: A cross-sectional study.
Vaccine. 2021 Oct 1. pii: S0264-410X(21)01264.
PubMed Abstract available

September 2021

NIEUWENHUIZEN NE, Zyla J, Zedler U, Bandermann S, et al
Weaker protection against tuberculosis in BCG-vaccinated male 129 S2 mice compared to females.
Vaccine. 2021 Sep 30. pii: S0264-410X(21)01230.
PubMed Abstract available

LEWIS G, Lazzaro T, Crawford NW
Recurrent lipoatrophy following multiple vaccinations: A case study.
Vaccine. 2021 Sep 30. pii: S0264-410X(21)01237.
PubMed

KHAIMOVA R, Fischetti B, Cope R, Berkowitz L, et al
Serological response with Heplisav-B(R) in prior Hepatitis B vaccine non-responders living with HIV.
Vaccine. 2021 Sep 29. pii: S0264-410X(21)01251.
PubMed Abstract available

FRANCIS-OLIVIERO F, Bozoki S, Micsik A, Kieny MP, et al
Research priorities to increase vaccination coverage in Europe (EU joint action on vaccination).
Vaccine. 2021 Sep 28. pii: S0264-410X(21)01224.
PubMed Abstract available

YACOUB MR, Cucca V, Asperti C, Ramirez GA, et al
Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine.
Vaccine. 2021 Sep 28. pii: S0264-410X(21)01239.
PubMed Abstract available

ROMANO CJ, Hall C, Khodr ZG, Bukowinski AT, et al
History of pandemic H1N1-containing influenza vaccination and risk for spontaneous abortion and birth defects.
Vaccine. 2021 Sep 28. pii: S0264-410X(21)01171.
PubMed Abstract available

HOFMEISTER MG, Weng MK, Thoroughman D, Thomasson ED, et al
Prevalence of indications for adult hepatitis A vaccination among hepatitis A outbreak-associated cases, Three US States, 2016-2019.
Vaccine. 2021 Sep 28. pii: S0264-410X(21)01254.
PubMed Abstract available

MOON JE, Greenleaf ME, Regules JA, Debois M, et al
A phase IIA extension study evaluating the effect of booster vaccination with a fractional dose of RTS,S/AS01E in a controlled human malaria infection challenge.
Vaccine. 2021 Sep 27. pii: S0264-410X(21)01203.
PubMed Abstract available

CASEY RM, Adrien N, Badiane O, Diallo A, et al
National introduction of HPV vaccination in Senegal-Successes, challenges, and lessons learned.
Vaccine. 2021 Sep 27. pii: S0264-410X(21)01075.
PubMed Abstract available

SINGH AK, Srikrishna G, Bivalacqua TJ, Bishai WR, et al
Recombinant BCGs for tuberculosis and bladder cancer.
Vaccine. 2021 Sep 27. pii: S0264-410X(21)01231.
PubMed Abstract available

VIEIRA REZENDE RP, Braz AS, Guimaraes MFB, Ribeiro SLE, et al
Characteristics associated with COVID-19 vaccine hesitancy: A nationwide survey of 1000 patients with immune-mediated inflammatory diseases.
Vaccine. 2021 Sep 25. pii: S0264-410X(21)01260.
PubMed Abstract available

BLEICHER I, Kadour-Peero E, Sagi-Dain L, Sagi S, et al
Early exploration of COVID-19 vaccination safety and effectiveness during pregnancy: interim descriptive data from a prospective observational study.
Vaccine. 2021 Sep 25. pii: S0264-410X(21)01234.
PubMed Abstract available

SHEVZOV-ZEBRUN N, Caplan A
Parental consent for vaccination of minors against COVID-19.
Vaccine. 2021 Sep 25. pii: S0264-410X(21)01250.
PubMed

FISHER KA, Nguyen N, Crawford S, Fouayzi H, et al
Preferences for COVID-19 vaccination information and location: Associations with vaccine hesitancy, race and ethnicity.
Vaccine. 2021 Sep 25. pii: S0264-410X(21)01261.
PubMed Abstract available

MOLODECKY NA, Jafari H, Safdar RM, Ahmed JA, et al
Modelling the spread of serotype-2 vaccine derived-poliovirus outbreak in Pakistan and Afghanistan to inform outbreak control strategies in the context of the COVID-19 pandemic.
Vaccine. 2021 Sep 25. pii: S0264-410X(21)01228.
PubMed Abstract available

ZENG W, Cui Y, Jarawan E, Avila C, et al
Optimizing immunization schedules in endemic cholera regions: cost-effectiveness assessment of vaccination strategies for cholera control in Bangladesh.
Vaccine. 2021 Sep 24. pii: S0264-410X(21)01235.
PubMed Abstract available

AKSNES BN, Walldorf JA, Nkwenkeu SF, Zoma RL, et al
Vaccination information, motivations, and barriers in the context of meningococcal serogroup A conjugate vaccine introduction: A qualitative assessment among caregivers in Burkina Faso, 2018.
Vaccine. 2021 Sep 24. pii: S0264-410X(21)01229.
PubMed Abstract available

FADLYANA E, Rusmil K, Tarigan R, Rahmadi AR, et al
A phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18-59 years: An interim analysis in Indonesia.
Vaccine. 2021 Sep 24. pii: S0264-410X(21)01255.
PubMed Abstract available

SINGH AK, Phatak SR, Singh R, Bhattacharjee K, et al
Antibody response after first and second-dose of ChAdOx1-nCOV (Covishield(TM)(R)) and BBV-152 (Covaxin(TM)(R)) among health care workers in India: The final results of cross-sectional coronavirus vaccine-induced antibody titre (COVAT) study.
Vaccine. 2021 Sep 24. pii: S0264-410X(21)01258.
PubMed Abstract available

YAMAZAKI Y, Ikeda M, Imada T, Furuno K, et al
A phase 3, multicenter, single-arm, open-label study to assess the safety, tolerability, and immunogenicity of a single dose of 13-valent pneumococcal conjugate vaccine in Japanese participants aged 6-64 years who are considered to be at increased ris
Vaccine. 2021 Sep 23. pii: S0264-410X(21)01168.
PubMed Abstract available

MOORE KA, Ostrowsky JT, Kraigsley AM, Mehr AJ, et al
A Research and Development (R&D) roadmap for influenza vaccines: Looking toward the future.
Vaccine. 2021 Sep 23. pii: S0264-410X(21)01028.
PubMed Abstract available

CHOWDHURY F, Akter A, Rahman Bhuiyan T, Tauheed I, et al
A non-inferiority trial comparing two recombinant vaccines (Hepa-B vs. Engerix-B) for hepatitis B among adults in Dhaka, Bangladesh.
Vaccine. 2021 Sep 21. pii: S0264-410X(21)01222.
PubMed Abstract available

MELGAARD A, Krogsgaard LW, Randrup T, Plana-Ripoll O, et al
Pre-vaccination vulnerability and suspected adverse events following HPV vaccination. A case-control study nested in the Danish national birth cohort.
Vaccine. 2021 Sep 21. pii: S0264-410X(21)01232.
PubMed Abstract available

LIU CH, Huang WT, Chie WC, Arnold Chan K, et al
Safety surveillance of varicella vaccine using tree-temporal scan analysis.
Vaccine. 2021 Sep 21. pii: S0264-410X(21)01226.
PubMed Abstract available

GIESE H, Neth H, Gaissmaier W
Determinants of information diffusion in online communication on vaccination: The benefits of visual displays.
Vaccine. 2021 Sep 21. pii: S0264-410X(21)01195.
PubMed Abstract available

MAHAPATRA SR, Dey J, Kaur T, Sarangi R, et al
Immunoinformatics and molecular docking studies reveal a novel Multi-Epitope peptide vaccine against pneumonia infection.
Vaccine. 2021 Sep 20. pii: S0264-410X(21)01204.
PubMed Abstract available

PARK SJ, Kang YM, Cho HK, Kim DY, et al
Cross-protective efficacy of inactivated whole influenza vaccines against Korean Y280 and Y439 lineage H9N2 viruses in mice.
Vaccine. 2021 Sep 20. pii: S0264-410X(21)01207.
PubMed Abstract available

ANGSUWATCHARAKON P, Puthanakit T, Bunjoungmanee P, Anugulruengkitt S, et al
High seroprevalence of rubella in Thai children with a 2-dose MMR national immunization policy.
Vaccine. 2021 Sep 20. pii: S0264-410X(21)01127.
PubMed Abstract available

SCHNEIDER JC, Chen HC, Bautista E, Retallack D, et al
Safety and immunogenicity of Px563L, a recombinant anthrax vaccine candidate, in a two-dose regimen for post-exposure prophylaxis in healthy adults.
Vaccine. 2021 Sep 17. pii: S0264-410X(21)01123.
PubMed Abstract available

WILEY KE, Levy D, Shapiro GK, Dube E, et al
A user-centered approach to developing a new tool measuring the behavioural and social drivers of vaccination.
Vaccine. 2021 Sep 17. pii: S0264-410X(21)01186.
PubMed Abstract available

ELBASHA EH, Choi Y, Daniels V, Goveia MG, et al
Cost-effectiveness of routine catch-up hepatitis a vaccination in the United States: Dynamic transmission modeling study.
Vaccine. 2021 Sep 17. pii: S0264-410X(21)01147.
PubMed Abstract available

MANSUY JM, Sagna AS, Laurent M, Izopet J, et al
COVID-19 diagnosis in a Senegalese company: A model for COVID-19 vaccination?
Vaccine. 2021 Sep 17. pii: S0264-410X(21)01227.
PubMed

RAINA MACINTYRE C, Costantino V, Chanmugam A
The use of face masks during vaccine roll-out in New YorkCity and impact on epidemic control.
Vaccine. 2021 Sep 16. pii: S0264-410X(21)01164.
PubMed Abstract available

WANG J, Wu QS, Lu J, Ni YH, et al
Low vaccination coverage of pneumococcal conjugate vaccines (PCVs) in Shanghai, China: A database analysis based on birth cohorts from 2012 to 2020.
Vaccine. 2021 Sep 16. pii: S0264-410X(21)01190.
PubMed Abstract available

OZAWA S, Chen HH, Rao GG, Eguale T, et al
Value of pneumococcal vaccination in controlling the development of antimicrobial resistance (AMR): Case study using DREAMR in Ethiopia.
Vaccine. 2021 Sep 16. pii: S0264-410X(21)00471.
PubMed Abstract available

CHARD AN, Martinez M, Matanock A, Kassem AM, et al
Estimation of oral poliovirus vaccine effectiveness in Afghanistan, 2010-2020.
Vaccine. 2021 Sep 16. pii: S0264-410X(21)01199.
PubMed Abstract available

MOSINA L, Kulper-Schiek W, Jacques-Carroll L, Earnshaw A, et al
Supporting National Immunization Technical Advisory Groups in the WHO European Region in developing national COVID-19 vaccination recommendations through online communication platform.
Vaccine. 2021 Sep 16. pii: S0264-410X(21)01225.
PubMed Abstract available

AUGUSTO HERNANDES ROCHA T, Grapiuna de Almeida D, Shankar Kozhumam A, Cristina da Silva N, et al
Microplanning for designing vaccination campaigns in low-resource settings: A geospatial artificial intelligence-based framework.
Vaccine. 2021 Sep 15. pii: S0264-410X(21)01197.
PubMed Abstract available

ABAYNEH T, Getachew B, Gelaye E, Traxler R, et al
Viability evaluation of freeze dried and suspension anthrax spore vaccine formulations stored at different temperatures.
Vaccine. 2021 Sep 15. pii: S0264-410X(21)01202.
PubMed Abstract available

LEE SI, Jeong CG, Ul Salam Mattoo S, Nazki S, et al
Protective immunity induced by concurrent intradermal injection of porcine circovirus type 2 and Mycoplasma hyopneumoniae inactivated vaccines in pigs.
Vaccine. 2021 Sep 15. pii: S0264-410X(21)00921.
PubMed Abstract available

SULIMAN S, Pelzer PT, Shaku M, Rozot V, et al
Meeting report: Virtual Global Forum on Tuberculosis Vaccines, 20-22 April 2021.
Vaccine. 2021 Sep 15. pii: S0264-410X(21)01154.
PubMed Abstract available

KOSHAL SS, Ray A, Mehra R, Kaur A, et al
Partnering for rotavirus vaccine introduction in India: A retrospective analysis.
Vaccine. 2021 Sep 15. pii: S0264-410X(21)01193.
PubMed Abstract available

KIM DY, Kang YM, Cho HK, Park SJ, et al
Development of a recombinant H9N2 influenza vaccine candidate against the Y280 lineage field virus and its protective efficacy.
Vaccine. 2021 Sep 14. pii: S0264-410X(21)01149.
PubMed Abstract available

VAN HOOSTE WLC
Influenza vaccination at the workplace.
Vaccine. 2021 Sep 14. pii: S0264-410X(21)01188.
PubMed

BENJAMIN-CHUNG J, Arnold BF, Mishra K, Kennedy CJ, et al
City-wide school-located influenza vaccination: A retrospective cohort study.
Vaccine. 2021 Sep 14. pii: S0264-410X(21)01161.
PubMed Abstract available

KNUF M, Haas H, Garcia-Corbeira P, Turriani E, et al
Hexavalent vaccines: What can we learn from head-to-head studies?
Vaccine. 2021 Sep 13. pii: S0264-410X(21)01146.
PubMed Abstract available

MKOPI A, Mtenga S, Festo C, Mhalu G, et al
Factors affecting non-coverage of measles-rubella vaccination among children aged 9-59 months in Tanzania.
Vaccine. 2021 Sep 13. pii: S0264-410X(21)01196.
PubMed Abstract available

PALACHE A, Rockman S, Taylor B, Akcay M, et al
Vaccine complacency and dose distribution inequities limit the benefits of seasonal influenza vaccination, despite a positive trend in use.
Vaccine. 2021 Sep 11. pii: S0264-410X(21)01157.
PubMed Abstract available

YOSHIKAWA T
Third-generation smallpox vaccine strain-based recombinant vaccines for viral hemorrhagic fevers.
Vaccine. 2021 Sep 11. pii: S0264-410X(21)01169.
PubMed Abstract available

PARADOWSKA-STANKIEWICZ I, Rumik A, Bogusz J, Zbrzezniak J, et al
Duration of protection against Bordetella pertussis infection elicited by whole-cell and acellular vaccine priming in Polish children and adolescents.
Vaccine. 2021 Sep 9. pii: S0264-410X(21)01167.
PubMed Abstract available

FUJISAWA S, Murata S, Takehara M, Aoyama J, et al
In vitro characterization of adipocyte plasma membrane-associated protein from poultry red mites, Dermanyssus gallinae, as a vaccine antigen for chickens.
Vaccine. 2021 Sep 8. pii: S0264-410X(21)01166.
PubMed Abstract available

THOMPSON MG, Soto G, Perez A, Newes-Adeyim G, et al
Influenza vaccine effectiveness within prospective cohorts of healthcare personnel in Israel and Peru 2016-2019.
Vaccine. 2021 Sep 8. pii: S0264-410X(21)00982.
PubMed Abstract available

PERRY M, Akbari A, Cottrell S, Gravenor MB, et al
Inequalities in coverage of COVID-19 vaccination: A population register based cross-sectional study in Wales, UK.
Vaccine. 2021 Sep 8. pii: S0264-410X(21)01198.
PubMed Abstract available

PLATT HL, Cardona JF, Haranaka M, Schwartz HI, et al
A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and older (PNEU-AGE).
Vaccine. 2021 Sep 7. pii: S0264-410X(21)01097.
PubMed Abstract available

ABREU E SILVA HB, Correa HP, Ribeiro IA, Nascimento VAM, et al
Impact of six years of routine varicella vaccination on the disease-related hospitalizations at Minas Gerais, Brazil.
Vaccine. 2021 Sep 7. pii: S0264-410X(21)01009.
PubMed Abstract available

KUNITOKI K, Funato M, Mitsunami M, Kinoshita T, et al
Access to HPV vaccination in Japan: Increasing social trust to regain vaccine confidence.
Vaccine. 2021 Sep 7. pii: S0264-410X(21)01145.
PubMed Abstract available

MOLL K, Wong HL, Fingar K, Ke Zhou C, et al
Vaccine exposure during pregnancy among privately and publicly insured women in the United States, 2016-2018.
Vaccine. 2021 Sep 7. pii: S0264-410X(21)01151.
PubMed Abstract available

VAN DONGEN JAP, Rouers EDM, Bonten MJM, Bruijning-Verhagen PCJ, et al
Evaluation of non-specific effects of human rotavirus vaccination in medical risk infants.
Vaccine. 2021 Sep 7. pii: S0264-410X(21)01115.
PubMed Abstract available

JACOBI CJ, Vaidyanathan B
Racial differences in anticipated COVID-19 vaccine acceptance among religious populations in the US.
Vaccine. 2021 Sep 7. pii: S0264-410X(21)01184.
PubMed Abstract available

MOORE DCBC, Nehab MF, Camacho KG, Reis AT, et al
Low COVID-19 vaccine hesitancy in Brazil.
Vaccine. 2021 Sep 7. pii: S0264-410X(21)01192.
PubMed Abstract available

EBERHARDT J, Ling J
Predicting COVID-19 vaccination intention using protection motivation theory and conspiracy beliefs.
Vaccine. 2021 Sep 7. pii: S0264-410X(21)01189.
PubMed Abstract available

WAINSTOCK T, Yoles I, Sergienko R, Sheiner E, et al
Prenatal maternal COVID-19 vaccination and pregnancy outcomes.
Vaccine. 2021 Sep 7. pii: S0264-410X(21)01191.
PubMed Abstract available

SULIMAN DM, Nawaz FA, Mohanan P, Modber MAKA, et al
UAE efforts in promoting COVID-19 vaccination and building vaccine confidence.
Vaccine. 2021 Sep 7. pii: S0264-410X(21)01194.
PubMed Abstract available

BHAT S, Caldera F, Farraye FA
Standardizing shared vaccination responsibilities among specialists to improve vaccination rates of immunosuppressed patients.
Vaccine. 2021 Sep 4. pii: S0264-410X(21)01121.
PubMed

RANE MS, Rohani P, Halloran ME
Durability of protection after 5 doses of acellular pertussis vaccine among 5-9 year old children in King County, Washington.
Vaccine. 2021 Sep 4. pii: S0264-410X(21)01118.
PubMed Abstract available

SISNOWSKI J, Vujovich-Dunn C, Gidding H, Brotherton J, et al
Differences in school factors associated with adolescent HPV vaccination initiation and completion coverage in three Australian states.
Vaccine. 2021 Sep 4. pii: S0264-410X(21)01124.
PubMed Abstract available

LEVIN D, Shimon G, Fadlon-Derai M, Gershovitz L, et al
Myocarditis following COVID-19 vaccination - A case series.
Vaccine. 2021 Sep 4. pii: S0264-410X(21)01172.
PubMed Abstract available

BOZORGI A, Fahimnia B
Micro array patch (MAP) for the delivery of thermostable vaccines in Australia: A cost/benefit analysis.
Vaccine. 2021 Sep 3. pii: S0264-410X(21)01036.
PubMed Abstract available

BOZORGI A, Fahimnia B
Transforming the vaccine supply chain in Australia: Opportunities and challenges.
Vaccine. 2021 Sep 3. pii: S0264-410X(21)01066.
PubMed Abstract available

SONG JY, Chang CJ, Andrews C, Diez-Domingo J, et al
Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by sequential PPSV23 vaccination in healthy adults aged>/=50years: A randomized phase III trial (PNEU-PATH).
Vaccine. 2021 Sep 3. pii: S0264-410X(21)01071.
PubMed Abstract available

LAWRENCE J, Kitchin N, Anderson AS, Pride MW, et al
Safety and immunogenicity of different Clostridioides (Clostridium) difficile vaccine formulations in two early phase randomized studies of healthy adults aged 50-85 years.
Vaccine. 2021 Sep 3. pii: S0264-410X(21)00592.
PubMed Abstract available

ZHOU Z, Zhang X, Li Q, Fu L, et al
Unmethylated CpG motif-containing genomic DNA fragments of bacillus calmette-guerin improves immune response towards a DNA vaccine for COVID-19.
Vaccine. 2021 Sep 3. pii: S0264-410X(21)01165.
PubMed Abstract available

VOORMAN A, O'Reilly K, Lyons H, Goel AK, et al
Real-time prediction model of cVDPV2 outbreaks to aid outbreak response vaccination strategies.
Vaccine. 2021 Sep 2. pii: S0264-410X(21)01112.
PubMed Abstract available

KARAFILLAKIS E, Peretti-Watel P, Verger P, Chantler T, et al
The role of maturity in adolescent decision-making around HPV vaccination in France.
Vaccine. 2021 Sep 2. pii: S0264-410X(21)01156.
PubMed Abstract available

ALI A, Dwyer D, Wu Q, Wang Q, et al
Characterization of humoral response to COVID mRNA vaccines in multiple sclerosis patients on disease modifying therapies.
Vaccine. 2021 Sep 2. pii: S0264-410X(21)01126.
PubMed Abstract available

MCCLAIN JB, Chuang A, Reid C, Moore SM, et al
Rabies virus neutralizing activity, pharmacokinetics, and safety of the monoclonal antibody mixture SYN023 in combination with rabies vaccination: Results of a phase 2, randomized, blinded, controlled trial.
Vaccine. 2021 Sep 2. pii: S0264-410X(21)01114.
PubMed Abstract available

DRUEDAHL LC, Minssen T, Price WN
Collaboration in times of crisis: A study on COVID-19 vaccine R&D partnerships.
Vaccine. 2021 Sep 2. pii: S0264-410X(21)01163.
PubMed Abstract available

ZAMAN K, Kovacs SD, Vanderende K, Aziz A, et al
Assessing the immunogenicity of three different inactivated polio vaccine schedules for use after oral polio vaccine cessation, an open label, phase IV, randomized controlled trial.
Vaccine. 2021 Sep 1. pii: S0264-410X(21)01113.
PubMed Abstract available

BARRY M, Temsah MH, Aljamaan F, Saddik B, et al
COVID-19 vaccine uptake among healthcare workers in the fourth country to authorize BNT162b2 during the first month of rollout.
Vaccine. 2021 Sep 1. pii: S0264-410X(21)01131.
PubMed Abstract available

KOTLER L, Greenberg D, Givon-Lavi N, van der Beek BA, et al
Decline in pneumococcal nasopharyngeal carriage in children 6-23 months with respiratory illnesses following pneumococcal conjugate vaccine implementation.
Vaccine. 2021 Sep 1. pii: S0264-410X(21)01130.
PubMed Abstract available

CLAYTON K, Finley C, Flynn DJ, Graves M, et al
Evaluating the effects of vaccine messaging on immunization intentions and behavior: Evidence from two randomized controlled trials in Vermont.
Vaccine. 2021 Sep 1. pii: S0264-410X(21)01095.
PubMed Abstract available

AZAM JM, Saitta B, Bonner K, Ferrari MJ, et al
Modelling the relative benefits of using the measles vaccine outside cold chain for outbreak response.
Vaccine. 2021 Sep 1. pii: S0264-410X(21)01101.
PubMed Abstract available

August 2021

PRIVOR-DUMM LA, Poland GA, Barratt J, Durrheim DN, et al
A global agenda for older adult immunization in the COVID-19 era: A roadmap for action.
Vaccine. 2021;39:5240-5250.
PubMed Abstract available

TROGSTAD L, Robertson AH, Mjaaland S, Magnus P, et al
Association between ChAdOx1 nCoV-19 vaccination and bleeding episodes: Large population-based cohort study.
Vaccine. 2021 Aug 31. pii: S0264-410X(21)01103.
PubMed Abstract available

CANTARELLI P, Belle N, Quattrone F
Nudging influenza vaccination among health care workers.
Vaccine. 2021 Aug 31. pii: S0264-410X(21)01073.
PubMed Abstract available

ALBANI VVL, Loria J, Massad E, Zubelli JP, et al
The impact of COVID-19 vaccination delay: A data-driven modeling analysis for Chicago and New York City.
Vaccine. 2021 Aug 31. pii: S0264-410X(21)01158.
PubMed Abstract available

FOWLER A, Sampson M, Remaley AT, Chackerian B, et al
A VLP-based vaccine targeting ANGPTL3 lowers plasma triglycerides in mice.
Vaccine. 2021 Aug 30. pii: S0264-410X(21)01125.
PubMed Abstract available

BROSH-NISSIMOV T, Sorek N, Yeshayahu M, Zherebovich I, et al
Oropharyngeal shedding of herpesviruses before and after BNT162b2 mRNA vaccination against COVID-19.
Vaccine. 2021 Aug 30. pii: S0264-410X(21)01148.
PubMed Abstract available

BATOOL R, Tahir Yousafzai M, Qureshi S, Ali M, et al
Effectiveness of typhoid conjugate vaccine against culture-confirmed typhoid in a peri-urban setting in Karachi: A case-control study.
Vaccine. 2021 Aug 28. pii: S0264-410X(21)01099.
PubMed Abstract available

CAMPBELL JD, Pasetti MF, Oot L, Adam Z, et al
Linked vaccination coverage surveys plus serosurveys among Ethiopian toddlers undertaken three years apart to compare coverage and serologic evidence of protection in districts implementing the RED-QI approach.
Vaccine. 2021 Aug 28. pii: S0264-410X(21)01119.
PubMed Abstract available

BAQUI AH, Koffi AK, McCollum ED, Roy AD, et al
Impact of national introduction of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in Bangladesh: Case-control and time-trend studies.
Vaccine. 2021 Aug 28. pii: S0264-410X(21)01116.
PubMed Abstract available

PRELOG M, Almanzar G, Stern R, Robrade K, et al
Humoral and cellular immune response to tick-borne-encephalitis (TBE) vaccination depends on booster doses in patients with Juvenile Idiopathic Arthritis (JIA).
Vaccine. 2021 Aug 27. pii: S0264-410X(21)01049.
PubMed Abstract available

O'LORCAIN P, Cotter S, Walsh C
Influenza vaccine uptake among healthcare workers and residents in public health care facilities in Ireland over nine influenza seasons (2011-2012 to 2019-2020).
Vaccine. 2021 Aug 27. pii: S0264-410X(21)00987.
PubMed Abstract available

MALTEZOU HC, Effraimidou E, Cassimos DC, Medic S, et al
Vaccination programs for pregnant women in Europe, 2021.
Vaccine. 2021 Aug 27. pii: S0264-410X(21)01122.
PubMed Abstract available

GORANDER S, Honda-Okubo Y, Backstrom M, Baldwin J, et al
A truncated glycoprotein G vaccine formulated with Advax-CpG adjuvant provides protection of mice against genital herpes simplex virus 2 infection.
Vaccine. 2021 Aug 26. pii: S0264-410X(21)01098.
PubMed Abstract available

SILCOCK R, Moghimi A, Perrett K, Crawford N, et al
Subcutaneous nodule at the vaccine injection site - A case of mistaken identity.
Vaccine. 2021 Aug 26. pii: S0264-410X(21)01069.
PubMed

NOWAK SA, Gidengil CA, Parker AM, Matthews LJ, et al
Association among trust in health care providers, friends, and family, and vaccine hesitancy.
Vaccine. 2021 Aug 26. pii: S0264-410X(21)01068.
PubMed Abstract available

HARPAZ R
COVID-19 vaccine safety monitoring: Might differential healthcare seeking introduce detection bias into rates of medical events and cause false safety signals?
Vaccine. 2021 Aug 25. pii: S0264-410X(21)00712.
PubMed

AZIZ AB, Zaman K, Kim DR, Park JY, et al
Re-evaluation of population-level protection conferred by a rotavirus vaccine using the 'fried-egg' approach in a rural setting in Bangladesh.
Vaccine. 2021 Aug 25. pii: S0264-410X(21)01096.
PubMed Abstract available

DECKER MD, Garman PM, Hughes H, Yacovone MA, et al
Enhanced safety surveillance study of ACAM2000 smallpox vaccine among US military service members.
Vaccine. 2021 Aug 25. pii: S0264-410X(21)01074.
PubMed Abstract available

KUROKAWA N, Robinson MK, Bernard C, Kawaguchi Y, et al
Safety and immunogenicity of a plant-derived rotavirus-like particle vaccine in adults, toddlers and infants.
Vaccine. 2021 Aug 25. pii: S0264-410X(21)01100.
PubMed Abstract available

LEWIN BJ, Rodriguez J, Yang SJ, Tartof SY, et al
Predictors of hepatitis A immunity in adults in California in order to better utilize hepatitis A vaccine.
Vaccine. 2021 Aug 25. pii: S0264-410X(21)01104.
PubMed Abstract available

XU X, Rodgers MD, Guo WG
A hub-and-spoke design for ultra-cold COVID-19 vaccine distribution.
Vaccine. 2021 Aug 25. pii: S0264-410X(21)01117.
PubMed Abstract available

ODUWOLE EO, Mahomed H, Laurenzi CA, Larson HJ, et al
Point-of-care vaccinators' perceptions of vaccine hesitancy drivers: A qualitative study from the cape metropolitan district, South Africa.
Vaccine. 2021 Aug 24. pii: S0264-410X(21)01102.
PubMed Abstract available

ROTENBERG S, Downer MB, Cooper J
Making COVID-19 vaccinations accessible for people with disabilities.
Vaccine. 2021 Aug 24. pii: S0264-410X(21)01110.
PubMed

MORAIS E, El Mouaddin N, Schuurman S, De A, et al
Landscape assessment for gender neutral human papillomavirus vaccination recommendations including head and neck cancer burden data.
Vaccine. 2021 Aug 24. pii: S0264-410X(21)01076.
PubMed Abstract available

MORIKAWA Y, Sakakibara H, Kimiya T, Obonai T, et al
Live attenuated vaccine efficacy six months after intravenous immunoglobulin therapy for Kawasaki disease.
Vaccine. 2021 Aug 24. pii: S0264-410X(21)01011.
PubMed Abstract available

SUZUKI H, Noguchi T, Ogawa K, Miyazato P, et al
Fusion of parvovirus B19 receptor-binding domain and pneumococcal surface protein A induces protective immunity against parvovirus B19 and Streptococcus pneumoniae.
Vaccine. 2021;39:5146-5152.
PubMed Abstract available

AHMED D, VanderEnde K, Harvey P, Bhatnagar P, et al
Human papillomavirus (HPV) vaccine introduction in Sikkim state: Best practices from the first statewide multiple-age cohort HPV vaccine introduction in India-2018-2019.
Vaccine. 2021 Aug 21. pii: S0264-410X(21)00901.
PubMed Abstract available

HAUSI H, Nicks P, Mzengeza T, Tsega A, et al
The challenge of identifying eligible girls for HPV vaccination: HPV mapping data verification in Malawi.
Vaccine. 2021 Aug 20. pii: S0264-410X(21)00902.
PubMed Abstract available

NIKOLAY B, Ribeiro Dos Santos G, Lipsitch M, Rahman M, et al
Assessing the feasibility of Nipah vaccine efficacy trials based on previous outbreaks in Bangladesh.
Vaccine. 2021 Aug 20. pii: S0264-410X(21)01047.
PubMed Abstract available

DUDLEY MZ, Bernier R, Brewer J, Salmon DA, et al
Walking the Tightrope: Reevaluating science communication in the era of COVID-19 vaccines.
Vaccine. 2021 Aug 19. pii: S0264-410X(21)01070.
PubMed Abstract available

JUNG Y, Min JY, Kim HJ, Min KB, et al
Disparities in infant mortality from all-infectious, vaccine-preventable, and non-vaccine preventable diseases in relation to parental education.
Vaccine. 2021 Aug 19. pii: S0264-410X(21)01012.
PubMed Abstract available

VENEGAS-VARGAS C, Taylor LP, Foss DL, Godbee TK, et al
Cellular and humoral immunity following vaccination with two different PCV2 vaccines (containing PCV2a or PCV2a/PCV2b) and challenge with virulent PCV2d.
Vaccine. 2021 Aug 19. pii: S0264-410X(21)01033.
PubMed Abstract available

ZHANG N, Zheng T, Chen Y, Zhu H, et al
Coxsackievirus B5 virus-like particle vaccine exhibits greater immunogenicity and immunoprotection than its inactivated counterpart in mice.
Vaccine. 2021 Aug 19. pii: S0264-410X(21)01007.
PubMed Abstract available

WIEMKEN TL, Salas J, Hoft DF, Jacobs C, et al
Dementia risk following influenza vaccination in a large veteran cohort running head: Influenza vaccination and dementia.
Vaccine. 2021 Aug 19. pii: S0264-410X(21)01079.
PubMed Abstract available

BRAEYE T, Cornelissen L, Catteau L, Haarhuis F, et al
Vaccine effectiveness against infection and onwards transmission of COVID-19: Analysis of Belgian contact tracing data, January-June 2021.
Vaccine. 2021 Aug 19. pii: S0264-410X(21)01108.
PubMed Abstract available

LEE T, Gutierrez RL, Maciel M, Poole S, et al
Safety and immunogenicity of intramuscularly administered CS6 subunit vaccine with a modified heat-labile enterotoxin from enterotoxigenic Escherichia coli.
Vaccine. 2021 Aug 18. pii: S0264-410X(21)01065.
PubMed Abstract available

HUANG XX, Bose AS, Gupta BP, Rai P, et al
Vaccine preventable diseases surveillance in Nepal: How much does it cost?
Vaccine. 2021 Aug 18. pii: S0264-410X(21)00915.
PubMed Abstract available

KARAFILLAKIS E, Paterson P, Larson HJ
'My primary purpose is to protect the unborn child': Understanding pregnant women's perceptions of maternal vaccination and vaccine trials in Europe.
Vaccine. 2021 Aug 18. pii: S0264-410X(21)01014.
PubMed Abstract available

BEDFORD H, Firman N, Waller J, Marlow L, et al
Which young women are not being vaccinated against HPV? Cross-sectional analysis of a UK national cohort study.
Vaccine. 2021 Aug 18. pii: S0264-410X(21)01005.
PubMed Abstract available

KOHL-HECKL WK, Schroter M, Dobos G, Cramer H, et al
Complementary medicine use and flu vaccination - A nationally representative survey of US adults.
Vaccine. 2021 Aug 18. pii: S0264-410X(21)01037.
PubMed Abstract available

NACIUTE M, Kiwitt T, Kemp RA, Hook S, et al
Bacteria biohybrid oral vaccines for colorectal cancer treatment reduce tumor growth and increase immune infiltration.
Vaccine. 2021 Aug 18. pii: S0264-410X(21)01048.
PubMed Abstract available

LIU S, Liu J
Public attitudes toward COVID-19 vaccines on English-language Twitter: A sentiment analysis.
Vaccine. 2021 Aug 17. pii: S0264-410X(21)01106.
PubMed Abstract available

LAMM DL, Morales A
A BCG success story: From prevention of tuberculosis to optimal bladder cancer treatment.
Vaccine. 2021 Aug 17. pii: S0264-410X(21)01046.
PubMed Abstract available

MVUNDURA M, Frivold C, Janik Osborne A, Soni P, et al
Vaccine innovation prioritisation strategy: Findings from three country-stakeholder consultations on vaccine product innovations.
Vaccine. 2021 Aug 16. pii: S0264-410X(21)01044.
PubMed Abstract available

JIANG Y, Li X, Yu L, Tong W, et al
Immune efficacy of a candidate porcine reproductive and respiratory syndrome vaccine rHN-NP49 administered by a Needle-free intradermal delivery system in comparison with intramuscular injection.
Vaccine. 2021 Aug 16. pii: S0264-410X(21)01043.
PubMed Abstract available

HASSAN AS, Perera DJ, Ward BJ, Ndao M, et al
Therapeutic activity of a Salmonella-vectored Schistosoma mansoni vaccine in a mouse model of chronic infection.
Vaccine. 2021 Aug 16. pii: S0264-410X(21)01051.
PubMed Abstract available

LAIGLE V, Postma MJ, Pavlovic M, Cadeddu C, et al
Vaccine market access pathways in the EU27 and the United Kingdom-analysis and recommendations for improvements.
Vaccine. 2021 Aug 14. pii: S0264-410X(21)00918.
PubMed Abstract available

JANSSEN RS, Bruxvoort K, Jacobsen SJ, Slezak J, et al
Considerations for estimating real-world outcomes and value in vaccination: A case study with adult hepatitis B virus vaccination.
Vaccine. 2021 Aug 14. pii: S0264-410X(21)01015.
PubMed Abstract available

HAGAN LM, Dusseau C, Crockett M, Rodriguez T, et al
COVID-19 vaccination in the Federal Bureau of Prisons, December 2020-April 2021.
Vaccine. 2021 Aug 14. pii: S0264-410X(21)01078.
PubMed Abstract available

PRESTON KB, Wong TAS, To A, Tashiro TE, et al
Single-vial filovirus glycoprotein vaccines: Biophysical characteristics and immunogenicity after co-lyophilization with adjuvant.
Vaccine. 2021 Aug 13. pii: S0264-410X(21)01002.
PubMed Abstract available

LI L, Hessell AJ, Kong XP, Haigwood NL, et al
A large repertoire of B cell lineages targeting one cluster of epitopes in a vaccinated rhesus macaque.
Vaccine. 2021 Aug 13. pii: S0264-410X(21)01035.
PubMed Abstract available

RODRIGUES DE OLIVEIRA N, Jorge S, Andrade Colares Maia M, Thurow Bunde T, et al
Protective efficacy of whole-cell inactivated Leptospira vaccines made using virulent or avirulent strains in a hamster model.
Vaccine. 2021 Aug 13. pii: S0264-410X(21)01034.
PubMed Abstract available

CIAPPONI A, Bardach A, Mazzoni A, Alconada T, et al
Safety of components and platforms of COVID-19 vaccines considered for use in pregnancy: A rapid review.
Vaccine. 2021 Aug 13. pii: S0264-410X(21)01067.
PubMed Abstract available

SCHLEISS MR, John CC, Permar SR
Children are the key to the Endgame: A case for routine pediatric COVID vaccination.
Vaccine. 2021 Aug 12. pii: S0264-410X(21)01004.
PubMed

ROBERTSON RC, Church JA, Edens TJ, Mutasa K, et al
The fecal microbiome and rotavirus vaccine immunogenicity in rural Zimbabwean infants.
Vaccine. 2021 Aug 12. pii: S0264-410X(21)00981.
PubMed Abstract available

WEBSTER H, Valencia S, Kumar A, Chan C, et al
Pre-existing immunity to cytomegalovirus in macaques influences human CMV vaccine responses in preclinical models.
Vaccine. 2021 Aug 12. pii: S0264-410X(21)01029.
PubMed Abstract available

IWAMOTO M, Hickman CJ, Colley H, Arciuolo RJ, et al
Measles infection in persons with secondary vaccine failure, New York City, 2018-19.
Vaccine. 2021 Aug 12. pii: S0264-410X(21)00983.
PubMed Abstract available

PALLADINO G, Ferrari A, Music N, Settembre EC, et al
Improved immunologic responses to heterologous influenza strains in children with low preexisting antibody response vaccinated with MF59-adjuvanted influenza vaccine.
Vaccine. 2021 Aug 12. pii: S0264-410X(21)01041.
PubMed Abstract available

GRUPEL D, Gazit S, Schreiber L, Nadler V, et al
Kinetics of SARS-CoV-2 anti-S IgG after BNT162b2 vaccination.
Vaccine. 2021 Aug 11. pii: S0264-410X(21)01045.
PubMed Abstract available

STINSON JA, Boopathy AV, Cieslewicz BM, Zhang Y, et al
Enhancing influenza vaccine immunogenicity and efficacy through infection mimicry using silk microneedles.
Vaccine. 2021 Aug 11. pii: S0264-410X(21)00957.
PubMed Abstract available

OKAMURA S, Ebina H
Could live attenuated vaccines better control COVID-19?
Vaccine. 2021 Aug 11. pii: S0264-410X(21)01038.
PubMed Abstract available

KANJI JN, Bailey A, Fenton J, Ling SH, et al
Detection of SARS-CoV-2 antibodies formed in response to the BNT162b2 and mRNA-1237 mRNA vaccine by commercial antibody tests.
Vaccine. 2021 Aug 11. pii: S0264-410X(21)01042.
PubMed Abstract available

RIZK JG, Barr CE, Rizk Y, Lewin JC, et al
The next frontier in vaccine safety and VAERS: Lessons from COVID-19 and ten recommendations for action.
Vaccine. 2021 Aug 10. pii: S0264-410X(21)01006.
PubMed

GALOR I, Hartal M, Perry Markovich M, Avramovich E, et al
Population seroprotection against hepatitis a virus in Israel 18 years after introduction of inactivated vaccine into the routine childhood vaccination schedule: Response letter, to letter to the editor.
Vaccine. 2021;39:4777.
PubMed

HERZOG C
Immune memory persistence is well documented for hepatitis A vaccines.
Vaccine. 2021;39:4775-4776.
PubMed

STAPLES JN, Nelamangala SL, Morris S, Wells K, et al
Exploring socio-demographic and geospatial variation in human papillomavirus vaccination uptake in Virginia.
Vaccine. 2021 Aug 9. pii: S0264-410X(21)00984.
PubMed Abstract available

GOUD R, Thompson D, Welsh K, Lu M, et al
ICD-10 anaphylaxis algorithm and the estimate of vaccine-attributable anaphylaxis incidence in Medicare.
Vaccine. 2021 Aug 9. pii: S0264-410X(21)01003.
PubMed Abstract available

PETRIE JG, Fligiel H, Lamerato L, Martin ET, et al
Agreement between state registry, health record, and self-report of influenza vaccination.
Vaccine. 2021 Aug 9. pii: S0264-410X(21)00995.
PubMed Abstract available

KRISTINSDOTTIR I, Haraldsson A, Love A, Asgeirsdottir TL, et al
Burden of rotavirus disease in young children in Iceland - Time to vaccinate?
Vaccine. 2021 Aug 9. pii: S0264-410X(21)00944.
PubMed Abstract available

BRITTON KJ, Pickering JL, Pomat WS, de Gier C, et al
Lack of effectiveness of 13-valent pneumococcal conjugate vaccination against pneumococcal carriage density in Papua New Guinean infants.
Vaccine. 2021 Aug 9. pii: S0264-410X(21)00990.
PubMed Abstract available

ILLOUZ T, Madar R, Hirsh T, Biragyn A, et al
Induction of an effective anti-Amyloid-beta humoral response in aged mice.
Vaccine. 2021;39:4817-4829.
PubMed Abstract available

PHILLIPS A, Carlson S, Danchin M, Beard F, et al
From program suspension to the pandemic: A qualitative examination of Australia's vaccine pharmacovigilance system over 10 years.
Vaccine. 2021 Aug 7. pii: S0264-410X(21)00950.
PubMed Abstract available

LYTLE KL, Collins SP, Feldstein LR, Baughman AH, et al
Influenza vaccine acceptance and hesitancy among adults hospitalized with severe acute respiratory illnesses, United States 2019-2020.
Vaccine. 2021 Aug 7. pii: S0264-410X(21)00948.
PubMed Abstract available

YLADE M, Agrupis KA, Daag JV, Crisostomo MV, et al
Effectiveness of a single-dose mass dengue vaccination in Cebu, Philippines: A case-control study.
Vaccine. 2021 Aug 7. pii: S0264-410X(21)00920.
PubMed Abstract available

YOSHIKAWA T
Implementing vaccination policies based upon scientific evidence in Japan.
Vaccine. 2021 Aug 7. pii: S0264-410X(21)00968.
PubMed Abstract available

ELDRIDGE JH, Egan MA, Matassov D, Hamm S, et al
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for a soluble glycoprotein vaccine to prevent disease caused by Nipah or Hendra viruses.
Vaccine. 2021 Aug 7. pii: S0264-410X(21)00907.
PubMed Abstract available

BORGHI L, Riva E
Was Aldo Castellani the inventor of combined and polyvalent vaccines?
Vaccine. 2021 Aug 6. pii: S0264-410X(21)00955.
PubMed Abstract available

FENG J, Li Q
How to ensure vaccine safety: An evaluation of China's vaccine regulation system.
Vaccine. 2021 Aug 6. pii: S0264-410X(21)00986.
PubMed Abstract available

MILLER CN, Kemp TJ, Abrahamsen M, Isaacs-Soriano K, et al
Increases in HPV-16/18 antibody avidity and HPV-specific memory B-cell response in mid-adult aged men post-dose three of the quadrivalent HPV vaccine.
Vaccine. 2021 Aug 6. pii: S0264-410X(21)00962.
PubMed Abstract available

TAYLOR SC, Hurst B, Martiszus I, Hausman MS, et al
Semi-quantitative, high throughput analysis of SARS-CoV-2 neutralizing antibodies: Measuring the level and duration of immune response antibodies post infection/vaccination.
Vaccine. 2021 Aug 6. pii: S0264-410X(21)01013.
PubMed Abstract available

JOHM P, Nkoum N, Ceesay A, Mbaye EH, et al
Erratum to 'Factors influencing acceptance of vaccination during pregnancy in The Gambia and Senegal' [Vaccine 39 (2021) 3926-3934].
Vaccine. 2021 Aug 5. pii: S0264-410X(21)00991.
PubMed

WILSON R
HPV vaccine acceptance in West Africa: A systematic literature review.
Vaccine. 2021 Aug 5. pii: S0264-410X(21)00835.
PubMed Abstract available

CHHATWAL J, Sapru A, Sundaram B, Shenoy B, et al
A phase 4 study of the safety of the 13-valent pneumococcal conjugate vaccine in children 6 to 17 years of age in India.
Vaccine. 2021 Aug 5. pii: S0264-410X(21)00946.
PubMed Abstract available

DODD RH, Pickles K, Cvejic E, Cornell S, et al
Perceived public health threat a key factor for willingness to get the COVID-19 vaccine in Australia.
Vaccine. 2021 Aug 5. pii: S0264-410X(21)01008.
PubMed Abstract available

FRIEDENSOHN L, Zur M, Timofeyev M, Burshtein S, et al
Sub-cutaneous Pfizer/BioNTech COVID-19 vaccine administration results in seroconversion among young adults.
Vaccine. 2021 Aug 5. pii: S0264-410X(21)01010.
PubMed Abstract available

HVASS AMF, Norredam M, Sodemann M, Thomsen MK, et al
Corrigendum to 'Are refugees arriving in Denmark an under-immunised group for measles? A cross-sectional serology study' [Vaccine 38 (2020) 2788-2794].
Vaccine. 2021 Aug 4. pii: S0264-410X(21)00993.
PubMed

HAYMAN B, Dennehy M
Developing-country vaccine manufacturers' technical capabilities can make a difference in global immunization.
Vaccine. 2021 Aug 3. pii: S0264-410X(21)00922.
PubMed Abstract available

SAKALA IG, Honda-Okubo Y, Li L, Baldwin J, et al
A M2 protein-based universal influenza vaccine containing Advax-SM adjuvant provides newborn protection via maternal or neonatal immunization.
Vaccine. 2021 Aug 3. pii: S0264-410X(21)00914.
PubMed Abstract available

HAUPT RE, Harberts EM, Kitz RJ, Strohmeier S, et al
Novel TLR4 adjuvant elicits protection against homologous and heterologous Influenza A infection.
Vaccine. 2021 Aug 3. pii: S0264-410X(21)00847.
PubMed Abstract available

SUN J, Zheng Z, Li M, Liu Z, et al
Development of a novel ZIKV vaccine comprised of immunodominant CD4+ and CD8+ T cell epitopes identified through comprehensive epitope mapping in Zika virus infected mice.
Vaccine. 2021 Aug 2. pii: S0264-410X(21)00913.
PubMed Abstract available

LEIDNER AJ, Tang Z, Guo A, Anderson TC, et al
Insurance reimbursements for recombinant zoster vaccine in the private sector.
Vaccine. 2021 Aug 2. pii: S0264-410X(21)00928.
PubMed Abstract available

July 2021

LITWIN C, Smith L, Donken R, Krajden M, et al
High-risk HPV prevalence among women undergoing cervical cancer screening: Findings a decade after HPV vaccine implementation in British Columbia, Canada.
Vaccine. 2021 Jul 31. pii: S0264-410X(21)00868.
PubMed Abstract available

ROSENTHAL EM, Hall EW, Rosenberg ES, Harris A, et al
Corrigendum to "Assessing the cost-utility of preferentially administering Heplisav-B vaccine to certain populations" [Vaccine 38(51) (2020) 8206-8215].
Vaccine. 2021 Jul 31. pii: S0264-410X(21)00963.
PubMed

REDONDO E, Drago G, Lopez-Belmonte JL, Guillen JM, et al
Cost-utility analysis of influenza vaccination in a population aged 65 years or older in Spain with a high-dose vaccine versus an adjuvanted vaccine.
Vaccine. 2021 Jul 31. pii: S0264-410X(21)00926.
PubMed Abstract available

KONTOPOULOU K, Ainatzoglou A, Nakas CT, Ifantidou A, et al
Second dose of the BNT162b2 mRNA vaccine: Value of timely administration but questionable necessity among the seropositive.
Vaccine. 2021 Jul 31. pii: S0264-410X(21)00958.
PubMed Abstract available

SIDDIQUI A, Ahmed A, Tanveer M, Saqlain M, et al
An overview of procurement, pricing, and uptake of COVID-19 vaccines in Pakistan.
Vaccine. 2021 Jul 31. pii: S0264-410X(21)00965.
PubMed

MAHAJAN A, Kaur J, Sidana C, Shivam S, et al
Geo-prioritization framework for COVID-19 vaccine allocation in India.
Vaccine. 2021 Jul 31. pii: S0264-410X(21)00989.
PubMed Abstract available

LUCINDE RK, Ong'ayo G, Houlihan C, Bottomley C, et al
Pneumococcal conjugate vaccine dose-ranging studies in humans: A systematic review.
Vaccine. 2021 Jul 30. pii: S0264-410X(21)00910.
PubMed Abstract available

JONES A, Kawesa-Newell N
Using branded behaviour change communication to create demand for the HPV vaccine among girls in Malawi: An evaluation of Girl Effect's Zathu mini magazine.
Vaccine. 2021 Jul 30. pii: S0264-410X(21)00870.
PubMed Abstract available

DOI H, Kanto T
Factors influencing the durability of hepatitis B vaccine responses.
Vaccine. 2021 Jul 30. pii: S0264-410X(21)00876.
PubMed Abstract available

RAGHUNANDAN R, Higgins D, Hosken N
RSV neutralization assays - Use in immune response assessment.
Vaccine. 2021;39:4591-4597.
PubMed Abstract available

VELANDIA-GONZALEZ M, Vilajeliu A, Contreras M, Trumbo SP, et al
Monitoring progress of maternal and neonatal immunization in Latin America and the Caribbean.
Vaccine. 2021;39 Suppl 2:B55-B63.
PubMed Abstract available

KOBAYASHI M, Abdul-Karim A, Milucky JL, Zakariah A, et al
Estimating the economic burden of pneumococcal meningitis and pneumonia in northern Ghana in the African meningitis belt post-PCV13 introduction.
Vaccine. 2021;39:4685-4699.
PubMed Abstract available

LIM H, In HJ, Kim YJ, Jang S, et al
Development of an attenuated smallpox vaccine candidate: The KVAC103 strain.
Vaccine. 2021 Jul 29. pii: S0264-410X(21)00810.
PubMed Abstract available

CARRICO J, Talbird SE, La EM, Poston S, et al
Cost-benefit analysis of vaccination against four preventable diseases in older adults: Impact of an aging population.
Vaccine. 2021 Jul 29. pii: S0264-410X(21)00906.
PubMed Abstract available

DALON F, Majed L, Belhassen M, Jacoud F, et al
Human papillomavirus (HPV) vaccine coverage rates (VCRs) in France: A French claims data study.
Vaccine. 2021 Jul 29. pii: S0264-410X(21)00945.
PubMed Abstract available

DIACO M, Yin K, Seet B, Samson S, et al
Author response to a Letter to the Editor on "Introductory paper: High dose influenza vaccine".
Vaccine. 2021 Jul 28. pii: S0264-410X(21)00917.
PubMed

GARLASCO J, Bordino V, Marengo N, Rainero E, et al
Pertussis immunisation during pregnancy: Antibody levels and the impact of booster vaccine.
Vaccine. 2021 Jul 27. pii: S0264-410X(21)00930.
PubMed Abstract available

YU VG, Lasco G, David CC
Fear, mistrust, and vaccine hesitancy: Narratives of the dengue vaccine controversy in the Philippines.
Vaccine. 2021 Jul 27. pii: S0264-410X(21)00929.
PubMed Abstract available

GEORGIADIS GP, Georgiadis MC
Optimal planning of the COVID-19 vaccine supply chain.
Vaccine. 2021 Jul 27. pii: S0264-410X(21)00961.
PubMed Abstract available

VINK M, Upadhaya N, Amin HA, Liwal MG, et al
Does support to Private Health Practitioners increase childhood vaccination coverage? Findings from a comparative study in Afghanistan.
Vaccine. 2021 Jul 26. pii: S0264-410X(21)00877.
PubMed Abstract available

KHAN SA, Choudhury P, Kakati S, Doley R, et al
Effectiveness of a single dose of Japanese encephalitis vaccine among adults, Assam, India, 2012-2018.
Vaccine. 2021 Jul 26. pii: S0264-410X(21)00919.
PubMed Abstract available

KUROKAWA N, Lavoie PO, D'Aoust MA, Couture MM, et al
Development and characterization of a plant-derived rotavirus-like particle vaccine.
Vaccine. 2021 Jul 26. pii: S0264-410X(21)00916.
PubMed Abstract available

KLEIN NP, Peyrani P, Yacisin K, Caldwell N, et al
A phase 3, randomized, double-blind study to evaluate the immunogenicity and safety of 3 lots of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults 18 through 49 years of age.
Vaccine. 2021 Jul 24. pii: S0264-410X(21)00863.
PubMed Abstract available

RAJAN S, Akhtar N, Sharma S, Chakrabarti D, et al
COVID-19 vaccination for cancer patients: Evidence, priority, and practice.
Vaccine. 2021 Jul 24. pii: S0264-410X(21)00956.
PubMed

MICHOS A, Tatsi EB, Filippatos F, Dellis C, et al
Association of total and neutralizing SARS-CoV-2 spike -receptor binding domain antibodies with epidemiological and clinical characteristics after immunization with the 1(st) and 2(nd) doses of the BNT162b2 vaccine.
Vaccine. 2021 Jul 24. pii: S0264-410X(21)00960.
PubMed Abstract available

ALVES MLF, Ferreira MRA, Donassolo RA, Rodrigues RR, et al
Clostridium septicum: A review in the light of alpha-toxin and development of vaccines.
Vaccine. 2021 Jul 23. pii: S0264-410X(21)00878.
PubMed Abstract available

BURKE PF, Masters D, Massey G
Enablers and barriers to COVID-19 vaccine uptake: An international study of perceptions and intentions.
Vaccine. 2021 Jul 23. pii: S0264-410X(21)00947.
PubMed Abstract available

TEASDALE CA, Borrell LN, Shen Y, Kimball S, et al
Parental plans to vaccinate children for COVID-19 in New York city.
Vaccine. 2021 Jul 23. pii: S0264-410X(21)00949.
PubMed Abstract available

SUNDARAM M, Nasreen S, Calzavara A, He S, et al
Background rates of all-cause mortality, hospitalizations, and emergency department visits among nursing home residents in Ontario, Canada to inform COVID-19 vaccine safety assessments.
Vaccine. 2021 Jul 23. pii: S0264-410X(21)00951.
PubMed Abstract available

CALLAHAN AG, Coleman-Cowger VH, Schulkin J, Power ML, et al
Racial disparities in influenza immunization during pregnancy in the United States: A narrative review of the evidence for disparities and potential interventions.
Vaccine. 2021 Jul 23. pii: S0264-410X(21)00905.
PubMed Abstract available

SCHEIBLHOFER S, Drothler S, Braun W, Braun R, et al
Laser-facilitated epicutaneous immunization of mice with SARS-CoV-2 spike protein induces antibodies inhibiting spike/ACE2 binding.
Vaccine. 2021;39:4399-4403.
PubMed Abstract available

TISSOT N, Brunel AS, Bozon F, Rosolen B, et al
Patients with history of covid-19 had more side effects after the first dose of covid-19 vaccine.
Vaccine. 2021 Jul 22. pii: S0264-410X(21)00925.
PubMed Abstract available

MATHIVATHANAN K
Will COVID-19 vaccine equity be possible in India?
Vaccine. 2021 Jul 22. pii: S0264-410X(21)00927.
PubMed

HERVE PL, Dhelft V, Zuniga A, Ghasparian A, et al
Epicutaneous immunization using synthetic virus-like particles efficiently boosts protective immunity to respiratory syncytial virus.
Vaccine. 2021;39:4555-4563.
PubMed Abstract available

VODICKA E, Nonvignon J, Antwi-Agyei KO, Bawa J, et al
The projected cost-effectiveness and budget impact of HPV vaccine introduction in Ghana.
Vaccine. 2021 Jul 21. pii: S0264-410X(21)00904.
PubMed Abstract available

JACKSON B, Harvey Y, Perez-Martin E, Wilsden G, et al
The selection of naturally stable candidate foot-and-mouth disease virus vaccine strains for East Africa.
Vaccine. 2021 Jul 21. pii: S0264-410X(21)00860.
PubMed Abstract available

PAUL E, Brown GW, Kalk A, Ridde V, et al
Playing vaccine roulette: Why the current strategy of staking everything on Covid-19 vaccines is a high-stakes wager.
Vaccine. 2021 Jul 20. pii: S0264-410X(21)00923.
PubMed

CHUA H, Kwan MYW, Chan ELY, Wong JSC, et al
Influenza vaccine effectiveness against influenza-associated hospitalization in children in Hong Kong, 2010-2020.
Vaccine. 2021 Jul 20. pii: S0264-410X(21)00873.
PubMed Abstract available

HECHT J, Suliman S, Wegiel B
Bacillus Calmette-Guerin (BCG) vaccination to treat endometriosis.
Vaccine. 2021 Jul 20. pii: S0264-410X(21)00879.
PubMed Abstract available

INGROLE RSJ, Tao W, Joshi G, Gill HS, et al
M2e conjugated gold nanoparticle influenza vaccine displays thermal stability at elevated temperatures and confers protection to ferrets.
Vaccine. 2021 Jul 20. pii: S0264-410X(21)00909.
PubMed Abstract available

CORCORAN M, Mereckiene J, Cotter S, Murchan S, et al
Using genomics to examine the persistence of Streptococcus pneumoniae serotype 19A in Ireland and the emergence of a sub-clade associated with vaccine failures.
Vaccine. 2021 Jul 20. pii: S0264-410X(21)00741.
PubMed Abstract available

COLTON H, Greenfield DM, Snowden JA, Miller PDE, et al
Long-term survivors following autologous haematopoetic stem cell transplantation have significant defects in their humoral immunity against vaccine preventable diseases, years on from transplant.
Vaccine. 2021 Jul 19. pii: S0264-410X(21)00881.
PubMed Abstract available

MADHIVANAN P, Krupp K, Coudray M, Colbert B, et al
Longitudinal assessment of nonavalent vaccine HPV types in a sample of sexually active African American women from ten U.S. Cities.
Vaccine. 2021 Jul 19. pii: S0264-410X(21)00903.
PubMed Abstract available

HANLY M, Churches T, Fitzgerald O, MacIntyre CR, et al
Vaccinating Australia: How long will it take?
Vaccine. 2021 Jul 17. pii: S0264-410X(21)00865.
PubMed Abstract available

SHILLING H, Garland SM, Atchison S, Cornall AM, et al
Human papillomavirus prevalence and risk factors among Australian women 9-12 years after vaccine program introduction.
Vaccine. 2021 Jul 16. pii: S0264-410X(21)00864.
PubMed Abstract available

FLUCKIGER AC, Ontsouka B, Bozic J, Diress A, et al
An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits highly potent immunity.
Vaccine. 2021 Jul 16. pii: S0264-410X(21)00911.
PubMed Abstract available

INSERRA F, Tajer C, Antonietti L, Mariani J, et al
Vitamin D supplementation: An alternative to enhance the effectiveness of vaccines against SARS-CoV-2?
Vaccine. 2021 Jul 16. pii: S0264-410X(21)00908.
PubMed

PATHIRANA J, Kwatra G, Maposa I, Groome MJ, et al
Effect of cytomegalovirus infection on humoral immune responses to select vaccines administered during infancy.
Vaccine. 2021 Jul 15. pii: S0264-410X(21)00661.
PubMed Abstract available

LAMONTAGNE DS, Manangazira P, Marembo J, Chigodo C, et al
HPV vaccination coverage in three districts in ZIMBABWE following national introduction of 0,12 month schedule among 10 to 14 year old girls.
Vaccine. 2021 Jul 15. pii: S0264-410X(21)00871.
PubMed Abstract available

ELAS M, Villatoro N, Pezzoli L
Disproportionality analysis of reported drug adverse events to assess a potential safety signal for pentavalent vaccine in 2019 in El Salvador.
Vaccine. 2021 Jul 15. pii: S0264-410X(21)00869.
PubMed Abstract available

MOGAJI E
Marketing the COVID-19 vaccine and the implications for public health.
Vaccine. 2021 Jul 13. pii: S0264-410X(21)00874.
PubMed Abstract available

O'DELL FJ, Williams AN, Poland A
The contributions of William Money MRCS to smallpox vaccination and control - A little-known story.
Vaccine. 2021 Jul 13. pii: S0264-410X(21)00844.
PubMed Abstract available

HAYMAN B, Suri R, Prasad SD
COVID-19 vaccine capacity: Challenges and mitigation - The DCVMN perspective.
Vaccine. 2021 Jul 13. pii: S0264-410X(21)00866.
PubMed Abstract available

LAZAROS G, Klein AL, Hatziantoniou S, Tsioufis C, et al
The Novel Platform of mRNA COVID-19 Vaccines and Myocarditis: Clues into the Potential Underlying Mechanism.
Vaccine. 2021 Jul 13. pii: S0264-410X(21)00875.
PubMed

WANG X, Xia A, Wang C, Tian H, et al
Clinical and molecular characterization of the first culture-confirmed pediatric fulminant meningococcemia case caused by a serogroup Y clonal complex 23 strain in China.
Vaccine. 2021;39:4261-4265.
PubMed Abstract available

TONG L, Jia Q, Li B, Li Z, et al
Investigation of the baseline tetanus antibody level and its persistence in a military unit.
Vaccine. 2021;39:4328-4334.
PubMed Abstract available

CLARKE M, Goodchild LM, Evans S, Giles LC, et al
Body mass index and vaccine responses following influenza vaccination during pregnancy.
Vaccine. 2021 Jul 12. pii: S0264-410X(21)00826.
PubMed Abstract available

GOMEZ M, McCollum J, Wang H, Bachchhav S, et al
Evaluation of the stability of a spray-dried tuberculosis vaccine candidate designed for dry powder respiratory delivery.
Vaccine. 2021 Jul 10. pii: S0264-410X(21)00861.
PubMed Abstract available

MACINTYRE CR, Veness B, Berger D, Hamad N, et al
Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination - A risk-benefit analysis for people < 60 years in Australia.
Vaccine. 2021 Jul 10. pii: S0264-410X(21)00872.
PubMed Abstract available

GUKTUR RE, Nep EI, Asala O, Olorunfemi PO, et al
Carboxymethylated and acetylated xerogel derivatives of Plectranthus esculentus starch protect Newcastle disease vaccines against cold chain failure.
Vaccine. 2021 Jul 9. pii: S0264-410X(21)00812.
PubMed Abstract available

ZHANG T, Zhang J, Shao X, Feng S, et al
Effectiveness of 13-valent pneumococcal conjugate vaccine against community acquired pneumonia among children in China, an observational cohort study.
Vaccine. 2021 Jul 9. pii: S0264-410X(21)00836.
PubMed Abstract available

FONGWEN N, Delrieu I, Ham LH, Gubler DJ, et al
Implementation strategies for the first licensed dengue vaccine: A meeting report.
Vaccine. 2021 Jul 9. pii: S0264-410X(21)00845.
PubMed Abstract available

TERNA RICHARD M, Taiwo L, Jean Baptiste AE, Bawa S, et al
Planning for supplemental immunization activities using the readiness assessment dashboard: Experience from 2017/2018 Measles vaccination campaign, Nigeria.
Vaccine. 2021 Jul 8. pii: S0264-410X(21)00831.
PubMed Abstract available

MATEO-URDIALES A, Del Manso M, Andrianou X, Spuri M, et al
Initial impact of SARS-Cov-2 vaccination on healthcare workers in Italy- Update on the 28th of March 2021.
Vaccine. 2021 Jul 7. pii: S0264-410X(21)00862.
PubMed Abstract available

DING Y, Luo L, Luo Y, Zhao D, et al
A novel combined vaccine against classical swine fever and porcine epidemic diarrhea viruses elicits a significant Th2-favored humoral response in mice.
Vaccine. 2021 Jul 7. pii: S0264-410X(21)00846.
PubMed Abstract available

AT THOBARI J, Damayanti W, Haposan JH, Nirwati H, et al
Safety and immunogenicity of human neonatal RV3 rotavirus vaccine (Bio Farma) in adults, children, and neonates in Indonesia: Phase I Trial.
Vaccine. 2021 Jul 6. pii: S0264-410X(21)00832.
PubMed Abstract available

GESSNER BD, Theilacker C, Mendez C, Jodar L, et al
Comment on "Vila-Corcoles et al., Clinical effectiveness of 13-valent and 23-valent pneumococcal vaccination in middle-aged and older adults: The EPIVAC cohort study, 2015-2016."
Vaccine. 2021;39:4032-4033.
PubMed

BELLIER L, Petitjean A, Sarazu T, Tresierra J, et al
Cost-effectiveness analysis of switching from a trivalent to a quadrivalent inactivated influenza vaccine in the Peruvian immunisation programme.
Vaccine. 2021;39:4144-4152.
PubMed Abstract available

OZAWA S, Yemeke TT, Mitgang E, Wedlock PT, et al
Systematic review of the costs for vaccinators to reach vaccination sites: Incremental costs of reaching hard-to-reach populations.
Vaccine. 2021 Jul 5. pii: S0264-410X(21)00581.
PubMed Abstract available

GENTILE A, Pacchiotti AC, Giglio N, Nolte MF, et al
Vaccine hesitancy in Argentina: Validation of WHO scale for parents.
Vaccine. 2021 Jul 5. pii: S0264-410X(21)00842.
PubMed Abstract available

MARTIN C, Marinova D, Aguilo N, Gonzalo-Asensio J, et al
MTBVAC, a live TB vaccine poised to initiate efficacy trials 100 years after BCG.
Vaccine. 2021 Jul 5. pii: S0264-410X(21)00799.
PubMed Abstract available

GOSSET A, Diallo MY, Betsem E, Schaeffer L, et al
Cost-effectiveness of adding a birth dose of hepatitis B vaccine in the Dafra district of the Hauts-Bassins Region in Burkina Faso (NeoVac Study).
Vaccine. 2021 Jul 5. pii: S0264-410X(21)00809.
PubMed Abstract available

KURITA J, Uematsu T, Sakurai N, Sugawara T, et al
Attenuation of antibody titer of measles and rubella virus among university students of department of healthcare providers during 2015-2018 in Japan.
Vaccine. 2021;39:4203-4209.
PubMed Abstract available

LUO J, Huo C, Qin H, Hu J, et al
Chimeric enterovirus 71 virus-like particle displaying conserved coxsackievirus A16 epitopes elicits potent immune responses and protects mice against lethal EV71 and CA16 infection.
Vaccine. 2021;39:4135-4143.
PubMed Abstract available

SIMAS C, Paterson P, Lees S, J Larson H, et al
"From my phone, I could rule the world": Critical engagement with maternal vaccine information, vaccine confidence builders and post-Zika outbreak rumours in Brazil.
Vaccine. 2021 Jul 3. pii: S0264-410X(21)00775.
PubMed Abstract available

LI AJ, Manzi F, Kyesi F, Makame Y, et al
Tanzania's human papillomavirus (HPV) vaccination program: Community awareness, feasibility, and acceptability of a national HPV vaccination program, 2019.
Vaccine. 2021 Jul 3. pii: S0264-410X(21)00797.
PubMed Abstract available

HUANG Y, Seaton KE, Casapia M, Polakowski L, et al
AIDSVAX protein boost improves breadth and magnitude of vaccine-induced HIV-1 envelope-specific responses after a 7-year rest period.
Vaccine. 2021 Jul 3. pii: S0264-410X(21)00827.
PubMed Abstract available

SCHALTZ-BUCHHOLZER F, Roth A, de Bree LCJ, Biering-Sorensen S, et al
Neonatal Bacille Calmette-Guerin vaccination and tuberculin skin test reactions at 2- and 6-months: Effects on mortality up to 1 year of age.
Vaccine. 2021 Jul 2. pii: S0264-410X(21)00839.
PubMed Abstract available

LO CY, Misplon JA, Li X, Price GE, et al
Universal influenza vaccine based on conserved antigens provides long-term durability of immune responses and durable broad protection against diverse challenge virus strains in mice.
Vaccine. 2021 Jul 2. pii: S0264-410X(21)00833.
PubMed Abstract available

RAHAMIMOV N, Baturov V, Shani A, Ben Zoor I, et al
Inadequate deltoid muscle penetration and concerns of improper COVID mRNA vaccine administration can be avoided by injection technique modification.
Vaccine. 2021 Jul 2. pii: S0264-410X(21)00843.
PubMed Abstract available

THIEM VD, Anh DD, Ha VH, Hien ND, et al
Safety and immunogenicity of two formulations of rotavirus vaccine in Vietnamese infants.
Vaccine. 2021 Jul 1. pii: S0264-410X(21)00806.
PubMed Abstract available

CHOWDHURY F, Ali Syed K, Akter A, Rahman Bhuiyan T, et al
A phase I/II study to evaluate safety, tolerability and immunogenicity of Hillchol(R), an inactivated single Hikojima strain based oral cholera vaccine, in a sequentially age descending population in Bangladesh.
Vaccine. 2021 Jul 1. pii: S0264-410X(21)00830.
PubMed Abstract available

YEMEKE TT, Mitgang E, Wedlock PT, Higgins C, et al
Promoting, seeking, and reaching vaccination services: A systematic review of costs to immunization programs, beneficiaries, and caregivers.
Vaccine. 2021 Jul 1. pii: S0264-410X(21)00670.
PubMed Abstract available

June 2021

MWABA J, Chisenga CC, Xiao S, Ng'ombe H, et al
Serum vibriocidal responses when second doses of oral cholera vaccine are delayed 6 months in Zambia.
Vaccine. 2021 Jun 30. pii: S0264-410X(21)00770.
PubMed Abstract available

SORENSEN MK, Schaltz-Buchholzer F, Jensen AM, Nielsen S, et al
Retesting the hypothesis that early Diphtheria-Tetanus-Pertussis vaccination increases female mortality: An observational study within a randomised trial.
Vaccine. 2021 Jun 30. pii: S0264-410X(21)00720.
PubMed Abstract available

HINES AM, Murphy N, Mullin C, Barillas J, et al
Henoch-Schonlein purpura presenting post COVID-19 vaccination.
Vaccine. 2021 Jun 30. pii: S0264-410X(21)00841.
PubMed

FISCHER P, Pawlowski A, Cao D, Bell D, et al
Safety and immunogenicity of a prototype recombinant alpha-like protein subunit vaccine (GBS-NN) against Group B Streptococcus in a randomised placebo-controlled double-blind phase 1 trial in healthy adult women.
Vaccine. 2021 Jun 29. pii: S0264-410X(21)00796.
PubMed Abstract available

OSTERGAARD L, Vesikari T, Senders SD, Flodmark CE, et al
Persistence of hSBA titers elicited by the meningococcal serogroup B vaccine menB-FHbp for up to 4 years after a 2- or 3-dose primary series and immunogenicity, safety, and tolerability of a booster dose through 26 months.
Vaccine. 2021 Jun 29. pii: S0264-410X(21)00717.
PubMed Abstract available

PLUTZER E, Warner SB
A potential new front in health communication to encourage vaccination: Health education teachers.
Vaccine. 2021 Jun 29. pii: S0264-410X(21)00800.
PubMed Abstract available

KAUR R, Pham M, Pichichero M
Serum antibody levels to pneumococcal polysaccharides 22F, 33F, 19A and 6A that correlate with protection from colonization and acute otitis media in children.
Vaccine. 2021;39:3900-3906.
PubMed Abstract available

KELLY SM, Larsen KR, Darling R, Petersen AC, et al
Single-dose combination nanovaccine induces both rapid and durable humoral immunity and toxin neutralizing antibody responses against Bacillus anthracis.
Vaccine. 2021;39:3862-3870.
PubMed Abstract available

AL-SHAIKH A, Muthu N, Aidyralieva C, Profili MC, et al
COVID-19 vaccine roll-out in middle-income countries: Lessons learned from the Jordan experience.
Vaccine. 2021 Jun 29. pii: S0264-410X(21)00840.
PubMed

BANKS C, Portnoy A, Moi F, Boonstoppel L, et al
Cost of vaccine delivery strategies in low- and middle-income countries during the COVID-19 pandemic.
Vaccine. 2021 Jun 29. pii: S0264-410X(21)00838.
PubMed Abstract available

VERGER P, Duale C, Lenzi N, Scronias D, et al
Vaccine hesitancy among hospital staff physicians: A cross-sectional survey in France in 2019.
Vaccine. 2021 Jun 28. pii: S0264-410X(21)00803.
PubMed Abstract available

BURNETT E, Juin S, Esona MD, Desormeaux AM, et al
Effectiveness of monovalent rotavirus vaccine against hospitalizations due to all rotavirus and equine-like G3P[8] genotypes in Haiti 2014-2019.
Vaccine. 2021 Jun 26. pii: S0264-410X(21)00805.
PubMed Abstract available

SARHAN AT, Bahey-El-Din M, Zaghloul TI
Recombinant Ax21 protein is a promising subunit vaccine candidate against Stenotrophomonas maltophilia in a murine infection model.
Vaccine. 2021 Jun 26. pii: S0264-410X(21)00801.
PubMed Abstract available

FUJIMOTO AB, Keskinocak P, Yildirim I
Significance of SARS-CoV-2 specific antibody testing during COVID-19 vaccine allocation.
Vaccine. 2021 Jun 26. pii: S0264-410X(21)00828.
PubMed Abstract available

FELIX S, Handem S, Nunes S, Paulo AC, et al
Impact of private use of the 13-valent pneumococcal conjugate vaccine (PCV13) on pneumococcal carriage among Portuguese children living in urban and rural regions.
Vaccine. 2021 Jun 25. pii: S0264-410X(21)00771.
PubMed Abstract available

CARNALLA M, Torres-Ibarra L, Barrientos-Gutierrez T, Cruz-Valdez A, et al
Reduction of HPV16/18 prevalence in young women after eight years of three- and two-dose vaccination schemes.
Vaccine. 2021 Jun 25. pii: S0264-410X(21)00776.
PubMed Abstract available

MYLES IA, Vinciguerra JS, Premus RT
Specialist confirmed allergic reactions to COVID-19 mRNA vaccines at a mass vaccination site.
Vaccine. 2021 Jun 25. pii: S0264-410X(21)00811.
PubMed Abstract available

TUO W, Feng X, Cao L, Vinyard B, et al
Vaccination with Neospora caninum-cyclophilin and -profilin confers partial protection against experimental neosporosis-induced abortion in sheep.
Vaccine. 2021 Jun 24. pii: S0264-410X(21)00768.
PubMed Abstract available

DESAI AP, Desai AP, Loomis GJ
Relationship between pre-existing allergies and anaphylactic reactions post mRNA COVID-19 vaccine administration.
Vaccine. 2021 Jun 23. pii: S0264-410X(21)00808.
PubMed Abstract available

BALDOLLI A, Michon J, Appia F, Galimard C, et al
Tolerance of BNT162b2 mRNA COVI-19 vaccine in patients with a medical history of COVID-19 disease: A case control study.
Vaccine. 2021 Jun 23. pii: S0264-410X(21)00804.
PubMed Abstract available

FURUYA-KANAMORI L, Xu C, Doi SAR, Clark J, et al
Comparison of immunogenicity and safety of licensed Japanese encephalitis vaccines: A systematic review and network meta-analysis.
Vaccine. 2021 Jun 23. pii: S0264-410X(21)00759.
PubMed Abstract available

DASSAH S, Adu B, Sirima SB, Mordmuller B, et al
Extended follow-up of children in a phase2b trial of the GMZ2 malaria vaccine.
Vaccine. 2021 Jun 23. pii: S0264-410X(21)00760.
PubMed Abstract available

MARTIN-MERINO E, Castillo-Cano B, Martin-Perez M, Llorente-Garcia A, et al
Papillomavirus vaccination and Guillain-Barre Syndrome among girls: A cohort study in Spain.
Vaccine. 2021 Jun 23. pii: S0264-410X(21)00765.
PubMed Abstract available

KRISTENSEN D, Giersing B, Hickling J, Kazi F, et al
A global collaboration to advance vaccine product innovations - The Vaccine Innovation Prioritisation Strategy.
Vaccine. 2021 Jun 23. pii: S0264-410X(21)00711.
PubMed

PHILLIP K, Nair N, Samanta K, Azevedo JF, et al
Maternal transfer of neutralizing antibodies to B. burgdorferi OspA after oral vaccination of the rodent reservoir.
Vaccine. 2021 Jun 23. pii: S0264-410X(21)00761.
PubMed Abstract available

OOSTDIJK C, Van Zoonen K, Ruijs WLM, Mollema L, et al
Household decision-making for the MenACWY vaccination: How parents and adolescents deal with an adolescent vaccination decision.
Vaccine. 2021 Jun 23. pii: S0264-410X(21)00772.
PubMed Abstract available

TRENT M, Seale H, Chughtai AA, Salmon D, et al
Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia.
Vaccine. 2021 Jun 23. pii: S0264-410X(21)00798.
PubMed Abstract available

JAYARAMAN Y, Veeraraghavan B, Girish Kumar CP, Sukumar B, et al
Hospital-based sentinel surveillance for bacterial meningitis in under-five children prior to the introduction of the PCV13 in India.
Vaccine. 2021;39:3737-3744.
PubMed Abstract available

MBAEYI C, Moran T, Wadood Z, Ather F, et al
Stopping a polio outbreak in the midst of war: Lessons from Syria.
Vaccine. 2021;39:3717-3723.
PubMed Abstract available

GOOCH KE, Smith TRF, Salguero FJ, Fotheringham SA, et al
One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model.
Vaccine. 2021 Jun 23. pii: S0264-410X(21)00807.
PubMed Abstract available

LUNDBERG L, Bygdell M, Stukat von Feilitzen G, Woxenius S, et al
Recent MMR vaccination in health care workers and Covid-19: A test negative case-control study.
Vaccine. 2021 Jun 22. pii: S0264-410X(21)00795.
PubMed Abstract available

CHEN IH, Ahorsu DK, Ko NY, Yen CF, et al
Adapting the Motors of Influenza Vaccination Acceptance Scale into the Motors of COVID-19 Vaccination Acceptance Scale: Psychometric evaluation among mainland Chinese university students.
Vaccine. 2021 Jun 22. pii: S0264-410X(21)00794.
PubMed Abstract available

WANG Z, Zhou C, Gao F, Zhu Q, et al
Preclinical evaluation of recombinant HFMD vaccine based on enterovirus 71 (EV71) virus-like particles (VLP): Immunogenicity, efficacy and toxicology.
Vaccine. 2021 Jun 21. pii: S0264-410X(21)00767.
PubMed Abstract available

RADHAKRISHNAN L, Stein Z, DeVies J, Smith A, et al
Syndromic surveillance of vaccine-associated adverse events in U.S. emergency departments.
Vaccine. 2021 Jun 21. pii: S0264-410X(21)00766.
PubMed Abstract available

SMITH KJ, Wateska AR, Nowalk MP, Lin CJ, et al
Should older adult pneumococcal vaccination recommendations change due to decreased vaccination in children during the pandemic? A cost-effectiveness analysis.
Vaccine. 2021 Jun 21. pii: S0264-410X(21)00773.
PubMed Abstract available

WEDLOCK PT, Cox SN, Bartsch SM, Randall SL, et al
Should countries switch to using five- or ten-dose rotavirus vaccines now that they are available?
Vaccine. 2021 Jun 19. pii: S0264-410X(21)00757.
PubMed Abstract available

FOGEL B, Schaefer EW, Hicks SD
Early influenza vaccination rates decline in children during the COVID-19 pandemic.
Vaccine. 2021 Jun 17. pii: S0264-410X(21)00777.
PubMed Abstract available

BROWN CC, Young SG, Pro GC
COVID-19 vaccination rates vary by community vulnerability: A county-level analysis.
Vaccine. 2021 Jun 17. pii: S0264-410X(21)00774.
PubMed Abstract available

LILES E, Irving SA, Dandamudi P, Belongia EA, et al
Incidence of pediatric inflammatory bowel disease within the Vaccine Safety Datalink network and evaluation of association with rotavirus vaccination.
Vaccine. 2021;39:3614-3620.
PubMed Abstract available

FENG Y, Yao T, Chang Y, Gao L, et al
Immunogenicity and persistence of high-dose recombinant hepatitis B vaccine in adults infected with human immunodeficiency virus in China: A randomized, double-blind, parallel controlled trial.
Vaccine. 2021;39:3582-3589.
PubMed Abstract available

VAILLANT L, Oster P, McMillan B, Velin D, et al
Gastric eosinophils are detrimental for Helicobacter pylori vaccine efficacy.
Vaccine. 2021;39:3590-3601.
PubMed Abstract available

JETHWA H, Wong R, Abraham S
Covid-19 vaccine trials: Ethnic diversity and immunogenicity.
Vaccine. 2021;39:3541-3543.
PubMed

PRASAD N, Read JM, Jewell C, Waite B, et al
Modelling the impact of respiratory syncytial virus (RSV) vaccine and immunoprophylaxis strategies in New Zealand.
Vaccine. 2021 Jun 16. pii: S0264-410X(21)00708.
PubMed Abstract available

FRADICO JRB, Campi-Azevedo AC, Peruhype-Magalhaes V, Coelho-Dos-Reis JGA, et al
CCL3, CCL5, IL-15, IL-1Ra and VEGF compose a reliable algorithm to discriminate classes of adverse events following 17DD-YF primary vaccination according to cause-specific definitions.
Vaccine. 2021 Jun 16. pii: S0264-410X(21)00709.
PubMed Abstract available

YITBAREK K, Tilahun T, Debela T, Abdena D, et al
Measles epidemiology and vaccination coverage in Oromia Region, Ethiopia: Evidence from surveillance, 2011-2018.
Vaccine. 2021 Jun 16. pii: S0264-410X(21)00739.
PubMed Abstract available

MOSS WJ, Shendale S, Lindstrand A, O'Brien KL, et al
Feasibility assessment of measles and rubella eradication.
Vaccine. 2021;39:3544-3559.
PubMed Abstract available

ANDRE GO, Borges MT, Assoni L, Ferraz LFC, et al
Protective role of PhtD and its amino and carboxyl fragments against pneumococcal sepsis.
Vaccine. 2021;39:3626-3632.
PubMed Abstract available

GARON JR, Mukavhi A, Rupfutse M, Bright S, et al
Multiple cohort HPV vaccination in Zimbabwe: 2018-2019 program feasibility, awareness, and acceptability among health, education, and community stakeholders.
Vaccine. 2021 Jun 15. pii: S0264-410X(21)00669.
PubMed Abstract available

ZIMMERMAN RK
Helping patients with ethical concerns about COVID-19 vaccines in light of fetal cell lines used in some COVID-19 vaccines.
Vaccine. 2021 Jun 15. pii: S0264-410X(21)00763.
PubMed Abstract available

SMITH LE, Hodson A, Rubin GJ
Parental attitudes towards mandatory vaccination; a systematic review.
Vaccine. 2021 Jun 14. pii: S0264-410X(21)00742.
PubMed Abstract available

IVANOV V, Oomens AGP, Papin JF, Staats R, et al
Intranasal and intrapulmonary vaccination with an M protein-deficient respiratory syncytial virus (RSV) vaccine improves clinical signs and reduces viral replication in infant baboons after an RSV challenge infection.
Vaccine. 2021 Jun 14. pii: S0264-410X(21)00737.
PubMed Abstract available

KOCHHAR GS, Desai A, Caldera DO F, El Hachem S, et al
Effectiveness of recombinant zoster vaccine (RZV) in patients with inflammatory bowel disease.
Vaccine. 2021 Jun 14. pii: S0264-410X(21)00615.
PubMed Abstract available

POLAND GA, Ovsyannikova IG, Kennedy RB
The need for broadly protective COVID-19 vaccines: Beyond S-only approaches.
Vaccine. 2021 Jun 14. pii: S0264-410X(21)00764.
PubMed

SCHALTZ-BUCHHOLZER F, Kjaer Sorensen M, Benn CS, Aaby P, et al
The introduction of BCG vaccination to neonates in Northern Sweden, 1927-31: Re-analysis of historical data to understand the lower mortality among BCG-vaccinated children.
Vaccine. 2021 Jun 13. pii: S0264-410X(21)00718.
PubMed Abstract available

LIPSITCH M, Kahn R
Interpreting vaccine efficacy trial results for infection and transmission.
Vaccine. 2021 Jun 12. pii: S0264-410X(21)00735.
PubMed Abstract available

FERRARI D, Di Resta C, Tomaiuolo R, Sabetta E, et al
Long-term antibody persistence and exceptional vaccination response on previously SARS-CoV-2 infected subjects.
Vaccine. 2021 Jun 12. pii: S0264-410X(21)00756.
PubMed Abstract available

MCFADDEN K, Heywood A, Dyda A, Kaufman J, et al
Minimising missed opportunities to promote and deliver immunization services to middle and older age adults: Can hospital-based programs be a solution?
Vaccine. 2021;39:3467-3472.
PubMed Abstract available

DAVIES C, Stoney T, Hutton H, Parrella A, et al
School-based HPV vaccination positively impacts parents' attitudes toward adolescent vaccination.
Vaccine. 2021 Jun 11. pii: S0264-410X(21)00637.
PubMed Abstract available

BEAU RENEER Z, Abreu RB, Jamal US, Corn MR, et al
Seasonal influenza vaccination does not effectively expand H2 cross-reactive antibodies in humans.
Vaccine. 2021 Jun 11. pii: S0264-410X(21)00659.
PubMed Abstract available

MESHER D, Thomas SL, Linley E, Edmundson C, et al
Post-vaccination HPV seroprevalence among female sexual health clinic attenders in England.
Vaccine. 2021 Jun 11. pii: S0264-410X(21)00580.
PubMed Abstract available

OH SH, Kim SH, Jeon JH, Kim EB, et al
Cytoplasmic expression of a model antigen with M Cell-Targeting moiety in lactic acid bacteria and implication of the mechanism as a mucosal vaccine via oral route.
Vaccine. 2021 Jun 11. pii: S0264-410X(21)00734.
PubMed Abstract available

HSIA J, Zhao G, Lu PJ, Town M, et al
Estimating bias from internet non-use for a hybrid web vaccination survey - 2013-2017 Behavioral Risk Factor Surveillance System.
Vaccine. 2021 Jun 11. pii: S0264-410X(21)00675.
PubMed Abstract available

ODITA CI, Conan A, Smith-Antony M, Battice J, et al
Non-specific effects of rabies vaccine on the incidence of self-reported common infectious disease episodes: A randomized controlled trial.
Vaccine. 2021 Jun 11. pii: S0264-410X(21)00719.
PubMed Abstract available

CHEN Y, Wang Y, Robertson ID, Hu C, et al
Key issues affecting the current status of infectious diseases in Chinese cattle farms and their control through vaccination.
Vaccine. 2021 Jun 11. pii: S0264-410X(21)00673.
PubMed Abstract available

RAHMAN T, de Gier C, Orami T, Seppanen EJ, et al
PCV10 elicits Protein D IgG responses in Papua New Guinean children but has no impact on NTHi carriage in the first two years of life.
Vaccine. 2021;39:3486-3492.
PubMed Abstract available

SORG AL, Obermeier V, Liese JG, von Kries R, et al
Incidence trends of parapneumonic pleural effusions/empyema in children 2009 to 2018 from health insurance data: Only temporal reduction after the introduction of PCV13.
Vaccine. 2021;39:3516-3519.
PubMed Abstract available

CHAUHAN AS, Kapoor I, Rana SK, Kumar D, et al
Cost effectiveness of typhoid vaccination in India.
Vaccine. 2021 Jun 10. pii: S0264-410X(21)00713.
PubMed Abstract available

VANDERSLOTT S, Marks T
Charting mandatory childhood vaccination policies worldwide.
Vaccine. 2021 Jun 10. pii: S0264-410X(21)00547.
PubMed Abstract available

LUTZ CS, Biggerstaff M, Rolfes MA, Lafond KE, et al
Estimating the number of averted illnesses and deaths as a result of vaccination against an influenza pandemic in nine low- and middle-income countries.
Vaccine. 2021 Jun 9. pii: S0264-410X(21)00557.
PubMed Abstract available

MUHI S, Stinear TP
Systematic review of M. Bovis BCG and other candidate vaccines for Buruli ulcer prophylaxis.
Vaccine. 2021 Jun 9. pii: S0264-410X(21)00700.
PubMed Abstract available

GUNTUKU SC, Buttenheim AM, Sherman G, Merchant RM, et al
Twitter discourse reveals geographical and temporal variation in concerns about COVID-19 vaccines in the United States.
Vaccine. 2021 Jun 9. pii: S0264-410X(21)00738.
PubMed Abstract available

HOEHL S, Ciesek S, Graf J, Wicker S, et al
A new group at increased risk of a SARS-CoV-2 infection emerges: The recently vaccinated.
Vaccine. 2021 Jun 8. pii: S0264-410X(21)00736.
PubMed

DE VRIES LM, Kellerborg KM, Brouwer WBF, van Baal PHM, et al
Don't forget about the future: The impact of including future costs on the cost-effectiveness of adult pneumococcal conjugate vaccination with PCV13 in the Netherlands.
Vaccine. 2021 Jun 8. pii: S0264-410X(21)00699.
PubMed Abstract available

STOECKEL F, Carter C, Lyons BA, Reifler J, et al
Association of vaccine hesitancy and immunization coverage rates in the European Union.
Vaccine. 2021 Jun 8. pii: S0264-410X(21)00657.
PubMed Abstract available

SUN Y, Jackson K, Dalmon CA, Shapiro BL, et al
Effectiveness of the recombinant zoster vaccine among Kaiser Permanente Hawaii enrollees aged 50 and older: A retrospective cohort study.
Vaccine. 2021 Jun 8. pii: S0264-410X(21)00642.
PubMed Abstract available

DIAZ-MITOMA F, Popovic V, Spaans JN
Assessment of immunogenicity and safety across two manufacturing lots of a 3-antigen hepatitis B vaccine, Sci-B-Vac(R), compared with Engerix-B(R) in healthy Asian adults: A phase 3 randomized clinical trial.
Vaccine. 2021 Jun 8. pii: S0264-410X(21)00662.
PubMed Abstract available

ANDAYI F, Emukule GO, Osoro E, Ndegwa LK, et al
Knowledge and attitude of Kenyan healthcare workers towards pandemic influenza disease and vaccination: 9 years after the last influenza pandemic.
Vaccine. 2021 Jun 7. pii: S0264-410X(21)00643.
PubMed Abstract available

RAZ A, Keshet Y, Popper-Giveon A, Karkabi MS, et al
One size does not fit all: Lessons from Israel's Covid-19 vaccination drive and hesitancy.
Vaccine. 2021 Jun 5. pii: S0264-410X(21)00714.
PubMed

CHUA JV, Davis C, Husson JS, Nelson A, et al
Safety and immunogenicity of an HIV-1 gp120-CD4 chimeric subunit vaccine in a phase 1a randomized controlled trial.
Vaccine. 2021 Jun 4. pii: S0264-410X(21)00685.
PubMed Abstract available

NOGUERA M, Vela A, Kraft C, Chevalier M, et al
Effects of three commercial vaccines against porcine parvovirus 1 in pregnant gilts.
Vaccine. 2021 Jun 4. pii: S0264-410X(21)00614.
PubMed Abstract available

KARAFILLAKIS E, Francis MR, Paterson P, Larson HJ, et al
Trust, emotions and risks: Pregnant women's perceptions, confidence and decision-making practices around maternal vaccination in France.
Vaccine. 2021 Jun 4. pii: S0264-410X(21)00704.
PubMed Abstract available

WOLFE LS, Smedley JG 3rd, Bubna N, Hussain A, et al
Development of a platform-based approach for the clinical production of HIV gp120 envelope glycoprotein vaccine candidates.
Vaccine. 2021 Jun 4. pii: S0264-410X(21)00668.
PubMed Abstract available

DAL-RE R, Launay O
Public trust on regulatory decisions: The European Medicines Agency and the AstraZeneca COVID-19 vaccine label.
Vaccine. 2021 Jun 4. pii: S0264-410X(21)00703.
PubMed

ITO N, Okamoto T, Sasaki M, Miyamoto S, et al
Safety enhancement of a genetically modified live rabies vaccine strain by introducing an attenuating Leu residue at position 333 in the glycoprotein.
Vaccine. 2021 Jun 3. pii: S0264-410X(21)00553.
PubMed Abstract available

CHANDRA D, Vipin B
On the vaccine supply chain coordination under subsidy contract.
Vaccine. 2021 Jun 3. pii: S0264-410X(21)00676.
PubMed Abstract available

STUURMAN AL, Biccler J, Carmona A, Descamps A, et al
Brand-specific influenza vaccine effectiveness estimates during 2019/20 season in Europe - Results from the DRIVE EU study platform.
Vaccine. 2021 Jun 3. pii: S0264-410X(21)00654.
PubMed Abstract available

UWINS C, Cyriac S, Bhandoria G
HPV vaccine: Expanding indications and global disparity.
Vaccine. 2021 Jun 3. pii: S0264-410X(21)00677.
PubMed

GATES A, Rahman S, Sim S, Pillay J, et al
Health inequities related to vaccination: An evidence map of potentially influential factors and systematic review of interventions.
Vaccine. 2021 Jun 3. pii: S0264-410X(21)00640.
PubMed Abstract available

FERDINANDS JM, Thompson MG, Blanton L, Spencer S, et al
Does influenza vaccination attenuate the severity of breakthrough infections? A narrative review and recommendations for further research.
Vaccine. 2021 Jun 2. pii: S0264-410X(21)00562.
PubMed Abstract available

LASKY T, McMahon AW, Hua W, Forshee R, et al
Methodologic approaches in studies using real-world data (RWD) to measure pediatric safety and effectiveness of vaccines administered to pregnant women: A scoping review.
Vaccine. 2021 Jun 2. pii: S0264-410X(21)00666.
PubMed Abstract available

SHINGAI M, Nomura N, Sekiya T, Ohno M, et al
Potent priming by inactivated whole influenza virus particle vaccines is linked to viral RNA uptake into antigen presenting cells.
Vaccine. 2021 Jun 2. pii: S0264-410X(21)00660.
PubMed Abstract available

YANG T, Liu B, Yue L, Xie T, et al
Preclinical safety assessment of a combined vaccine against Hepatitis a virus and enterovirus 71.
Vaccine. 2021 Jun 1. pii: S0264-410X(21)00653.
PubMed Abstract available

JOHM P, Nkoum N, Ceesay A, Mbaye EH, et al
Factors influencing acceptance of vaccination during pregnancy in The Gambia and Senegal.
Vaccine. 2021 Jun 1. pii: S0264-410X(21)00663.
PubMed Abstract available

SHI M, Chen X, Sun Y, Kim HK, et al
A protein A based Staphylococcus aureus vaccine with improved safety.
Vaccine. 2021 Jun 1. pii: S0264-410X(21)00667.
PubMed Abstract available

CHYDERIOTIS S, Sicsic J, Raude J, Bonmarin I, et al
Optimising HPV vaccination communication to adolescents: A discrete choice experiment.
Vaccine. 2021 Jun 1. pii: S0264-410X(21)00656.
PubMed Abstract available

WANG Y, Zhang Y, Wu H, Huang L, et al
Safety and immunogenicity of a quadrivalent inactivated subunit non-adjuvanted influenza vaccine: A randomized, double-blind, active-controlled phase 1 clinical trial.
Vaccine. 2021 Jun 1. pii: S0264-410X(21)00665.
PubMed Abstract available

DEY A, Chozhavel Rajanathan TM, Chandra H, Pericherla HPR, et al
Immunogenic potential of DNA vaccine candidate, ZyCoV-D against SARS-CoV-2 in animal models.
Vaccine. 2021 Jun 1. pii: S0264-410X(21)00706.
PubMed Abstract available

PATEL MK, Bergeri I, Bresee JS, Cowling BJ, et al
Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health Organization.
Vaccine. 2021 Jun 1. pii: S0264-410X(21)00707.
PubMed Abstract available

May 2021

BREWER NT, Mitchell CG, Alton Dailey S, Hora L, et al
HPV vaccine communication training in healthcare systems: Evaluating a train-the-trainer model.
Vaccine. 2021 May 30. pii: S0264-410X(21)00610.
PubMed Abstract available

ZIPFEL CM, Colizza V, Bansal S
The missing season: The impacts of the COVID-19 pandemic on influenza.
Vaccine. 2021 May 30. pii: S0264-410X(21)00635.
PubMed Abstract available

LEWIS NS, Banyard AC, Essen S, Whittard E, et al
Antigenic evolution of contemporary clade 2.3.4.4 HPAI H5 influenza A viruses and impact on vaccine use for mitigation and control.
Vaccine. 2021 May 29. pii: S0264-410X(21)00655.
PubMed Abstract available

GREWAL R, Deeks SL, Hart TA, Cox J, et al
Human papillomavirus (HPV) vaccine uptake among a community-recruited sample of gay, bisexual, and other men who have sex with men in the three largest cities in Canada from 2017 to 2019.
Vaccine. 2021 May 29. pii: S0264-410X(21)00603.
PubMed Abstract available

MCGUINNESS D, Kaufhold RM, McHugh PM, Winters MA, et al
Immunogenicity of PCV24, an expanded pneumococcal conjugate vaccine, in adult monkeys and protection in mice.
Vaccine. 2021 May 29. pii: S0264-410X(21)00549.
PubMed Abstract available

BARDENHEIER BH, Gravenstein S, Blackman C, Gutman R, et al
Adverse events following mRNA SARS-CoV-2 vaccination among U.S. nursing home residents.
Vaccine. 2021 May 28. pii: S0264-410X(21)00683.
PubMed Abstract available

ABU MOUCH S, Roguin A, Hellou E, Ishai A, et al
Myocarditis following COVID-19 mRNA vaccination.
Vaccine. 2021 May 28. pii: S0264-410X(21)00682.
PubMed Abstract available

WAGNER NM, Dempsey AF, Narwaney KJ, Gleason KS, et al
Addressing logistical barriers to childhood vaccination using an automated reminder system and online resource intervention: A randomized controlled trial.
Vaccine. 2021 May 28. pii: S0264-410X(21)00639.
PubMed Abstract available

SULLIVAN E, Lecollinet S, Kerviel A, Hue E, et al
Entry-competent-replication-abortive African horse sickness virus strains elicit robust immunity in ponies against all serotypes.
Vaccine. 2021;39:3161-3168.
PubMed Abstract available

BRANDILEONE MC, Almeida SCG, Bokermann S, Minamisava R, et al
Dynamics of antimicrobial resistance of Streptococcus pneumoniae following PCV10 introduction in Brazil: Nationwide surveillance from 2007 to 2019.
Vaccine. 2021;39:3207-3215.
PubMed Abstract available

GURWITZ D
COVID-19 vaccine hesitancy: Lessons from Israel.
Vaccine. 2021 May 27. pii: S0264-410X(21)00680.
PubMed

CHU H, Ko LK, Ibrahim A, Bille Mohamed F, et al
The impact of an educational forum intervention on East African mothers' HPV vaccine-related knowledge, attitudes, and intentions to vaccinate their adolescent children.
Vaccine. 2021 May 27. pii: S0264-410X(21)00593.
PubMed Abstract available

VUJOVICH-DUNN C, Kaufman J, King C, Skinner SR, et al
A systematic review and meta-analysis of effectiveness of decision aids for vaccination decision-making.
Vaccine. 2021 May 26. pii: S0264-410X(21)00583.
PubMed Abstract available

KESSELS R, Luyten J, Tubeuf S
Willingness to get vaccinated against Covid-19 and attitudes toward vaccination in general.
Vaccine. 2021 May 26. pii: S0264-410X(21)00664.
PubMed Abstract available

SATTLER C, Hoffmann P, Herzberg PY, Weber D, et al
Primary vaccination in adult patients after allogeneic hematopoietic stem cell transplantation - A single center retrospective efficacy analysis.
Vaccine. 2021 May 25. pii: S0264-410X(21)00511.
PubMed Abstract available

WATESKA AR, Nowalk MP, Jalal H, Lin CJ, et al
Is further research on adult pneumococcal vaccine uptake improvement programs worthwhile? Alpha value of information analysis.
Vaccine. 2021 May 24. pii: S0264-410X(21)00609.
PubMed Abstract available

COX SN, Wedlock PT, Pallas SW, Mitgang EA, et al
A systems map of the economic considerations for vaccination: Application to hard-to-reach populations.
Vaccine. 2021 May 24. pii: S0264-410X(21)00605.
PubMed Abstract available

VANHEMS P
A breath of humanity in the era of Covid-19 vaccine.
Vaccine. 2021 May 24. pii: S0264-410X(21)00638.
PubMed

EARLE KA, Ambrosino DM, Fiore-Gartland A, Goldblatt D, et al
Evidence for antibody as a protective correlate for COVID-19 vaccines.
Vaccine. 2021 May 24. pii: S0264-410X(21)00658.
PubMed Abstract available

GIDENGIL C, Goetz MB, Newberry S, Maglione M, et al
Safety of vaccines used for routine immunization in the United States: An updated systematic review and meta-analysis.
Vaccine. 2021 May 23. pii: S0264-410X(21)00385.
PubMed Abstract available

NADARZYNSKI T, Frost M, Miller D, Wheldon CW, et al
Vaccine acceptability, uptake and completion amongst men who have sex with men: A systematic review, meta-analysis and theoretical framework.
Vaccine. 2021 May 22. pii: S0264-410X(21)00564.
PubMed Abstract available

HIRST A, Hyer RN, Janssen RS
Comparative cost-effectiveness of a 2-dose versus 3-dose vaccine for hepatitis B prevention in selected adult populations.
Vaccine. 2021 May 21. pii: S0264-410X(21)00582.
PubMed Abstract available

TUFAIL S, Shah MA, Zafar M, Asif TA, et al
Identification of potent epitopes on hexon capsid protein and their evaluation as vaccine candidates against infections caused by members of Adenoviridae family.
Vaccine. 2021 May 21. pii: S0264-410X(21)00585.
PubMed Abstract available

ARDURA-GARCIA C, Kreis C, Rakic M, Jaboyedoff M, et al
Rotavirus disease and health care utilisation among children under 5 years of age in highly developed countries: A systematic review and meta-analysis.
Vaccine. 2021;39:2917-2928.
PubMed Abstract available

BIANCHI FP, Larocca AMV, Bozzi A, Spinelli G, et al
Long-term persistence of poliovirus neutralizing antibodies in the era of polio elimination: An Italian retrospective cohort study.
Vaccine. 2021;39:2989-2994.
PubMed Abstract available

VOGEL TP, Top KA, Karatzios C, Hilmers DC, et al
Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
Vaccine. 2021;39:3037-3049.
PubMed Abstract available

SERAZIN NA, Edem B, Williams SR, Ortiz JR, et al
Acute respiratory distress syndrome (ARDS) as an adverse event following immunization: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
Vaccine. 2021;39:3028-3036.
PubMed Abstract available

AIZAWA Y, Katsuta T, Sakiyama H, Tanaka-Taya K, et al
Changes in childhood vaccination during the coronavirus disease 2019 pandemic in Japan.
Vaccine. 2021 May 21. pii: S0264-410X(21)00636.
PubMed Abstract available

OKORONKWO C, Taiwo LA, Asolo JA, Baptiste AEJ, et al
Leveraging on the 2017/2018 measles vaccination campaign to improve health workers knowledge and practice on injection safety: A case study of north-central states, Nigeria.
Vaccine. 2021 May 20. pii: S0264-410X(21)00565.
PubMed Abstract available

SON HJ, Lee E, Park SY, Lee S, et al
Promotion of healthcare personnel vaccinations among newly employed doctors and nurses: Evidence-guided strategy.
Vaccine. 2021 May 20. pii: S0264-410X(21)00589.
PubMed Abstract available

BLANCHARD-ROHNER G, Enriquez N, Lemaitre B, Cadau G, et al
Pneumococcal immunity and PCV13 vaccine response in SOT-candidates and recipients.
Vaccine. 2021 May 20. pii: S0264-410X(21)00594.
PubMed Abstract available

NICHOLLS LAB, Gallant AJ, Cogan N, Rasmussen S, et al
Older adults' vaccine hesitancy: Psychosocial factors associated with influenza, pneumococcal, and shingles vaccine uptake.
Vaccine. 2021 May 19. pii: S0264-410X(21)00544.
PubMed Abstract available

DANG JHT, Stewart SL, Blumberg DA, Rodriguez HP, et al
Patient and clinician factors associated with uptake of the human papillomavirus (HPV) vaccine among adolescent patients of a primary care network.
Vaccine. 2021 May 19. pii: S0264-410X(21)00525.
PubMed Abstract available

KIM S, Williams TC, Viboud C, Campbell H, et al
RSV genomic diversity and the development of a globally effective RSV intervention.
Vaccine. 2021;39:2811-2820.
PubMed Abstract available

NAG K, Chandra Baray J, Rahman Khan M, Mahmud A, et al
An mRNA-based vaccine candidate against SARS-CoV-2 elicits stable immuno-response with single dose.
Vaccine. 2021 May 18. pii: S0264-410X(21)00607.
PubMed Abstract available

LUK TT, Zhao S, Wu Y, Wong JY, et al
Prevalence and determinants of SARS-CoV-2 vaccine hesitancy in Hong Kong: A population-based survey.
Vaccine. 2021 May 18. pii: S0264-410X(21)00608.
PubMed Abstract available

MENKIR TF, Jbaily A, Verguet S
Incorporating equity in infectious disease modeling: Case study of a distributional impact framework for measles transmission.
Vaccine. 2021;39:2894-2900.
PubMed Abstract available

GULLA K, Cibelli N, Cooper JW, Fuller HC, et al
A non-affinity purification process for GMP production of prefusion-closed HIV-1 envelope trimers from clades A and C for clinical evaluation.
Vaccine. 2021 May 18. pii: S0264-410X(21)00545.
PubMed Abstract available

FUKUDA M, Nakamura J, Ito S, Kawazoe K, et al
Vaccination inhibits the human adenoviral transduction in a mouse keratoconjunctivitis model.
Vaccine. 2021 May 17. pii: S0264-410X(21)00561.
PubMed Abstract available

NAKAHASHI-OUCHIDA R, Uchida Y, Yuki Y, Katakai Y, et al
A nanogel-based trivalent PspA nasal vaccine protects macaques from intratracheal challenge with pneumococci.
Vaccine. 2021 May 17. pii: S0264-410X(21)00552.
PubMed Abstract available

CHAN YW, Wong ML, Kwok FY, Au AK, et al
The effect of seasonal influenza vaccine on medically-attended influenza and non-influenza respiratory viruses infections at primary care level, Hong Kong SAR, 2017/18 to 2019/20.
Vaccine. 2021 May 17. pii: S0264-410X(21)00541.
PubMed Abstract available

MCGIRR A, Bourgoin T, Wortzman M, Millson B, et al
An early look at the second dose completion of the recombinant zoster vaccine in Canadian adults: A retrospective database study.
Vaccine. 2021 May 14. pii: S0264-410X(21)00523.
PubMed Abstract available

AWAD AM, Ntoso A, Connaire JJ, Hernandez GT, et al
An open-label, single-arm study evaluating the immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B(R)) in adults receiving hemodialysis.
Vaccine. 2021 May 14. pii: S0264-410X(21)00554.
PubMed Abstract available

WOOD RM, Murch BJ, Moss SJ, Tyler JMB, et al
Operational research for the safe and effective design of COVID-19 mass vaccination centres.
Vaccine. 2021 May 14. pii: S0264-410X(21)00588.
PubMed

GUBERNOT D, Jazwa A, Niu M, Baumblatt J, et al
U.S. Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines.
Vaccine. 2021 May 14. pii: S0264-410X(21)00578.
PubMed Abstract available

CHUNG JR, Flannery B, Kim SS, Gaglani M, et al
Sample size considerations for mid-season estimates from a large influenza vaccine effectiveness network in the United States.
Vaccine. 2021 May 13. pii: S0264-410X(21)00555.
PubMed Abstract available

WANG J, Jiang L, Zhang C, He W, et al
The changes in the epidemiology of hand, foot, and mouth disease after the introduction of the EV-A71 vaccine.
Vaccine. 2021 May 13. pii: S0264-410X(21)00560.
PubMed Abstract available

LIU Y, Xiong Y, Liang Y, Deng X, et al
Waning immunity and potential asymptomatic infection in 3-7 years old children who received one dose of measles-mumps-rubella vaccine: A 4-year prospective study.
Vaccine. 2021 May 13. pii: S0264-410X(21)00559.
PubMed Abstract available

KALKOWSKA DA, Pallansch MA, Wassilak SGF, Cochi SL, et al
Serotype 2 oral poliovirus vaccine (OPV2) choices and the consequences of delaying outbreak response.
Vaccine. 2021 May 13. pii: S0264-410X(21)00543.
PubMed Abstract available

BANNISTER S, Sudbury E, Villanueva P, Perrett K, et al
The safety of BCG revaccination: A systematic review.
Vaccine. 2021;39:2736-2745.
PubMed Abstract available

LONGCHAMPS C, Ducarroz S, Crouzet L, Vignier N, et al
COVID-19 vaccine hesitancy among persons living in homeless shelters in France.
Vaccine. 2021 May 12. pii: S0264-410X(21)00563.
PubMed Abstract available

GROENEWEG L, Loeffen YGT, Versluys AB, Wolfs TFW, et al
Safety and efficacy of early vaccination with live attenuated measles vaccine for hematopoietic stem cell transplant recipients and solid organ transplant recipients.
Vaccine. 2021 May 12. pii: S0264-410X(21)00508.
PubMed Abstract available

HAN B, Liu W, Du J, Liu H, et al
Immunogenicity and safety of hepatitis B vaccination in patients with type 2 diabetes in China: An open-label randomized controlled trial.
Vaccine. 2021 May 12. pii: S0264-410X(21)00540.
PubMed Abstract available

KIM TH, Choi JH, Park SH, Yoo JH, et al
Safety and immunogenicity of a seasonal quadrivalent influenza vaccine (GC3110A) in healthy participants aged >/= 65 years.
Vaccine. 2021 May 12. pii: S0264-410X(21)00551.
PubMed Abstract available

UWABOR E, Chau V, Romanin C, Loh LC, et al
Digital tools for vaccine reporting: A perspective from the province of Ontario.
Vaccine. 2021 May 12. pii: S0264-410X(21)00558.
PubMed

ARREDONDO JL, Villagomez Martinez SM, Concepcion Morales M, Meyer S, et al
Immunogenicity and safety of a tetravalent dengue vaccine and a bivalent HPV vaccine given concomitantly or sequentially in girls aged 9 to 14 years in Mexico.
Vaccine. 2021 May 12. pii: S0264-410X(21)00546.
PubMed Abstract available

KRAIGSLEY AM, Moore KA, Bolster A, Peters M, et al
Barriers and activities to implementing or expanding influenza vaccination programs in low- and middle-income countries: A global survey.
Vaccine. 2021 May 12. pii: S0264-410X(21)00502.
PubMed Abstract available

CHILENGI R, Mwila-Kazimbaya K, Chirwa M, Sukwa N, et al
Immunogenicity and safety of two monovalent rotavirus vaccine, ROTAVAC(R) and ROTAVAC 5D(R) in Zambian infants.
Vaccine. 2021 May 12. pii: S0264-410X(21)00542.
PubMed Abstract available

GLENN BA, Nonzee NJ, Tieu L, Pedone B, et al
Human papillomavirus (HPV) vaccination in the transition between adolescence and adulthood.
Vaccine. 2021 May 12. pii: S0264-410X(21)00454.
PubMed Abstract available

AFIFI TO, Salmon S, Taillieu T, Stewart-Tufescu A, et al
Older adolescents and young adults willingness to receive the COVID-19 vaccine: Implications for informing public health strategies.
Vaccine. 2021 May 12. pii: S0264-410X(21)00590.
PubMed Abstract available

LEUNG VKY, Fox A, Carolan LA, Aban M, et al
Impact of prior vaccination on antibody response and influenza-like illness among Australian healthcare workers after influenza vaccination in 2016.
Vaccine. 2021 May 10. pii: S0264-410X(21)00483.
PubMed Abstract available

POWELL H, Liu H, Pekosz A
Changes in sialic acid binding associated with egg adaptation decrease live attenuated influenza virus replication in human nasal epithelial cell cultures.
Vaccine. 2021 May 10. pii: S0264-410X(21)00535.
PubMed Abstract available

DU QQ, Zeng HL, Yuan L, Tang P, et al
One cross-sectional investigation revealed that non-vaccine serotypes of Streptococcus pneumoniae could be identified more frequently in elderly Chinese people.
Vaccine. 2021 May 9. pii: S0264-410X(21)00233.
PubMed Abstract available

PASTORINO R, Villani L, La Milia DI, Ieraci R, et al
Influenza and pneumococcal vaccinations are not associated to COVID-19 outcomes among patients admitted to a university hospital.
Vaccine. 2021 May 9. pii: S0264-410X(21)00566.
PubMed Abstract available

HUANG JM, Wang SY, Lai MR, Tseng YK, et al
Development of a respiratory syncytial virus vaccine using human hepatitis B core-based virus-like particles to induce mucosal immunity.
Vaccine. 2021 May 7. pii: S0264-410X(21)00485.
PubMed Abstract available

STABEL JR, Bannantine JP
Reduced tissue colonization of Mycobacterium avium subsp. paratuberculosis in neonatal calves vaccinated with a cocktail of recombinant proteins.
Vaccine. 2021 May 6. pii: S0264-410X(21)00510.
PubMed Abstract available

TANG XY, Yan XX, Wei X, Qin QL, et al
Timeliness, completeness, and timeliness-and-completeness of serial routine vaccinations among rural children in Southwest China: A multi-stage stratified cluster sampling survey.
Vaccine. 2021 May 6. pii: S0264-410X(21)00507.
PubMed Abstract available

KHALIL I, Walker R, Porter CK, Muhib F, et al
Enterotoxigenic Escherichia coli (ETEC) vaccines: Priority activities to enable product development, licensure, and global access.
Vaccine. 2021 May 6. pii: S0264-410X(21)00453.
PubMed Abstract available

SOMIYA M, Mine S, Yasukawa K, Ikeda S, et al
Sex differences in the incidence of anaphylaxis to LNP-mRNA COVID-19 vaccines.
Vaccine. 2021 May 6. pii: S0264-410X(21)00548.
PubMed

SATOH C, Toizumi M, Nguyen HAT, Hara M, et al
Prevalence and characteristics of children with otitis media with effusion in Vietnam.
Vaccine. 2021;39:2613-2619.
PubMed Abstract available

MANCA TA, Graham JE, MacDonald NE, Top KA, et al
Healthcare providers' interpretations of product labelling information developed through a consensus stakeholder approach.
Vaccine. 2021;39:2652-2659.
PubMed Abstract available

CORREIA R, Meneses L, Richheimer C, Alves PM, et al
Improved storage of influenza HA-VLPs using a trehalose-glycerol natural deep eutectic solvent system.
Vaccine. 2021 May 6. pii: S0264-410X(21)00480.
PubMed Abstract available

FAIRMAN J, Agarwal P, Barbanel S, Behrens C, et al
Non-clinical immunological comparison of a Next-Generation 24-valent pneumococcal conjugate vaccine (VAX-24) using site-specific carrier protein conjugation to the current standard of care (PCV13 and PPV23).
Vaccine. 2021 May 5. pii: S0264-410X(21)00374.
PubMed Abstract available

JO CL, Burchett H, Bastias M, Campbell P, et al
Using existing systematic reviews for developing vaccination recommendations: Results of an international expert workshop.
Vaccine. 2021 May 5. pii: S0264-410X(21)00504.
PubMed Abstract available

WANG J, Bai S, Zhou S, Zhao W, et al
Immunogenicity and safety of 7-valent pneumococcal conjugate vaccine (PCV7) in children aged 2-5 years in China.
Vaccine. 2021 May 5. pii: S0264-410X(21)00484.
PubMed Abstract available

BITENCOURT J, Sarno A, Oliveira C, Souza RA, et al
Comparing cytokine production and clinical response following vaccination with BCG Moreau and BCG Russia strains in a Brazilian infant population.
Vaccine. 2021 May 5. pii: S0264-410X(21)00475.
PubMed Abstract available

MILLAR EV, Bennett JW, Barin B, Carey PM, et al
Safety, immunogenicity, and efficacy of NDV-3A against Staphylococcus aureus colonization: A phase 2 vaccine trial among US Army Infantry trainees.
Vaccine. 2021 May 4. pii: S0264-410X(21)00478.
PubMed Abstract available

HALL GC, Douglas I, Heath PT, Prabhakar P, et al
Post-licensure observational safety study after meningococcal B vaccine 4CMenB (Bexsero) vaccination within the routine UK immunisation program.
Vaccine. 2021 May 4. pii: S0264-410X(21)00256.
PubMed Abstract available

MPHURU A, Li AJ, Kyesi F, Mwengee W, et al
National introduction of human papillomavirus (HPV) vaccine in Tanzania: Programmatic decision-making and implementation.
Vaccine. 2021 May 4. pii: S0264-410X(21)00472.
PubMed Abstract available

OTERI AJ, Adamu U, Dieng B, Bawa S, et al
Nigeria experience on the use of polio assets for the 2017/18 measles vaccination campaign follow-up.
Vaccine. 2021 May 4. pii: S0264-410X(21)00497.
PubMed Abstract available

LAURENZ M, von Eiff C, Borchert K, Jacob C, et al
Vaccination rates and adherence in pneumococcal conjugate vaccination in mature born infants before and after vaccination schedule change - A claims database analysis.
Vaccine. 2021 May 4. pii: S0264-410X(21)00476.
PubMed Abstract available

TAMANDJOU TCHUEM CR, Andersson MI, Wiysonge CS, Mufenda J, et al
Prevention of hepatitis B mother-to-child transmission in Namibia: A cost-effectiveness analysis.
Vaccine. 2021 May 4. pii: S0264-410X(21)00498.
PubMed Abstract available

MANDOMANDO I, Mumba M, Nsiari-Muzeyi Biey J, Kipese Paluku G, et al
Implementation of the World Health Organization recommendation on the use of rotavirus vaccine without age restriction by African countries.
Vaccine. 2021 May 3. pii: S0264-410X(21)00289.
PubMed Abstract available

YOSHIMURA M, Shinmura Y, Shishido T, Takagi S, et al
Persistence of neutralizing antibody and its protective efficacy induced by a live attenuated tetravalent dengue vaccine, KD-382, in cynomolgus monkeys.
Vaccine. 2021 May 1. pii: S0264-410X(21)00477.
PubMed Abstract available

April 2021

WELSH KJ, Baumblatt J, Chege W, Goud R, et al
Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS).
Vaccine. 2021 Apr 30. pii: S0264-410X(21)00524.
PubMed Abstract available

EYAL N, Gerhard T, Strom BL
Strengthening and accelerating SARS-CoV-2 vaccine safety surveillance through registered pre-approval rollout after challenge tests.
Vaccine. 2021 Apr 30. pii: S0264-410X(21)00526.
PubMed

ITO S, Nakamura J, Fukuta M, Ura T, et al
Prophylactic and therapeutic vaccine against Pseudomonas aeruginosa keratitis using bacterial membrane vesicles.
Vaccine. 2021 Apr 29. pii: S0264-410X(21)00482.
PubMed Abstract available

WILKINSON K, Righolt CH, Elliott LJ, Fanella S, et al
Pertussis vaccine effectiveness and duration of protection - A systematic review and meta-analysis.
Vaccine. 2021 Apr 29. pii: S0264-410X(21)00479.
PubMed Abstract available

POLKOWSKA A, Rinta-Kokko H, Toropainen M, Palmu AA, et al
Long-term population effects of infant 10-valent pneumococcal conjugate vaccination on pneumococcal meningitis in Finland.
Vaccine. 2021 Apr 29. pii: S0264-410X(21)00186.
PubMed Abstract available

KINI A, Morgan R, Kuo H, Shea P, et al
Differences and disparities in seasonal influenza vaccine, acceptance, adverse reactions, and coverage by age, sex, gender, and race.
Vaccine. 2021 Apr 28. pii: S0264-410X(21)00448.
PubMed Abstract available

DIAS HF, Kuhtreiber WM, Nelson KJ, Ng NC, et al
Epigenetic changes related to glucose metabolism in type 1 diabetes after BCG vaccinations: A vital role for KDM2B.
Vaccine. 2021 Apr 28. pii: S0264-410X(21)00446.
PubMed Abstract available

VEKEMANS J, Schellenberg D, Benns S, O'Brien K, et al
Meeting report: WHO consultation on malaria vaccine development, Geneva, 15-16 July 2019.
Vaccine. 2021 Apr 27. pii: S0264-410X(21)00409.
PubMed Abstract available

SAITOH A, Okabe N
Changes and remaining challenges for the Japanese immunization program: Closing the vaccine gap.
Vaccine. 2021 Apr 27. pii: S0264-410X(21)00460.
PubMed Abstract available

XU J, Doyon-Plourde P, Tunis M, Quach C, et al
Effect of early measles vaccination on long-term protection: A systematic review.
Vaccine. 2021 Apr 26. pii: S0264-410X(21)00447.
PubMed Abstract available

KWON JH, Criado MF, Killmaster L, Ali MZ, et al
Efficacy of two vaccines against recent emergent antigenic variants of clade 2.3.2.1a highly pathogenic avian influenza viruses in Bangladesh.
Vaccine. 2021 Apr 25. pii: S0264-410X(21)00459.
PubMed Abstract available

MACINTYRE CR, Costantino V, Trent M
Modelling of COVID-19 vaccination strategies and herd immunity, in scenarios of limited and full vaccine supply in NSW, Australia.
Vaccine. 2021 Apr 24. pii: S0264-410X(21)00501.
PubMed Abstract available

KREPS SE, Kriner DL
Factors influencing Covid-19 vaccine acceptance across subgroups in the United States: Evidence from a conjoint experiment.
Vaccine. 2021 Apr 24. pii: S0264-410X(21)00503.
PubMed Abstract available

PARK MA, Jenkins SM, Smith CY, Pyle RC, et al
Pneumococcal serotype-specific cut-offs based on antibody responses to pneumococcal polysaccharide vaccination in healthy adults.
Vaccine. 2021 Apr 22. pii: S0264-410X(21)00450.
PubMed Abstract available

XIRIDOU M, Visser M, Urbanus A, Matser A, et al
Ending risk-group HBV vaccination for MSM after the introduction of universal infant HBV vaccination: A mathematical modelling study.
Vaccine. 2021 Apr 22. pii: S0264-410X(21)00433.
PubMed Abstract available

OLATUNJI EA, Ogunsola AS, Khodakarami N, Callaghan T, et al
Who receives influenza vaccinations at the Pharmacy? An analysis of the Texas Behavioral Risk Factor Surveillance System.
Vaccine. 2021 Apr 22. pii: S0264-410X(21)00451.
PubMed Abstract available

SOLANS L, Debrie AS, Coutte L, Locht C, et al
Construction and evaluation of a pertactin-deficient live attenuated pertussis vaccine candidate BPZE1 derivative.
Vaccine. 2021 Apr 22. pii: S0264-410X(21)00449.
PubMed Abstract available

ROY CHOUDHURY A, Polachek SW
The impact of paid family leave on the timely vaccination of infants.
Vaccine. 2021 Apr 22. pii: S0264-410X(21)00403.
PubMed Abstract available

KAWAMURA Y, Hattori F, Higashimoto Y, Kozawa K, et al
Evaluation of varicella vaccine effectiveness during outbreaks in schools or nurseries by cross-sectional study.
Vaccine. 2021 Apr 21. pii: S0264-410X(21)00434.
PubMed Abstract available

STEVENS NE, van Wolfswinkel M, Bao W, Ryan FJ, et al
Immunisation with the BCG and DTPw vaccines induces different programs of trained immunity in mice.
Vaccine. 2021 Apr 21. pii: S0264-410X(21)00400.
PubMed Abstract available

HAMISU M, Dieng B, Taiwo L, Jean Baptiste AE, et al
Microplanning verification and 2017/2018 measles vaccination campaign in Nigeria: Lessons learnt.
Vaccine. 2021 Apr 20. pii: S0264-410X(21)00432.
PubMed Abstract available

PIERSON BC, Cardile AP, Okwesili AC, Downs IL, et al
Safety and immunogenicity of an inactivated eastern equine encephalitis virus vaccine.
Vaccine. 2021 Apr 19. pii: S0264-410X(21)00309.
PubMed Abstract available

JEAN BAPTISTE AE, Masresha B, Wagai J, Luce R, et al
Trends in measles incidence and measles vaccination coverage in Nigeria, 2008-2018.
Vaccine. 2021 Apr 17. pii: S0264-410X(21)00424.
PubMed Abstract available

SAVAGE RD, Bell CA, Righolt CH, Wilkinson K, et al
A multisite study of pertussis vaccine effectiveness by time since last vaccine dose from three Canadian provinces: A Canadian Immunization Research Network study.
Vaccine. 2021 Apr 16. pii: S0264-410X(21)00310.
PubMed Abstract available

OSTOLIN TLVDP, Gusmao MR, Mathias FAS, Cardoso JMO, et al
A chimeric vaccine combined with adjuvant system induces immunogenicity and protection against visceral leishmaniasis in BALB/c mice.
Vaccine. 2021 Apr 16. pii: S0264-410X(21)00429.
PubMed Abstract available

MARTIN JC, Petrecz ML, Stek JE, Simon JK, et al
Using the power law model to predict the long-term persistence and duration of detectable hepatitis A antibody after receipt of hepatitis A vaccine (VAQTA).
Vaccine. 2021 Apr 15. pii: S0264-410X(21)00345.
PubMed Abstract available

GUZMAN-HOLST A, Luna-Casas G, Cervantes-Apolinar MY, Huerta-Garcia GC, et al
Pertussis infant morbidity and mortality trends after universal maternal immunisation in Mexico: An ecological database study with time-series analysis.
Vaccine. 2021;39:2311-2318.
PubMed Abstract available

YAMADA M, Li M, Iino T
Pneumococcal vaccine coverage in Japan among patients with a history of splenectomy: Results of a retrospective administrative database study.
Vaccine. 2021 Apr 14. pii: S0264-410X(21)00338.
PubMed Abstract available

DANIEL M, Liang B, Luo M
Assessment of the population coverage of an HIV-1 vaccine targeting sequences surrounding the viral protease cleavage sites in Gag, Pol, or all 12 protease cleavage sites.
Vaccine. 2021 Apr 13. pii: S0264-410X(21)00372.
PubMed Abstract available

BROOK B, Schaltz-Buchholzer F, Ben-Othman R, Kollmann T, et al
A place for neutrophils in the beneficial pathogen-agnostic effects of the BCG vaccine.
Vaccine. 2021 Apr 13. pii: S0264-410X(21)00408.
PubMed Abstract available

LEVIN Y, Balakirski NM, Caraco Y, Ben-Ami E, et al
Ethics and execution of developing a 2nd wave COVID vaccine - Our interim phase I/II VSV-SARS-CoV2 vaccine experience.
Vaccine. 2021 Apr 13. pii: S0264-410X(21)00452.
PubMed

WANG C, Han B, Zhao T, Liu H, et al
Vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of COVID-19 vaccination in China: A national cross-sectional study.
Vaccine. 2021 Apr 13. pii: S0264-410X(21)00455.
PubMed Abstract available

YU Q, Li X, Fan M, Qiu H, et al
The impact of childhood pneumococcal conjugate vaccine immunisation on all-cause pneumonia admissions in Hong Kong: A 14-year population-based interrupted time series analysis.
Vaccine. 2021 Apr 12. pii: S0264-410X(21)00406.
PubMed Abstract available

PRYMULA R, Povey M, Brzostek J, Cabrnochova H, et al
Ten-year follow-up on efficacy, immunogenicity and safety of two doses of a combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: Results from five East European countries.
Vaccine. 2021 Apr 12. pii: S0264-410X(21)00401.
PubMed Abstract available

CHOI SK, Baik YO, Kim CW, Kim SK, et al
An open-label, comparative, single dose, clinical Phase study to assess the safety and immunogenicity of typhoid conjugate vaccine (Vi-CRM197) in healthy Filipino adults.
Vaccine. 2021 Apr 10. pii: S0264-410X(21)00405.
PubMed Abstract available

LA EM, Garbinsky D, Hunter S, Poston S, et al
Meningococcal B vaccination coverage among older adolescents in the United States.
Vaccine. 2021 Apr 10. pii: S0264-410X(21)00375.
PubMed Abstract available

HAMILTON RA, Krockow EM, Vekria P
Attitudes towards influenza and uptake of the flu vaccine: A survey of pharmacy staff working in English hospitals.
Vaccine. 2021 Apr 9. pii: S0264-410X(21)00407.
PubMed Abstract available

JENSEN KJ, Tolstrup LK, Knobel DL, Aaby P, et al
Non-specific effects of maternal and offspring rabies vaccination on mortality and antibiotic use in a Danish pig herd: A randomized trial.
Vaccine. 2021 Apr 9. pii: S0264-410X(21)00399.
PubMed Abstract available

PU J, Yu Q, Yin Z, Zhang Y, et al
The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18-59 years: A phase I randomized, double-blinded, controlled trial.
Vaccine. 2021 Apr 9. pii: S0264-410X(21)00431.
PubMed Abstract available

DE SL, May S, Shah K, Slawinski M, et al
Variable immunogenicity of a vivax malaria blood-stage vaccine candidate.
Vaccine. 2021 Apr 8. pii: S0264-410X(21)00376.
PubMed Abstract available

HOGAN AB, Winskill P, Watson OJ, Walker PGT, et al
Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis.
Vaccine. 2021 Apr 8. pii: S0264-410X(21)00427.
PubMed Abstract available

CEYHAN M, Karadag-Oncel E, Hascelik G, Ustundag G, et al
Nasopharyngeal carriage of Streptococcus pneumoniae in healthy children aged less than five years.
Vaccine. 2021;39:2041-2047.
PubMed Abstract available

PAGLIUSI S, Hayman B, Jarrett S
Vaccines for a healthy future: 21st DCVMN Annual General Meeting 2020 report.
Vaccine. 2021 Apr 7. pii: S0264-410X(21)00293.
PubMed Abstract available

GRAMACHO WG, Turgeon M
When politics collides with public health: COVID-19 vaccine country of origin and vaccination acceptance in Brazil.
Vaccine. 2021 Apr 6. pii: S0264-410X(21)00396.
PubMed Abstract available

HATZIANTONIOU S, Maltezou HC, Tsakris A, Poland GA, et al
Anaphylactic reactions to mRNA COVID-19 vaccines: A call for further study.
Vaccine. 2021 Apr 6. pii: S0264-410X(21)00377.
PubMed

DANIELS V, Saxena K, Roberts C, Kothari S, et al
Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: A model based analysis.
Vaccine. 2021 Apr 6. pii: S0264-410X(21)00428.
PubMed Abstract available

SMITH TG, Fooks AR, Moore SM, Freuling CM, et al
Negligible risk of rabies importation in dogs thirty days after demonstration of adequate serum antibody titer.
Vaccine. 2021 Apr 4. pii: S0264-410X(21)00368.
PubMed

DION SB, Major M, Gabriela Grajales A, Nepal RM, et al
Invasive pneumococcal disease in Canada 2010-2017: The role of current and next-generation higher-valent pneumococcal conjugate vaccines.
Vaccine. 2021 Apr 3. pii: S0264-410X(21)00260.
PubMed Abstract available

DONG TQ, Wakefield J
Modeling and presentation of vaccination coverage estimates using data from household surveys.
Vaccine. 2021 Apr 3. pii: S0264-410X(21)00275.
PubMed Abstract available

STALPERS CAL, Retmana IA, Pennings JLA, Vandebriel RJ, et al
Variability of in vivo potency tests of Diphtheria, Tetanus and acellular Pertussis (DTaP) vaccines.
Vaccine. 2021 Apr 3. pii: S0264-410X(21)00384.
PubMed Abstract available

YAO T, Shao Z, Wu L, Dong S, et al
Long-term persistent immunogenicity after successful standard and triple-dosed hepatitis B vaccine in hemodialysis patients: A 3-year follow-up study in China.
Vaccine. 2021 Apr 2. pii: S0264-410X(21)00378.
PubMed Abstract available

BEZERRA FSB, Silva MTO, Rezende AFS, Lopes AS, et al
Saponin-adjuvanted recombinant vaccines containing rCP00660, rCP09720 or rCP01850 proteins against Corynebacterium pseudotuberculosis infection in mice.
Vaccine. 2021 Apr 1. pii: S0264-410X(21)00366.
PubMed Abstract available

DE MIRANDA LOPES KA, Baptista PN, de Medeiros Nascimento R, Pimentel A, et al
Clinical repercussions in pertussis infants post-Tdpa vaccination of pregnant woman: An immunization success?
Vaccine. 2021 Apr 1. pii: S0264-410X(21)00373.
PubMed Abstract available

SUH J, Lee T, Choi JK, Lee J, et al
The impact of two-dose varicella vaccination on varicella and herpes zoster incidence in South Korea using a mathematical model with changing population demographics.
Vaccine. 2021 Apr 1. pii: S0264-410X(21)00349.
PubMed Abstract available

CARR DJJ, Berube AN, Filiberti A, Gmyrek GB, et al
Lack of neonatal Fc receptor does not diminish the efficacy of the HSV-1 0DeltaNLS vaccine against ocular HSV-1 challenge.
Vaccine. 2021 Apr 1. pii: S0264-410X(21)00379.
PubMed Abstract available

HOFFMAN BL, Colditz JB, Shensa A, Wolynn R, et al
#DoctorsSpeakUp: Lessons learned from a pro-vaccine Twitter event.
Vaccine. 2021 Apr 1. pii: S0264-410X(21)00365.
PubMed Abstract available

CROWCROFT NS, Bolotin S, Li Y, Campbell H, et al
Infant pertussis and maternal immunity: The curious case of Canada.
Vaccine. 2021;39:1977-1981.
PubMed Abstract available

AMIN-CHOWDHURY Z, Groves N, Sheppard CL, Litt D, et al
Invasive pneumococcal disease due to 22F and 33F in England: A tail of two serotypes.
Vaccine. 2021;39:1997-2004.
PubMed Abstract available

QUAN DH, Counoupas C, Nagalingam G, Pinto R, et al
Advax adjuvant formulations promote protective immunity against aerosol Mycobacterium tuberculosis in the absence of deleterious inflammation and reactogenicity.
Vaccine. 2021;39:1990-1996.
PubMed Abstract available

March 2021

ERIKSSON M, Kayhty H, Lahdenkari M, Makisalo H, et al
A randomized, controlled trial comparing the immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccination to a repeated dose 13-valent pneumococcal conjugate vaccination in adult liver transplant recipients.
Vaccine. 2021 Mar 31. pii: S0264-410X(21)00367.
PubMed Abstract available

KLOUWENS MJ, Salverda MLM, Trentelman JJ, Ersoz JI, et al
Vaccination with meningococcal outer membrane vesicles carrying Borrelia OspA protects against experimental Lyme borreliosis.
Vaccine. 2021 Mar 31. pii: S0264-410X(21)00363.
PubMed Abstract available

AZZI L, Focosi D, Dentali F, Baj A, et al
Anti-SARS-CoV-2 RBD IgG responses in convalescent versus naive BNT162b2 vaccine recipients.
Vaccine. 2021 Mar 30. pii: S0264-410X(21)00402.
PubMed

CHEN H, Gao Z, Bai S, Liu X, et al
Immunogenicity and safety of sabin-strain based inactivated poliovirus vaccine replacing salk-strain based inactivated poliovirus vaccine: An innovative application of different strain-IPVs replacement.
Vaccine. 2021 Mar 30. pii: S0264-410X(21)00264.
PubMed Abstract available

PELTON SI, Divino V, Postma MJ, Shah D, et al
A retrospective cohort study assessing relative effectiveness of adjuvanted versus high-dose trivalent influenza vaccines among older adults in the United States during the 2018-19 influenza season.
Vaccine. 2021 Mar 30. pii: S0264-410X(21)00347.
PubMed Abstract available

GUR-ARIE R, Katz MA, Hirsch A, Greenberg D, et al
"You Have to Die Not to Come to Work": A Mixed Methods Study of Attitudes and Behaviors regarding Presenteeism, Absenteeism and Influenza Vaccination among Healthcare Personnel with Respiratory Illness in Israel, 2016-2019.
Vaccine. 2021 Mar 29. pii: S0264-410X(21)00361.
PubMed Abstract available

YAMAWAKI RA, Rubio MDS, Alves LBR, de Almeida AM, et al
Evaluation of transfer of maternal immunity to the offspring of broiler breeders vaccinated with a candidate recombinant vaccine against Salmonella Enteritidis.
Vaccine. 2021 Mar 26. pii: S0264-410X(21)00343.
PubMed Abstract available

BAVANANTHASIVAM J, Alizadeh M, Astill J, Alqazlan N, et al
Effects of administration of probiotic lactobacilli on immunity conferred by the herpesvirus of turkeys vaccine against challenge with a very virulent Marek's disease virus in chickens.
Vaccine. 2021 Mar 26. pii: S0264-410X(21)00339.
PubMed Abstract available

WIJAYANTI KE, Schutze H, MacPhail C, Braunack-Mayer A, et al
Parents' knowledge, beliefs, acceptance and uptake of the HPV vaccine in members of The Association of Southeast Asian Nations (ASEAN): A systematic review of quantitative and qualitative studies.
Vaccine. 2021 Mar 26. pii: S0264-410X(21)00342.
PubMed Abstract available

KUTER BJ, Offit PA, Poland GA
The development of COVID-19 vaccines in the United States: Why and how so fast?
Vaccine. 2021 Mar 26. pii: S0264-410X(21)00383.
PubMed

RUSSO AG, Decarli A, Valsecchi MG
Strategy to identify priority groups for COVID-19 vaccination: A population based cohort study.
Vaccine. 2021 Mar 26. pii: S0264-410X(21)00382.
PubMed Abstract available

LAMPONEN T, Hetemaki I, Niemi HJ, Jarva H, et al
Heterologous boosting of nonrelated toxoid immunity during acute Puumala hantavirus infection.
Vaccine. 2021;39:1818-1825.
PubMed Abstract available

VREMAN S, Rebel JMJ, McCaffrey J, Ledl K, et al
Early immune responses in skin and lymph node after skin delivery of Toll-like receptor agonists in neonatal and adult pigs.
Vaccine. 2021;39:1857-1869.
PubMed Abstract available

WAN C, Gao C, Xie Q, Wang Y, et al
Flagella hook protein FlgE is a novel vaccine candidate of Pseudomonas aeruginosa identified by a genomic approach.
Vaccine. 2021 Mar 25. pii: S0264-410X(21)00344.
PubMed Abstract available

NGUYEN KH, Santibanez TA, Stokley S, Lindley MC, et al
Parental vaccine hesitancy and its association with adolescent HPV vaccination.
Vaccine. 2021 Mar 25. pii: S0264-410X(21)00341.
PubMed

GKENTZI D, Aggelopoulos K, Karatza A, Sinopidis X, et al
Influenza vaccination among caregivers and household contacts of children with asthma.
Vaccine. 2021 Mar 25. pii: S0264-410X(21)00325.
PubMed Abstract available

MPHAHLELE MJ, Groome MJ, Page NA, Bhagwandin N, et al
A decade of rotavirus vaccination in Africa - Saving lives and changing the face of diarrhoeal diseases: Report of the 12(th) African Rotavirus Symposium.
Vaccine. 2021 Mar 25. pii: S0264-410X(21)00282.
PubMed Abstract available

SALMON DA, Dudley MZ, Brewer J, Kan L, et al
COVID-19 vaccination attitudes, values and intentions among United States adults prior to emergency use authorization.
Vaccine. 2021 Mar 24. pii: S0264-410X(21)00315.
PubMed Abstract available

MURRAY SM, McKay PF
Chlamydia trachomatis: Cell biology, immunology and vaccination.
Vaccine. 2021 Mar 24. pii: S0264-410X(21)00326.
PubMed Abstract available

BEISSBARTH J, Wilson N, Arrowsmith B, Binks MJ, et al
Nasopharyngeal carriage of otitis media pathogens in infants receiving 10-valent non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10), 13-valent pneumococcal conjugate vaccine (PCV13) or a mixed primary schedule of both vaccines
Vaccine. 2021 Mar 23. pii: S0264-410X(21)00311.
PubMed Abstract available

ROSA SS, Prazeres DMF, Azevedo AM, Marques MPC, et al
mRNA vaccines manufacturing: Challenges and bottlenecks.
Vaccine. 2021 Mar 23. pii: S0264-410X(21)00319.
PubMed Abstract available

HAEDER SF
Joining the herd? U.S. public opinion and vaccination requirements across educational settings during the COVID-19 pandemic.
Vaccine. 2021 Mar 23. pii: S0264-410X(21)00348.
PubMed Abstract available

ANGELIS A, Darrow J
Safeguarding evidence-based decision making in the FDA for COVID-19 vaccines.
Vaccine. 2021 Mar 22. pii: S0264-410X(21)00346.
PubMed

KOCHHAR S, Dube E, Graham J, Jee Y, et al
COVID-19 vaccine safety questions and answers for healthcare providers (CONSIDER).
Vaccine. 2021 Mar 22. pii: S0264-410X(21)00364.
PubMed

ZHANG Y, Li D, Zhao H, Wang L, et al
The role of multiple SARS-CoV-2 viral antigens in a vaccine-induced integrated immune response.
Vaccine. 2021 Mar 22. pii: S0264-410X(21)00371.
PubMed

ANTONELLI INCALZI R, Trevisan C, Del Signore S, Volpato S, et al
Are vaccines against COVID-19 tailored to the most vulnerable people?
Vaccine. 2021 Mar 22. pii: S0264-410X(21)00370.
PubMed

KENDAL A
Safety monitoring of COVID-19 vaccines - Lessons learned from the 1976 national influenza immunization program about detecting rare vaccine-related severe adverse events in emergency mass-vaccination programs.
Vaccine. 2021 Mar 20. pii: S0264-410X(21)00283.
PubMed

CHEN D, Ye Z, Pi Z, Mizukami S, et al
Cost-effectiveness of dual influenza and pneumococcal vaccination among the elderly in Shenzhen, China.
Vaccine. 2021 Mar 20. pii: S0264-410X(21)00324.
PubMed Abstract available

VILCHES TN, Zhang K, Van Exan R, Langley JM, et al
Projecting the impact of a two-dose COVID-19 vaccination campaign in Ontario, Canada.
Vaccine. 2021 Mar 20. pii: S0264-410X(21)00362.
PubMed Abstract available

ARTENSTEIN AW
A half-century of meningococcal vaccines.
Vaccine. 2021 Mar 19. pii: S0264-410X(21)00292.
PubMed Abstract available

EL BARA A, Pivert A, Veillon P, Ng Wing Sang C, et al
From national HBV and HDV screenings to vaccination and treatment in healthcare workers: The Mauritanian pilot study.
Vaccine. 2021 Mar 19. pii: S0264-410X(21)00279.
PubMed Abstract available

ZHANG Z, Pan J, Chen M, Zhang T, et al
Seroepidemiology of pertussis in China: A population-based, cross-sectional study.
Vaccine. 2021;39:1687-1692.
PubMed Abstract available

RANE MS, Page LC, McVeigh E, Miller K, et al
Improving adolescent human papillomavirus (HPV) immunization uptake in school-based health centers through awareness campaigns.
Vaccine. 2021;39:1765-1772.
PubMed Abstract available

KHANNA M, Rady H, Dai G, Ramsay AJ, et al
Intranasal boosting with MVA encoding secreted mycobacterial proteins Ag85A and ESAT-6 generates strong pulmonary immune responses and protection against M. tuberculosis in mice given BCG as neonates.
Vaccine. 2021;39:1780-1787.
PubMed Abstract available

TEMPLE B, Nation ML, Dai VTT, Beissbarth J, et al
Effect of a 2+1 schedule of ten-valent versus 13-valent pneumococcal conjugate vaccine on pneumococcal carriage: Results from a randomised controlled trial in Vietnam.
Vaccine. 2021 Mar 18. pii: S0264-410X(21)00223.
PubMed Abstract available

NWOGU IB, Jones M, Langley T
Economic evaluation of meningococcal serogroup B (MenB) vaccines: A systematic review.
Vaccine. 2021 Mar 18. pii: S0264-410X(21)00229.
PubMed Abstract available

BROWN DR, Joura EA, Yen GP, Kothari S, et al
Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence.
Vaccine. 2021 Mar 17. pii: S0264-410X(20)31564.
PubMed Abstract available

PHUA LC, Choi HCW, Wu J, Jit M, et al
Cost-effectiveness analysis of the nonavalent human papillomavirus vaccine for the prevention of cervical cancer in Singapore.
Vaccine. 2021 Mar 17. pii: S0264-410X(21)00321.
PubMed Abstract available

AGOCS M, Ismail A, Kamande K, Tabu C, et al
Reasons why children miss vaccinations in Western Kenya; A step in a five-point plan to improve routine immunization.
Vaccine. 2021 Mar 17. pii: S0264-410X(21)00262.
PubMed Abstract available

CAMBOU MC, Copeland TP, Nielsen-Saines K, Macinko J, et al
Insurance status predicts self-reported influenza vaccine coverage among pregnant women in the United States: A cross-sectional analysis of the National Health Interview Study Data from 2012 to 2018.
Vaccine. 2021 Mar 17. pii: S0264-410X(21)00294.
PubMed Abstract available

HAMIDI A, Hoeksema F, Velthof P, Lemckert A, et al
Developing a manufacturing process to deliver a cost effective and stable liquid human rotavirus vaccine.
Vaccine. 2021 Mar 17. pii: S0264-410X(21)00312.
PubMed Abstract available

UEKI S, Matsunaka E, Takao K, Kitao M, et al
The effectiveness of vibratory stimulation in reducing pain in children receiving vaccine injection: A randomized controlled trial.
Vaccine. 2021 Mar 17. pii: S0264-410X(21)00281.
PubMed Abstract available

SZIGETI R, Kellermayer R
Natural unblinding of BCG vaccination trials.
Vaccine. 2021 Mar 17. pii: S0264-410X(21)00320.
PubMed Abstract available

GRAUPENSPERGER S PHD, Abdallah DA, Lee CM
Social norms and vaccine uptake: College students' COVID vaccination intentions, attitudes, and estimated peer norms and comparisons with influenza vaccine.
Vaccine. 2021 Mar 17. pii: S0264-410X(21)00286.
PubMed Abstract available

STEIMLE LN, Havumaki J, Eisenberg MC, Eisenberg JNS, et al
Cost-effectiveness of pediatric norovirus vaccination in daycare settings.
Vaccine. 2021 Mar 16. pii: S0264-410X(21)00257.
PubMed Abstract available

SUSARLA SK, Palkar S, Sv PS, Diwan A, et al
Safety and immunogenicity of inactivated hepatitis-A vaccine developed by Human Biologicals Institute in two age groups of healthy subjects: A phase I open label study.
Vaccine. 2021 Mar 16. pii: S0264-410X(21)00280.
PubMed Abstract available

DEERIN JF, Clifton R, Elmi A, Lewis PE, et al
Hepatitis B birth dose vaccination patterns in the military health System, 2014-2018.
Vaccine. 2021 Mar 16. pii: S0264-410X(21)00278.
PubMed Abstract available

ALLINGTON D, McAndrew S, Moxham-Hall VL, Duffy B, et al
Media usage predicts intention to be vaccinated against SARS-CoV-2 in the US and the UK.
Vaccine. 2021 Mar 16. pii: S0264-410X(21)00234.
PubMed Abstract available

CHOI UY, Kim KH, Lee KY, Kim JH, et al
Active-controlled phase III study of an egg-cultivated quadrivalent inactivated split-virion influenza vaccine (GC3110A) in healthy Korean children aged 6-35 months.
Vaccine. 2021 Mar 15. pii: S0264-410X(21)00273.
PubMed Abstract available

HARRISON GBL, Heath DD, Robinson CM, Lawrence SB, et al
Combined use of two separate but protective vaccine antigens provides protection against Taenia ovis infection in lambs in the presence of protective maternal antibody.
Vaccine. 2021 Mar 15. pii: S0264-410X(21)00308.
PubMed Abstract available

MOLODECKY NA, Usman A, Javaid A, Wahdan A, et al
Quantifying movement patterns and vaccination status of high risk mobile populations in Pakistan and Afghanistan to inform poliovirus risk and vaccination strategy.
Vaccine. 2021 Mar 15. pii: S0264-410X(21)00269.
PubMed Abstract available

HABIB MA, Prymula R, Carryn S, Esposito S, et al
Correlation of protection against varicella in a randomized Phase III varicella-containing vaccine efficacy trial in healthy infants.
Vaccine. 2021 Mar 15. pii: S0264-410X(21)00265.
PubMed Abstract available

NET P, Colrat F, Nascimento Costa M, Bianic F, et al
Estimating public health and economic benefits along 10 years of Fluzone(R) High Dose in the United States.
Vaccine. 2021;39 Suppl 1:A56-A69.
PubMed Abstract available

FERREIRA MN, Netto EM, Nascimento-Carvalho CM
The impact of 10-valent pneumococcal conjugate vaccine upon hospitalization rate of children with pneumonia in different Brazilian administrative regions.
Vaccine. 2021 Mar 14. pii: S0264-410X(21)00231.
PubMed Abstract available

WILLIAMSON JD, Gould KG, Brown K
Richard Pfeiffer's typhoid vaccine and Almroth Wright's claim to priority.
Vaccine. 2021 Mar 13. pii: S0264-410X(21)00285.
PubMed Abstract available

RIGHOLT CH, Pabla G, Donelle J, Brna P, et al
Vaccine coverage among children with epilepsy in two Canadian provinces: A Canadian immunization research network study.
Vaccine. 2021 Mar 13. pii: S0264-410X(21)00277.
PubMed Abstract available

BUTTERY JP
Developing standard safety outcomes for COVID-19 vaccines.
Vaccine. 2021 Mar 12. pii: S0264-410X(21)00272.
PubMed

THANAWASTIEN A, Joyce KE, Cartee RT, Haines LA, et al
Preclinical in vitro and in vivo profile of a highly-attenuated, broadly efficacious pneumolysin genetic toxoid.
Vaccine. 2021;39:1652-1660.
PubMed Abstract available

LEE J, Li Y, Li Y, Cino-Ozuna AG, et al
Bat influenza vectored NS1-truncated live vaccine protects pigs against heterologous virus challenge.
Vaccine. 2021 Mar 11. pii: S0264-410X(21)00268.
PubMed Abstract available

BERTRAN K, Kassa A, Criado MF, Nunez IA, et al
Efficacy of recombinant Marek's disease virus vectored vaccines with computationally optimized broadly reactive antigen (COBRA) hemagglutinin insert against genetically diverse H5 high pathogenicity avian influenza viruses.
Vaccine. 2021 Mar 11. pii: S0264-410X(21)00266.
PubMed Abstract available

EBAMA MS, Chu SY, Azziz-Baumgartner E, Lafond KE, et al
Ancillary benefits of seasonal influenza vaccination in middle-income countries.
Vaccine. 2021 Mar 10. pii: S0264-410X(21)00228.
PubMed Abstract available

GBENEWEI E, Nomhwange T, Taiwo L, Ayodeji I, et al
Adverse events following immunization: Findings from 2017/2018 measles vaccination campaign, Nigeria AEFI reporting in 2017/2018 measles vaccination campaign.
Vaccine. 2021 Mar 10. pii: S0264-410X(21)00258.
PubMed Abstract available

MOMOH J, Oteri AJ, Mogekwu F, Onwu N, et al
Ensuring accountability in implementation of supplementary immunisation activities: A case study of the 2017/2018 measles vaccination campaign in Nigeria.
Vaccine. 2021 Mar 10. pii: S0264-410X(21)00259.
PubMed Abstract available

REPERANT LA, Osterhaus ADME
COVID-19 vaccination and critical care capacity: Perilous months ahead.
Vaccine. 2021 Mar 10. pii: S0264-410X(21)00316.
PubMed

WENTZELL E, Racila AM
The social experience of participation in a COVID-19 vaccine trial: Subjects' motivations, others' concerns, and insights for vaccine promotion.
Vaccine. 2021 Mar 10. pii: S0264-410X(21)00317.
PubMed Abstract available

LATKIN C, Dayton LA, Yi G, Konstantopoulos A, et al
COVID-19 vaccine intentions in the United States, a social-ecological framework.
Vaccine. 2021 Mar 10. pii: S0264-410X(21)00238.
PubMed Abstract available

KWAK BO, Kwon YS, Hong YJ, Shin SH, et al
Immunogenicity and safety of the third booster dose of the inactivated Japanese encephalitis vaccine in Korean children: A prospective multicenter study.
Vaccine. 2021 Mar 9. pii: S0264-410X(21)00267.
PubMed Abstract available

STEFFEN CA, Henaff L, Durupt A, Omeiri NE, et al
Evidence-informed vaccination decision-making in countries: Progress, challenges and opportunities.
Vaccine. 2021 Mar 9. pii: S0264-410X(21)00235.
PubMed Abstract available

GATWOOD J, Chiu CY, Shuvo S, Ramachandran S, et al
Role of social determinants of health in pneumococcal vaccination among high-risk adults.
Vaccine. 2021 Mar 9. pii: S0264-410X(21)00241.
PubMed Abstract available

GUIDRY JPD, Perrin PB, Laestadius LI, Vraga EK, et al
U.S. public support for COVID-19 vaccine donation to low- and middle-income countries during the COVID-19 pandemic.
Vaccine. 2021 Mar 9. pii: S0264-410X(21)00306.
PubMed Abstract available

MINTA AA, Silva MWT, Shrestha A, de Quiroz-Castro M, et al
Hepatitis B surface antigen seroprevalence among children in the Philippines, 2018.
Vaccine. 2021 Mar 9. pii: S0264-410X(21)00222.
PubMed Abstract available

SADARANGANI M, Abu Raya B, Conway JM, Iyaniwura SA, et al
Importance of COVID-19 vaccine efficacy in older age groups.
Vaccine. 2021 Mar 8. pii: S0264-410X(21)00288.
PubMed Abstract available

KISZEWSKI AE, Cleary EG, Jackson MJ, Ledley FD, et al
NIH funding for vaccine readiness before the COVID-19 pandemic.
Vaccine. 2021 Mar 8. pii: S0264-410X(21)00290.
PubMed Abstract available

PULLAN S, Dey M
Vaccine hesitancy and anti-vaccination in the time of COVID-19: A Google Trends analysis.
Vaccine. 2021 Mar 6. pii: S0264-410X(21)00287.
PubMed Abstract available

DONADEL M, Panero MS, Ametewee L, Shefer AM, et al
National decision-making for the introduction of new vaccines: A systematic review, 2010-2020.
Vaccine. 2021 Mar 6. pii: S0264-410X(21)00239.
PubMed Abstract available

WILLIAMSON SL, Gadd E, Pillay T, Toldi G, et al
Non-specific effects of BCG vaccination on neutrophil and lymphocyte counts of healthy neonates from a developed country.
Vaccine. 2021 Mar 6. pii: S0264-410X(21)00255.
PubMed Abstract available

HASNAN S, Tan NC
Multi-domain narrative review of vaccine hesitancy in childhood.
Vaccine. 2021 Mar 6. pii: S0264-410X(21)00237.
PubMed Abstract available

BLACK SB, Law B, Chen RT, Dekker CL, et al
The critical role of background rates of possible adverse events in the assessment of COVID-19 vaccine safety.
Vaccine. 2021 Mar 6. pii: S0264-410X(21)00284.
PubMed Abstract available

PIRAS-DOUCE F, Raynal F, Raquin A, Girerd-Chambaz Y, et al
Next generation live-attenuated yellow fever vaccine candidate: Safety and immuno-efficacy in small animal models.
Vaccine. 2021 Mar 5. pii: S0264-410X(21)00200.
PubMed Abstract available

YOKOMICHI H, Kojima R, Horiuchi S, Ooka T, et al
Effectiveness of influenza vaccination in infants and toddlers with and without prior infection history: The Japan Environment and Children's Study.
Vaccine. 2021 Mar 5. pii: S0264-410X(21)00224.
PubMed Abstract available

DU Y, Xu Y, Feng J, Hu L, et al
Intranasal administration of a recombinant RBD vaccine induced protective immunity against SARS-CoV-2 in mouse.
Vaccine. 2021 Mar 5. pii: S0264-410X(21)00274.
PubMed Abstract available

KUO H, Shapiro JR, Dhakal S, Morgan R, et al
Sex-specific effects of age and body mass index on antibody responses to seasonal influenza vaccines in healthcare workers.
Vaccine. 2021 Mar 4. pii: S0264-410X(21)00227.
PubMed Abstract available

WOO EJ, Moro PL
Postmarketing safety surveillance of quadrivalent recombinant influenza vaccine: Reports to the vaccine adverse event reporting system.
Vaccine. 2021 Mar 4. pii: S0264-410X(21)00232.
PubMed Abstract available

STURM L, Kasting ML, Head KJ, Hartsock JA, et al
Influenza vaccination in the time of COVID-19: A national U.S. survey of adults.
Vaccine. 2021 Mar 4. pii: S0264-410X(21)00271.
PubMed Abstract available

HELMKAMP LJ, Szilagyi PG, Zimet G, Saville AW, et al
A validated modification of the vaccine hesitancy scale for childhood, influenza and HPV vaccines.
Vaccine. 2021 Mar 3. pii: S0264-410X(21)00206.
PubMed Abstract available

JOURA EA, Ulied A, Vandermeulen C, Rua Figueroa M, et al
Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27-45years of age compared to women 16-26years of age: An open-label phase 3 study.
Vaccine. 2021 Mar 3. pii: S0264-410X(21)00128.
PubMed Abstract available

WENDLAND EM, Kops NL, Bessel M, Comerlato J, et al
Effectiveness of a universal vaccination program with an HPV quadrivalent vaccine in young Brazilian women.
Vaccine. 2021 Mar 2. pii: S0264-410X(21)00207.
PubMed Abstract available

FELL DB, Dimitris MC, Hutcheon JA, Ortiz JR, et al
Guidance for design and analysis of observational studies of fetal and newborn outcomes following COVID-19 vaccination during pregnancy.
Vaccine. 2021 Mar 2. pii: S0264-410X(21)00261.
PubMed Abstract available

CUTTS FT, Danovaro-Holliday MC, Rhoda DA
Challenges in measuring supplemental immunization activity coverage among measles zero-dose children.
Vaccine. 2021;39:1359-1363.
PubMed

WANG Y, Huang C, Tang J, Liu G, et al
Salmonella Pullorum spiC mutant is a desirable LASV candidate with proper virulence, high immune protection and easy-to-use oral administration.
Vaccine. 2021;39:1383-1391.
PubMed Abstract available

February 2021

STANLEY M, Joura E, Yen GP, Kothari S, et al
Systematic literature review of neutralizing antibody immune responses to non-vaccine targeted high-risk HPV types induced by the bivalent and the quadrivalent vaccines.
Vaccine. 2021 Feb 28. pii: S0264-410X(21)00099.
PubMed Abstract available

WANG J, Lyu Y, Zhang H, Jing R, et al
Willingness to pay and financing preferences for COVID-19 vaccination in China.
Vaccine. 2021 Feb 27. pii: S0264-410X(21)00240.
PubMed Abstract available

SHEN M, Zu J, Fairley CK, Pagan JA, et al
Projected COVID-19 epidemic in the United States in the context of the effectiveness of a potential vaccine and implications for social distancing and face mask use.
Vaccine. 2021 Feb 27. pii: S0264-410X(21)00236.
PubMed Abstract available

BERNSTEIN DN, Alokozai A, Humbyrd CJ
Vaccinating America's children: A job for orthopaedic surgeons & other non-primary care specialists?
Vaccine. 2021 Feb 26. pii: S0264-410X(21)00175.
PubMed

AYASSE M, Ahmed A, McCullum C, Espinosa ML, et al
Vaccines do not cause atopic dermatitis: A systematic review and meta-analysis.
Vaccine. 2021 Feb 26. pii: S0264-410X(21)00203.
PubMed Abstract available

WON H, Kim AR, Yoo JS, Chung GT, et al
Cross-neutralization between vaccine and circulating wild-type mumps viruses in Korea.
Vaccine. 2021 Feb 25. pii: S0264-410X(21)00055.
PubMed Abstract available

ANDERSEN AR, Kolmos SK, Flanagan KL, Benn CS, et al
Systematic review and meta-analysis of the effect of pertussis vaccine in pregnancy on the risk of chorioamnionitis, non-pertussis infectious diseases and other adverse pregnancy outcomes.
Vaccine. 2021 Feb 25. pii: S0264-410X(21)00166.
PubMed Abstract available

SPENCER JA, Penfound T, Salehi S, Aranha MP, et al
Cross-reactive immunogenicity of group A streptococcal vaccines designed using a recurrent neural network to identify conserved M protein linear epitopes.
Vaccine. 2021 Feb 25. pii: S0264-410X(21)00129.
PubMed Abstract available

SANDBRINK JB, Koblentz GD
Biosecurity risks associated with vaccine platform technologies.
Vaccine. 2021 Feb 25. pii: S0264-410X(21)00171.
PubMed Abstract available

LEE MHP, Tan CW, Tee HK, Ong KC, et al
Vaccine candidates generated by codon and codon pair deoptimization of enterovirus A71 protect against lethal challenge in mice.
Vaccine. 2021 Feb 24. pii: S0264-410X(21)00172.
PubMed Abstract available

SELL TK, Gastfriend D, Watson M, Watson C, et al
Building the global vaccine manufacturing capacity needed to respond to pandemics.
Vaccine. 2021 Feb 24. pii: S0264-410X(21)00165.
PubMed

MUNOZ FM, Cramer JP, Dekker CL, Dudley MZ, et al
Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
Vaccine. 2021 Feb 23. pii: S0264-410X(21)00094.
PubMed Abstract available

ALDAKAK L, Huber VM, Ruhli F, Bender N, et al
Sex difference in the immunogenicity of the quadrivalent Human Papilloma Virus vaccine: Systematic review and meta-analysis.
Vaccine. 2021 Feb 23. pii: S0264-410X(21)00170.
PubMed Abstract available

BONANNI P, Villani A, Scotti S, Biasci P, et al
The recommended lifetime immunization schedule from the board of vaccination calendar for life in Italy: A continuing example of impact on public health policies.
Vaccine. 2021;39:1183-1186.
PubMed Abstract available

VERELST F, Beutels P, Hens N, Willem L, et al
Workplace influenza vaccination to reduce employee absenteeism: An economic analysis from the employers' perspective.
Vaccine. 2021 Feb 22. pii: S0264-410X(21)00168.
PubMed Abstract available

SU QD, Zou YN, Yi Y, Shen LP, et al
Recombinant SARS-CoV-2 RBD with a built in T helper epitope induces strong neutralization antibody response.
Vaccine. 2021;39:1241-1247.
PubMed Abstract available

BLUNCK BN, Aideyan L, Ye X, Avadhanula V, et al
A prospective surveillance study on the kinetics of the humoral immune response to the respiratory syncytial virus fusion protein in adults in Houston, Texas.
Vaccine. 2021;39:1248-1256.
PubMed Abstract available

CHOI UY, Kim KH, Lee J, Eun BW, et al
Immunogenicity and safety profiles of a new MAV/06 strain varicella vaccine in healthy children: A multinational, multicenter, randomized, double-blinded, active-controlled phase III study.
Vaccine. 2021 Feb 21. pii: S0264-410X(21)00161.
PubMed Abstract available

REN S, Attia J, Li SC, Newby D, et al
Pneumococcal polysaccharide vaccine is a cost saving strategy for prevention of acute coronary syndrome.
Vaccine. 2021 Feb 21. pii: S0264-410X(21)00167.
PubMed Abstract available

MCPHERSON AS, Whittington RJ, Hall E, Cook EJ, et al
A comparison of multivalent and bivalent vaccination strategies for the control of virulent ovine footrot.
Vaccine. 2021 Feb 20. pii: S0264-410X(21)00159.
PubMed Abstract available

KABIR A, Newall AT, Randall D, Menzies R, et al
Estimating pneumococcal vaccine coverage among Australian Indigenous children and children with medically at-risk conditions using record linkage.
Vaccine. 2021 Feb 20. pii: S0264-410X(21)00163.
PubMed Abstract available

DAS SC, Price JD, Gosling K, MacLennan N, et al
Liposome engraftment and antigen combination potentiate the immune response towards conserved epitopes of the malaria vaccine candidate MSP2.
Vaccine. 2021 Feb 20. pii: S0264-410X(21)00158.
PubMed Abstract available

SAUER M, Vasudevan P, Meghani A, Luthra K, et al
Situational assessment of adult vaccine preventable disease and the potential for immunization advocacy and policy in low- and middle-income countries.
Vaccine. 2021 Feb 19. pii: S0264-410X(21)00107.
PubMed Abstract available

CHOI J, Jo HJ, Jung SS, Choi J, et al
Evaluation of swine protection with foot-and-mouth disease O1/Campos and O/Primorsky/2014 vaccines against the O Mya-98 lineage virus from East Asia.
Vaccine. 2021 Feb 19. pii: S0264-410X(21)00173.
PubMed Abstract available

ORTIZ JR, Robertson J, Hsu JS, Yu SL, et al
The potential effects of deploying SARS-Cov-2 vaccines on cold storage capacity and immunization workload in countries of the WHO African Region.
Vaccine. 2021 Feb 19. pii: S0264-410X(21)00204.
PubMed Abstract available

DENG L, Danchin M, Lewis G, Cheung A, et al
Revaccination outcomes of children with vaccine proximate seizures.
Vaccine. 2021 Feb 18. pii: S0264-410X(21)00164.
PubMed Abstract available

MARTINON-TORRES F, Halperin SA, Nolan T, Tapiero B, et al
Impact of maternal diphtheria-tetanus-acellular pertussis vaccination on pertussis booster immune responses in toddlers: Follow-up of a randomized trial.
Vaccine. 2021 Feb 18. pii: S0264-410X(21)00130.
PubMed Abstract available

CHANG LJ, Anderson EJ, Jeanfreau R, He Y, et al
Safety and immunogenicity of high doses of quadrivalent influenza vaccine in children 6months through<18years of age: A randomized controlled phase II dose-finding trial.
Vaccine. 2021 Feb 18. pii: S0264-410X(21)00162.
PubMed Abstract available

CONSTANTINOU CA, Ziogas DC, Venetsanopoulou A, Gamaletsou MN, et al
A clinical audit of pneumococcal vaccination among patients with autoimmune rheumatic diseases living in Greece: The power of awareness.
Vaccine. 2021 Feb 17. pii: S0264-410X(21)00157.
PubMed Abstract available

PALMU AA, De Wals P, Toropainen M, Ladhani SN, et al
Similar impact and replacement disease after pneumococcal conjugate vaccine introduction in hospitalised children with invasive pneumococcal disease in Europe and North America.
Vaccine. 2021 Feb 17. pii: S0264-410X(21)00111.
PubMed Abstract available

KUTER BJ, Browne S, Momplaisir FM, Feemster KA, et al
Perspectives on the receipt of a COVID-19 vaccine: A survey of employees in two large hospitals in Philadelphia.
Vaccine. 2021 Feb 16. pii: S0264-410X(21)00185.
PubMed Abstract available

JUSTE RA, Geijo MV, Elguezabal N, Sevilla IA, et al
Paratuberculosis vaccination specific and non-specific effects on cattle lifespan.
Vaccine. 2021 Feb 15. pii: S0264-410X(21)00097.
PubMed Abstract available

WU MJ, Chung JR, Kim SS, Jackson ML, et al
Influenza vaccination coverage among persons seeking outpatient medical care for acute respiratory illness in five states in the United States, 2011-2012 through 2018-2019.
Vaccine. 2021 Feb 15. pii: S0264-410X(21)00106.
PubMed Abstract available

TZANAKAKI G, Xirogianni A, Tsitsika A, Clark SA, et al
Estimated strain coverage of serogroup B meningococcal vaccines: A retrospective study for disease and carrier strains in Greece (2010-2017).
Vaccine. 2021 Feb 14. pii: S0264-410X(21)00127.
PubMed Abstract available

RID A, Shah SK, Miller FG, Danis M, et al
Ethical trade-offs in vaccine development and distribution-Response to Gurwitz.
Vaccine. 2021;39:1028-1029.
PubMed

GURWITZ D
Ethical tradeoffs in SARS-CoV-2 vaccine development: Assuring fair availability for low-income countries.
Vaccine. 2021;39:1027.
PubMed

MCALISTER SM, van den Biggelaar AHJ, Woodman TL, Hutton H, et al
An observational study of antibody responses to a primary or subsequent pertussis booster vaccination in Australian healthcare workers.
Vaccine. 2021 Feb 12. pii: S0264-410X(21)00068.
PubMed Abstract available

NICACIO AAMF, Peracchi OAB, Yamada J, Fraga MM, et al
Tdap booster to adolescents with juvenile idiopathic arthritis on and off anti-TNF agents is safe and immunogenic.
Vaccine. 2021;39:1165-1172.
PubMed Abstract available

HAI NM, Dung ND, Pho DC, Son VT, et al
Immunogenicity, safety and reactogenicity of ROTAVAC(R) in healthy infants aged 6-8 weeks in Vietnam.
Vaccine. 2021;39:1140-1147.
PubMed Abstract available

DOCKRELL HM, Butkeviciute E
Can what have we learnt about BCG vaccination in the last 20 years help us to design a better tuberculosis vaccine?
Vaccine. 2021 Feb 11. pii: S0264-410X(21)00109.
PubMed Abstract available

KHETSURIANI N, Zaika O, Chitadze N, Slobodianyk L, et al
Seroprevalence of hepatitis B virus infection markers among children in Ukraine, 2017.
Vaccine. 2021 Feb 11. pii: S0264-410X(21)00133.
PubMed Abstract available

LIN J, Dobbins T, Wood JG, Bernardo C, et al
Effectiveness of the live-attenuated herpes zoster vaccine 2 years after its introduction in Australia.
Vaccine. 2021 Feb 10. pii: S0264-410X(21)00108.
PubMed Abstract available

WARD BJ, Seguin A, Couillard J, Trepanier S, et al
Phase III: Randomized observer-blind trial to evaluate lot-to-lot consistency of a new plant-derived quadrivalent virus like particle influenza vaccine in adults 18-49 years of age.
Vaccine. 2021 Feb 10. pii: S0264-410X(21)00004.
PubMed Abstract available

POLAND CM, Matthews AKS, Poland GA
Improving COVID-19 vaccine acceptance: Including insights from human decision-making under conditions of uncertainty and human-centered design.
Vaccine. 2021 Feb 10. pii: S0264-410X(21)00154.
PubMed

BRUCE-STASKAL PJ, Woods RM, Borisov OV, Massare MJ, et al
Corrigendum to "Hemagglutinin from multiple divergent influenza A and B viruses bind to a distinct branched, sialylated poly-LacNAc glycan by surface plasmon resonance" [Vaccine 38(43) (2020) 6757-6765].
Vaccine. 2021 Feb 9. pii: S0264-410X(21)00105.
PubMed

CHU L, McPhee R, Huang W, Bennett H, et al
A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine.
Vaccine. 2021 Feb 9. pii: S0264-410X(21)00153.
PubMed Abstract available

VULPE SN, Rughinis C
Social amplification of risk and "probable vaccine damage": A typology of vaccination beliefs in 28 European countries.
Vaccine. 2021 Feb 8. pii: S0264-410X(21)00102.
PubMed Abstract available

SINGH A
Why not the 'marker' or DIVA vaccines for the control of emerging infectious diseases of humans?
Vaccine. 2021 Feb 8. pii: S0264-410X(21)00110.
PubMed

ROBINSON E, Jones A, Lesser I, Daly M, et al
International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples.
Vaccine. 2021 Feb 6. pii: S0264-410X(21)00140.
PubMed Abstract available

BAUER BU, Knittler MR, Prufer TL, Wolf A, et al
Humoral immune response to Q fever vaccination of three sheep flocks naturally pre-infected with Coxiella burnetii.
Vaccine. 2021 Feb 5. pii: S0264-410X(21)00101.
PubMed Abstract available

DUDLEY MZ, Taitel MS, Smith-Ray R, Singh T, et al
Effect of educational and financial incentive-based interventions on immunization attitudes, beliefs, intentions and receipt among close contacts of pregnant women.
Vaccine. 2021;39:961-967.
PubMed Abstract available

HODGKINSON B, Wang T, Byrnes J, Scuffham P, et al
Modelling a cost-effective vaccination strategy for the prevention of varicella and herpes zoster infection: A systematic review.
Vaccine. 2021 Feb 4. pii: S0264-410X(21)00100.
PubMed Abstract available

SPANOS KE, Kraschnewski JL, Moss JL, Wong A, et al
Parent support for social media standards combatting vaccine misinformation.
Vaccine. 2021 Feb 4. pii: S0264-410X(21)00005.
PubMed Abstract available

PINPATHOMRAT N, Bull N, Pasricha J, Harrington-Kandt R, et al
Using an effective TB vaccination regimen to identify immune responses associated with protection in the murine model.
Vaccine. 2021 Feb 3. pii: S0264-410X(21)00050.
PubMed Abstract available

DIACO M, Chang LJ, Seet B, Robertson CA, et al
Introductory paper: High dose influenza vaccine.
Vaccine. 2021 Feb 3. pii: S0264-410X(20)31147.
PubMed Abstract available

BABAKURA B, Nomhwange T, Jean Baptiste AE, Dede O, et al
The challenges of insecurity on implementing vaccination campaign and its effect on measles elimination and control efforts: A case study of 2017/18 measles campaign in Borno state, Nigeria.
Vaccine. 2021 Feb 2. pii: S0264-410X(21)00040.
PubMed Abstract available

SATO R, Thompson A, Sani I, Metiboba L, et al
Effect of Vaccine Direct Delivery (VDD) on vaccine stockouts and number of vaccinations: Case study from Bauchi State, Nigeria.
Vaccine. 2021 Feb 1. pii: S0264-410X(21)00053.
PubMed Abstract available

GAO J, Tang F, Wang Z, Yu J, et al
Post-marketing safety surveillance for inactivated Enterovirus 71 vaccines in Jiangsu, China from 2017 to 2019.
Vaccine. 2021 Feb 1. pii: S0264-410X(21)00075.
PubMed Abstract available

WILCK MB, Jin Xu Z, Stek JE, Goveia MG, et al
Protective immune responses against Haemophilus influenza type B elicited by a fully-liquid DTaP-IPV-Hib-HepB vaccine (VAXELIS).
Vaccine. 2021 Feb 1. pii: S0264-410X(21)00073.
PubMed Abstract available

January 2021

AXELSEN PH, Poland GA
Vaccines, masks, distancing and credibility: An urgent warning for pandemic management.
Vaccine. 2021 Jan 31. pii: S0264-410X(21)00079.
PubMed

LIU Y, Li W, Dong Q, Chen M, et al
Non-linear relationships between children age and pneumococcal vaccine coverage: Important implications for vaccine prevention strategies.
Vaccine. 2021 Jan 30. pii: S0264-410X(21)00095.
PubMed Abstract available

LUANGASANATIP N, Mahikul W, Poovorawan K, Cooper BS, et al
Cost-effectiveness and budget impact analyses for the prioritisation of the four available rotavirus vaccines in the national immunisation programme in Thailand.
Vaccine. 2021 Jan 30. pii: S0264-410X(21)00078.
PubMed Abstract available

D'ARCO C, McCormick AA, Arnaboldi PM
Single-dose intranasal subunit vaccine rapidly clears secondary sepsis in a high-dose pneumonic plague infection.
Vaccine. 2021 Jan 30. pii: S0264-410X(21)00067.
PubMed Abstract available

ANDANI A, van Damme P, Bunge EM, Salgado F, et al
One or two doses of hepatitis A vaccine in universal vaccination programs in children in 2020: A systematic review.
Vaccine. 2021 Jan 29. pii: S0264-410X(21)00054.
PubMed Abstract available

XU W, Yang M
Genetic variation and evolution of foot-and-mouth disease virus serotype A in relation to vaccine matching.
Vaccine. 2021 Jan 29. pii: S0264-410X(21)00069.
PubMed Abstract available

COLRAT F, Thommes E, Largeron N, Alvarez FP, et al
Economic evaluation of high-dose inactivated influenza vaccine in adults aged >/=65 years: A systematic literature review.
Vaccine. 2021 Jan 29. pii: S0264-410X(20)31603.
PubMed Abstract available

HAMPTON LM, Aggarwal R, Evans SJW, Law B, et al
General determination of causation between Covid-19 vaccines and possible adverse events.
Vaccine. 2021 Jan 29. pii: S0264-410X(21)00096.
PubMed

KROLIK M, Csepregi L, Hartmann F, Engetschwiler C, et al
Recombinant lymphocytic choriomeningitis virus-based vaccine vector protects type I interferon receptor deficient mice from viral challenge.
Vaccine. 2021 Jan 28. pii: S0264-410X(21)00074.
PubMed Abstract available

SORUP S, Englund H, Laake I, Nieminen H, et al
Revaccination with measles-mumps-rubella vaccine and hospitalization for infection in Denmark and Sweden - An interrupted time-series analysis.
Vaccine. 2021 Jan 28. pii: S0264-410X(21)00044.
PubMed Abstract available

SEREMBA E, Ocama P, Ssekitoleko R, Mayanja-Kizza H, et al
Immune response to the hepatitis B vaccine among HIV-infected adults in Uganda.
Vaccine. 2021 Jan 27. pii: S0264-410X(21)00070.
PubMed Abstract available

LI AJ, Kyesi F, Mwengee W, Mphuru A, et al
Impact of the human papillomavirus (HPV) vaccine supply shortage on Tanzania's national HPV vaccine introduction.
Vaccine. 2021 Jan 25. pii: S0264-410X(21)00052.
PubMed

LY TDA, Castaneda S, Hoang VT, Dao TL, et al
Vaccine-preventable diseases other than tuberculosis, and homelessness: A scoping review of the published literature, 1980 to 2020.
Vaccine. 2021 Jan 25. pii: S0264-410X(21)00051.
PubMed Abstract available

JONSSON G, Hansson C, Mellhammar L, Gullstrand B, et al
Increased serum bactericidal activity of autologous serum in C2 deficiency after vaccination against Haemophilus influenzae type b, and further support for an MBL-dependent C2 bypass mechanism.
Vaccine. 2021 Jan 25. pii: S0264-410X(21)00007.
PubMed Abstract available

BELCHER T, Kammoun H, Coutte L, Debrie AS, et al
Live attenuated Bordetella pertussis vaccine candidate BPZE1 transiently protects against lethal pneumococcal disease in mice.
Vaccine. 2021 Jan 25. pii: S0264-410X(21)00041.
PubMed Abstract available

KIM SH, Paldurai A, Xiao S, Collins PL, et al
Retraction notice to "Modified Newcastle disease virus vectors expressing the H5 hemagglutinin induce enhanced protection against highly pathogenic H5N1 avian influenza virus in chickens" [Vaccine 32(35) (2014) 4428-4435].
Vaccine. 2021;39:775.
PubMed

KNOBEL DL, Arega SM, Conan A
Sex-differential non-specific effects of rabies vaccine in dogs: An extended analysis of a randomized controlled trial in a high-mortality population.
Vaccine. 2021 Jan 22. pii: S0264-410X(21)00045.
PubMed Abstract available

AMANI A, Tatang CA, Bayiha CN, Woung M, et al
A reactive vaccination campaign with single dose oral cholera vaccine (OCV) during a cholera outbreak in Cameroon.
Vaccine. 2021 Jan 22. pii: S0264-410X(21)00021.
PubMed Abstract available

HUTTON DW, McCullough JS, Prosser L, Ye W, et al
Costs implications of pneumococcal vaccination of adults aged 30-60 with a recent diagnosis of diabetes.
Vaccine. 2021 Jan 22. pii: S0264-410X(20)31535.
PubMed Abstract available

OKOLI GN, Racovitan F, Abdulwahid T, Righolt CH, et al
Variable seasonal influenza vaccine effectiveness across geographical regions, age groups and levels of vaccine antigenic similarity with circulating virus strains: A systematic review and meta-analysis of the evidence from test-negative design studie
Vaccine. 2021 Jan 22. pii: S0264-410X(21)00048.
PubMed Abstract available

FRIEDMAN-KLABANOFF DJ, Berry AA, Travassos MA, Cox C, et al
Low dose recombinant full-length circumsporozoite protein-based Plasmodium falciparum vaccine is well-tolerated and highly immunogenic in phase 1 first-in-human clinical testing.
Vaccine. 2021 Jan 22. pii: S0264-410X(20)31590.
PubMed Abstract available

JAMROZIK E, Littler K, Bull S, Emerson C, et al
Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group.
Vaccine. 2021;39:633-640.
PubMed Abstract available

MENZIES R, Stein AN, Booy R, Van Buynder PG, et al
The impact of the changing pneumococcal national immunisation program among older Australians.
Vaccine. 2021;39:720-728.
PubMed Abstract available

COX AD, Kuo Lee R, Ulanova M, Bruce MG, et al
Proceedings of a workshop to discuss the epidemiology of invasive Haemophilus influenzae disease with emphasis on serotype a and b in the Americas, 2019.
Vaccine. 2021;39:627-632.
PubMed Abstract available

JIANG R, Liu X, Sun X, Wang J, et al
Immunogenicity and safety of the inactivated poliomyelitis vaccine made from Sabin strains in a phase IV clinical trial for the vaccination of a large population.
Vaccine. 2021 Jan 21. pii: S0264-410X(21)00043.
PubMed Abstract available

KLASSEN AC, Milliron BJ, Reynolds L, Bakhtibekova Z, et al
Formative research to address vaccine hesitancy in Tajikistan.
Vaccine. 2021 Jan 21. pii: S0264-410X(21)00049.
PubMed Abstract available

ALDRICH C, Leroux-Roels I, Huang KB, Bica MA, et al
Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers: A phase 1 trial.
Vaccine. 2021 Jan 21. pii: S0264-410X(20)31667.
PubMed Abstract available

NIYIBITEGEKA F, Riewpaiboon A, Youngkong S, Thavorncharoensap M, et al
Economic analysis for national immunization program planning: A case of rotavirus vaccines in Burundi.
Vaccine. 2021 Jan 21. pii: S0264-410X(21)00047.
PubMed Abstract available

HAYMAN B, Bowles A, Evans B, Eyermann E, et al
Advancing innovation for vaccine manufacturers from developing countries: Prioritization, barriers, opportunities.
Vaccine. 2021 Jan 21. pii: S0264-410X(21)00009.
PubMed Abstract available

POLAND EG, McGuire DK, Ratishvili T, Poland GA, et al
The economics of global COVID vaccine administration during a pandemic - Why continue skin alcohol preparation as a costly but ineffective practice?
Vaccine. 2021 Jan 20. pii: S0264-410X(20)31694.
PubMed

WINOKUR P, El Sahly HM, Mulligan MJ, Frey SE, et al
Immunogenicity and safety of different dose schedules and antigen doses of an MF59-adjuvanted H7N9 vaccine in healthy adults aged 65 years and older.
Vaccine. 2021 Jan 20. pii: S0264-410X(20)31504.
PubMed Abstract available

JAS D, Frances-Duvert V, Brunet S, Oberli F, et al
Evaluation of safety and immunogenicity of feline vaccines with reduced volume.
Vaccine. 2021 Jan 20. pii: S0264-410X(21)00042.
PubMed Abstract available

MUGO N, Eckert LO, Odero L, Gakuo S, et al
Antibody responses to prophylactic quadrivalent human papillomavirus vaccine at 48 months among HIV-infected girls and boys ages 9-14 in Kenya, Africa.
Vaccine. 2021 Jan 20. pii: S0264-410X(20)31587.
PubMed Abstract available

BALASUBRAMANI GK, Zimmerman RK, Eng H, Lyons J, et al
Comparison of local influenza vaccine effectiveness using two methods.
Vaccine. 2021 Jan 20. pii: S0264-410X(21)00017.
PubMed Abstract available

DAL-RE R
US FDA erratic approach to placebo-controlled trials after issuing an emergency use authorization for a COVID-19 vaccine.
Vaccine. 2021 Jan 20. pii: S0264-410X(21)00077.
PubMed

LOIACONO MM, Pool V, van Aalst R
DTaP combination vaccine use and adherence: A retrospective cohort study.
Vaccine. 2021 Jan 19. pii: S0264-410X(21)00013.
PubMed Abstract available

CAO L, Lou J, Zhao S, Chan RWY, et al
In silico prediction of influenza vaccine effectiveness by sequence analysis.
Vaccine. 2021 Jan 19. pii: S0264-410X(21)00006.
PubMed Abstract available

EINARSDOTTIR S, Nicklasson M, Veje M, Bergstrom T, et al
Vaccination against tick-borne encephalitis (TBE) after autologous and allogeneic stem cell transplantation.
Vaccine. 2021 Jan 19. pii: S0264-410X(20)31670.
PubMed Abstract available

BROCATO RL, Kwilas SA, Josleyn MD, Long S, et al
Small animal jet injection technique results in enhanced immunogenicity of hantavirus DNA vaccines.
Vaccine. 2021 Jan 19. pii: S0264-410X(21)00002.
PubMed Abstract available

REEMERS S, Verstegen I, Basten S, Hubers W, et al
A broad spectrum HVT-H5 avian influenza vector vaccine which induces a rapid onset of immunity.
Vaccine. 2021 Jan 19. pii: S0264-410X(21)00022.
PubMed Abstract available

FATOBA AJ, Maharaj L, Adeleke VT, Okpeku M, et al
Immunoinformatics prediction of overlapping CD8(+) T-cell, IFN-gamma and IL-4 inducer CD4(+) T-cell and linear B-cell epitopes based vaccines against COVID-19 (SARS-CoV-2).
Vaccine. 2021 Jan 18. pii: S0264-410X(21)00003.
PubMed Abstract available

SCOTT EM, Stein R, Brown MF, Hershberger J, et al
Vaccination patterns of the northeast Ohio Amish revisited.
Vaccine. 2021 Jan 18. pii: S0264-410X(21)00026.
PubMed Abstract available

OTERI J, Idi Hussaini M, Bawa S, Ibizugbe S, et al
Application of the Geographic Information System (GIS) in immunisation service delivery; its use in the 2017/2018 measles vaccination campaign in Nigeria.
Vaccine. 2021 Jan 18. pii: S0264-410X(21)00025.
PubMed Abstract available

SOHN S, Hong K, Hwang H, Chun BC, et al
Paradoxical health care utilization patterns among children in Korea who did not receive mandatory pneumococcal vaccination.
Vaccine. 2021 Jan 18. pii: S0264-410X(21)00016.
PubMed Abstract available

XU C, Lau CL, Clark J, Rafferty AC, et al
Immunogenicity after pre- and post-exposure rabies vaccination: A systematic review and dose-response meta-analysis.
Vaccine. 2021 Jan 18. pii: S0264-410X(21)00039.
PubMed Abstract available

WHITAKER JA, Parikh SA, Shanafelt TD, Kay NE, et al
The humoral immune response to high-dose influenza vaccine in persons with monoclonal B-cell lymphocytosis (MBL) and chronic lymphocytic leukemia (CLL).
Vaccine. 2021 Jan 15. pii: S0264-410X(21)00001.
PubMed Abstract available

MOGEKWU FI, Oteri JA, Nsubuga P, Ezebilo O, et al
Using data to improve outcomes of supplemental immunisation activities: 2017/2018 Nigeria measles vaccination campaign.
Vaccine. 2021 Jan 15. pii: S0264-410X(20)31659.
PubMed Abstract available

ZHAO X, Zeng X, Dai Q, Hou Y, et al
Immunogenicity and protection efficacy of a Salmonella enterica serovar Typhimurium fnr, arcA and fliC mutant.
Vaccine. 2021;39:588-595.
PubMed Abstract available

VAN DEN BOOGAARD J, de Gier B, de Oliveira Bressane Lima P, Desai S, et al
Immunogenicity, duration of protection, effectiveness and safety of rubella containing vaccines: A systematic literature review and meta-analysis.
Vaccine. 2021 Jan 13. pii: S0264-410X(20)31691.
PubMed Abstract available

WHITWORTH HS, Schiller J, Markowitz LE, Jit M, et al
Continued HPV vaccination in the face of unexpected challenges: A commentary on the rationale for an extended interval two-dose schedule.
Vaccine. 2021 Jan 13. pii: S0264-410X(20)31598.
PubMed

OTERI J, Bawa S, Christopher E, Nsubuga P, et al
Potential for improving routine immunisation waste management using measles vaccination campaign 2017 in Kebbi State, Nigeria.
Vaccine. 2021 Jan 12. pii: S0264-410X(20)31654.
PubMed Abstract available

ATSMON J, Machluf N, Yagon-Gur V, Sabbah C, et al
Rapid and high seroprotection rates achieved with a tri-antigenic Hepatitis B vaccine in healthy young adults: Results from a Phase IV study.
Vaccine. 2021 Jan 12. pii: S0264-410X(20)31630.
PubMed Abstract available

YANG R, Liu Q, Pang W, Gao F, et al
Two immunogenic recombinant protein vaccine candidates showed disparate protective efficacy against Zika virus infection in rhesus macaques.
Vaccine. 2021 Jan 12. pii: S0264-410X(20)31674.
PubMed Abstract available

ARCON N, Picchio MS, Fenoy IM, Moretta RE, et al
Synergistic effect of GRA7 and profilin proteins in vaccination against chronic Toxoplasma gondii infection.
Vaccine. 2021 Jan 12. pii: S0264-410X(20)31669.
PubMed Abstract available

GUALANO MR, Corradi A, Voglino G, Catozzi D, et al
Healthcare Workers' (HCWs) attitudes towards mandatory influenza vaccination: A systematic review and meta-analysis.
Vaccine. 2021 Jan 12. pii: S0264-410X(20)31655.
PubMed Abstract available

AKMATOV MK, Holstiege J, Steffen A, Batzing J, et al
Utilization of influenza vaccination among chronically ill individuals in Germany: A nationwide claims-based analysis.
Vaccine. 2021 Jan 12. pii: S0264-410X(20)31693.
PubMed Abstract available

FENTON ATHR, Orefice C, Eun TJ, Biancarelli D, et al
Effect of provider recommendation style on the length of adolescent vaccine discussions.
Vaccine. 2021 Jan 11. pii: S0264-410X(20)31441.
PubMed Abstract available

KORNUTA CA, Langellotti CA, Bidart JE, Soria I, et al
A plasmid encoding the extracellular domain of CD40 ligand and Montanide GEL01 as adjuvants enhance the immunogenicity and the protection induced by a DNA vaccine against BoHV-1.
Vaccine. 2021 Jan 11. pii: S0264-410X(20)31553.
PubMed Abstract available

SANTANA CP, Luhm KR, Shimakura SE
Impact of Tdap vaccine during pregnancy on the incidence of pertussis in children under one year in Brazil - A time series analysis.
Vaccine. 2021 Jan 11. pii: S0264-410X(20)31636.
PubMed Abstract available

ACKERSON B, Qian L, Sy LS, Bruxvoort K, et al
Completion of the two-dose recombinant zoster vaccine series in adults 50 years and older.
Vaccine. 2021 Jan 11. pii: S0264-410X(20)31673.
PubMed Abstract available

BURGER AE, Reither EN, Mamelund SE, Lim S, et al
Black-white disparities in 2009 H1N1 vaccination among adults in the United States: A cautionary tale for the COVID-19 pandemic.
Vaccine. 2021 Jan 11. pii: S0264-410X(20)31666.
PubMed Abstract available

SINGH J, Malik D, Raina A
Immuno-informatics approach for B-cell and T-cell epitope based peptide vaccine design against novel COVID-19 virus.
Vaccine. 2021 Jan 9. pii: S0264-410X(21)00015.
PubMed Abstract available

RUIZ JB, Bell RA
Predictors of intention to vaccinate against COVID-19: Results of a nationwide survey.
Vaccine. 2021 Jan 9. pii: S0264-410X(21)00014.
PubMed Abstract available

WIEMKEN TL, Rutschman AS
Development of vaccines for influenza disease: Opportunity costs of the COVID-19 pandemic.
Vaccine. 2021 Jan 9. pii: S0264-410X(21)00018.
PubMed

BEIGI RH, Krubiner C, Jamieson DJ, Lyerly AD, et al
The need for inclusion of pregnant women in COVID-19 vaccine trials.
Vaccine. 2021 Jan 8. pii: S0264-410X(20)31671.
PubMed

CHAUDHURY S, MacGill RS, Early AM, Bolton JS, et al
Breadth of humoral immune responses to the C-terminus of the circumsporozoite protein is associated with protective efficacy induced by the RTS,S malaria vaccine.
Vaccine. 2021 Jan 8. pii: S0264-410X(20)31635.
PubMed Abstract available

ABDI I, Gidding H, Leong RN, Moore HC, et al
Vaccine coverage in children born to migrant mothers in Australia: A population-based cohort study.
Vaccine. 2021 Jan 8. pii: S0264-410X(20)31638.
PubMed Abstract available

DESMET S, Wouters I, Heirstraeten LV, Beutels P, et al
In-depth analysis of pneumococcal serotypes in Belgian children (2015-2018): Diversity, invasive disease potential, and antimicrobial susceptibility in carriage and disease.
Vaccine. 2021;39:372-379.
PubMed Abstract available

MAITI S, Howlader DR, Halder P, Bhaumik U, et al
Bivalent non-typhoidal Salmonella outer membrane vesicles immunized mice sera confer passive protection against gastroenteritis in a suckling mice model.
Vaccine. 2021;39:380-393.
PubMed Abstract available

WILLIAMS J, Degeling C, McVernon J, Dawson A, et al
How should we conduct pandemic vaccination?
Vaccine. 2021 Jan 7. pii: S0264-410X(20)31639.
PubMed Abstract available

SHARMA H, Anil K, Parekh S, Pujari P, et al
A phase-I, open label clinical trial to assess the safety of Tdap vaccine manufactured by Serum Institute of India Pvt. Ltd. in adults.
Vaccine. 2021 Jan 7. pii: S0264-410X(20)31656.
PubMed Abstract available

CALDERA F, Mercer M, Samson SI, Pitt JM, et al
Influenza vaccination in immunocompromised populations: Strategies to improve immunogenicity.
Vaccine. 2021 Jan 7. pii: S0264-410X(20)31490.
PubMed Abstract available

KELSO JM
Anaphylactic reactions to novel mRNA SARS-CoV-2/COVID-19 vaccines.
Vaccine. 2021 Jan 6. pii: S0264-410X(20)31696.
PubMed

SU JR, McNeil MM, Welsh KJ, Marquez PL, et al
Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990-2018.
Vaccine. 2021 Jan 6. pii: S0264-410X(20)31614.
PubMed Abstract available

NISAR MI, Ahmed S, Jehan F, Shahid S, et al
Direct and indirect effect of 10 valent pneumococcal vaccine on nasopharyngeal carriage in children under 2 years of age in Matiari, Pakistan.
Vaccine. 2021 Jan 6. pii: S0264-410X(20)31662.
PubMed Abstract available

SCHEPPLER L, De Clercq N, McGoldrick M, Dias J, et al
Regulatory Harmonization and Streamlining of Clinical Trial Applications globally should lead to faster clinical development and earlier access to life-saving vaccines.
Vaccine. 2021 Jan 6. pii: S0264-410X(20)31569.
PubMed Abstract available

KOHLI M, Maschio M, Becker D, Weinstein MC, et al
The potential public health and economic value of a hypothetical COVID-19 vaccine in the United States: Use of cost-effectiveness modeling to inform vaccination prioritization.
Vaccine. 2021 Jan 6. pii: S0264-410X(20)31690.
PubMed Abstract available

MIDDELDORP M, van Lier A, van der Maas N, Veldhuijzen I, et al
Short term impact of the COVID-19 pandemic on incidence of vaccine preventable diseases and participation in routine infant vaccinations in the Netherlands in the period March-September 2020.
Vaccine. 2021 Jan 6. pii: S0264-410X(20)31692.
PubMed Abstract available

WONG MCS, Wong ELY, Huang J, Cheung AWL, et al
Acceptance of the COVID-19 vaccine based on the health belief model: A population-based survey in Hong Kong.
Vaccine. 2021 Jan 6. pii: S0264-410X(20)31695.
PubMed Abstract available

GODINOT LD, Sicsic J, Lachatre M, Bouvet E, et al
Quantifying preferences around vaccination against frequent, mild disease with risk for vulnerable persons: A discrete choice experiment among French hospital health care workers.
Vaccine. 2021 Jan 5. pii: S0264-410X(20)31637.
PubMed Abstract available

SCHLEY K, Malerczyk C, Beier D, Schiffner-Rohe J, et al
Vaccination rate and adherence of tick-borne encephalitis vaccination in Germany.
Vaccine. 2021 Jan 4. pii: S0264-410X(20)31615.
PubMed Abstract available

FIELDING J, Sullivan SG, Beard F, Macartney K, et al
Constructing an ethical framework for priority allocation of pandemic vaccines.
Vaccine. 2021 Jan 3. pii: S0264-410X(20)31633.
PubMed Abstract available

RUSSELL LB, Kim SY, Toscano C, Cosgriff B, et al
Comparison of static and dynamic models of maternal immunization to prevent infant pertussis in Brazil.
Vaccine. 2021;39:158-166.
PubMed Abstract available

BAGATTINI AM, Policena G, Minamisava R, Andrade ALS, et al
The data used to build the models: Pertussis morbidity and mortality burden considering various Brazilian data sources.
Vaccine. 2021;39:137-146.
PubMed Abstract available

RUSSELL LB, Sobanjo-Ter Meulen A, Toscano CM
Evaluating the cost-effectiveness of maternal pertussis immunization in low- and middle-income countries: A review of lessons learnt.
Vaccine. 2021;39:121-124.
PubMed Abstract available

MITCHELL T, Dalal W, Klosovsky A, Yen C, et al
An immunization program for US-bound refugees: Development, challenges, and opportunities 2012-present.
Vaccine. 2021;39:68-77.
PubMed Abstract available

December 2020

JIANG X, Shang X, Lin J, Zhao Y, et al
Impacts of free vaccination policy and associated factors on influenza vaccination behavior of the elderly in China: A quasi-experimental study.
Vaccine. 2020 Dec 31. pii: S0264-410X(20)31608.
PubMed Abstract available

GROVES PJ, Williamson SL, Ahaduzzaman M, Diamond M, et al
Can a combination of vaccination, probiotic and organic acid treatment in layer hens protect against early life exposure to Salmonella Typhimurium and challenge at sexual maturity?
Vaccine. 2020 Dec 31. pii: S0264-410X(20)31612.
PubMed Abstract available

DAMJANOVSKA S, Smith C, Sayin I, Burant CJ, et al
Adjuvant effect of type I interferon induced by many but not all commercial influenza vaccines.
Vaccine. 2020 Dec 31. pii: S0264-410X(20)31631.
PubMed Abstract available

SRINIVASA REDDY Y, Narendra Babu K, Uday Kumar P, Harishankar N, et al
Nonclinical safety evaluation of oral recombinant anti-human papilloma virus vaccine (RHPV 16 & 18): Regulatory toxicology studies in mice, rats and rabbits - An innovative approach.
Vaccine. 2020 Dec 30. pii: S0264-410X(20)31463.
PubMed Abstract available

PRETO C, Maron de Mello A, Cesario Pereira Maluf EM, Teixeira Krainski E, et al
Vaccination coverage and adherence to a dengue vaccination program in the state of Parana, Brazil.
Vaccine. 2020 Dec 29. pii: S0264-410X(20)31597.
PubMed Abstract available

GUPTA S, Tiku VR, Gauhar M, Khatoon K, et al
Genetic diversity of G9 rotavirus strains circulating among diarrheic children in North India: A comparison with 116E rotavirus vaccine strain.
Vaccine. 2020 Dec 29. pii: S0264-410X(20)31604.
PubMed Abstract available

TOMLJENOVIC M, Petrovic G, Antoljak N, Hansen L, et al
Vaccination attitudes, beliefs and behaviours among primary health care workers in northern Croatia.
Vaccine. 2020 Dec 29. pii: S0264-410X(20)31502.
PubMed Abstract available

ZHONG Y, Clapham HE, Aishworiya R, Chua YX, et al
Childhood vaccinations: Hidden impact of COVID-19 on children in Singapore.
Vaccine. 2020 Dec 26. pii: S0264-410X(20)31634.
PubMed Abstract available

PITTET LF, Tebruegge M, Dutta B, Donath S, et al
Mycobacterium ulcerans-specific immune response after immunisation with bacillus Calmette-Guerin (BCG) vaccine.
Vaccine. 2020 Dec 25. pii: S0264-410X(20)31498.
PubMed Abstract available

SUAU R, Vidal M, Aguilar R, Ruiz-Olalla G, et al
RTS,S/AS01E malaria vaccine induces IgA responses against CSP and vaccine-unrelated antigens in African children in the phase 3 trial.
Vaccine. 2020 Dec 24. pii: S0264-410X(20)31606.
PubMed Abstract available

MORO PL, Marquez P
Reports of cell-based influenza vaccine administered during pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 2013-2020.
Vaccine. 2020 Dec 24. pii: S0264-410X(20)31613.
PubMed Abstract available

ULANOVA M, Huska B, Desbiens A, Gaultier GN, et al
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in 23-valent pneumococcal polysaccharide vaccine-naive and previously immunized adult patients with severe chronic kidney disease.
Vaccine. 2020 Dec 24. pii: S0264-410X(20)31602.
PubMed Abstract available

THANGARAJAH D, Malo JA, Field E, Andrews R, et al
Effectiveness of quadrivalent influenza vaccination in the first year of a funded childhood program in Queensland, Australia, 2018.
Vaccine. 2020 Dec 23. pii: S0264-410X(20)31579.
PubMed Abstract available

KOSKAN A, Klasko-Foster L, Stecher C, Rodriguez S, et al
Human papillomavirus vaccine guideline adherence among Arizona's Medicaid beneficiaries.
Vaccine. 2020 Dec 23. pii: S0264-410X(20)31609.
PubMed Abstract available

CUI YA, Folaranmi T, Buchwald UK
The Japanese 23-valent pneumococcal polysaccharide vaccine randomized clinical trial: Further reflections on the design and results.
Vaccine. 2020 Dec 22. pii: S0264-410X(20)31600.
PubMed Abstract available

APARECIDO NUNES A, De Jesus Lopes De Abreu A, Cintra O, A C T Cintra M, et al
Meningococcal disease epidemiology in Brazil (2005-2018) and impact of MenC vaccination.
Vaccine. 2020 Dec 22. pii: S0264-410X(20)31542.
PubMed Abstract available

GINI R, Dodd CN, Bollaerts K, Bartolini C, et al
Quantifying outcome misclassification in multi-database studies: The case study of pertussis in the ADVANCE project.
Vaccine. 2020;38 Suppl 2:B56-B64.
PubMed Abstract available

ITTEFAQ M, Baines A, Abwao M, Shah SFA, et al
"Does Pakistan still have polio cases?": Exploring discussions on polio and polio vaccine in online news comments in Pakistan.
Vaccine. 2020 Dec 21. pii: S0264-410X(20)31607.
PubMed Abstract available

MCFADDEN K, Seale H
A review of hospital-based interventions to improve inpatient influenza vaccination uptake for high-risk adults.
Vaccine. 2020 Dec 21. pii: S0264-410X(20)31610.
PubMed Abstract available

RAMAKRISHNAN A, Joseph SS, Reynolds ND, Poncet D, et al
Evaluation of the immunogenicity and protective efficacy of a recombinant CS6-based ETEC vaccine in an Aotus nancymaae CS6 + ETEC challenge model.
Vaccine. 2020 Dec 20. pii: S0264-410X(20)31601.
PubMed Abstract available

MARCHAL C, Belhassen M, Guiso N, Jacoud F, et al
Vaccination coverage rates for Diphtheria, Tetanus, Poliomyelitis and Pertussis booster vaccination in France between 2013 and 2017: Learnings from an analysis of National Health System Real-World Data.
Vaccine. 2020 Dec 20. pii: S0264-410X(20)31588.
PubMed Abstract available

DOUGLASS N, van Diepen MT, Chapman R, Galant S, et al
Modifications to the HIV-1 SAAVI MVA-C vaccine improve in vitro expression and in vivo immunogenicity.
Vaccine. 2020 Dec 17. pii: S0264-410X(20)31591.
PubMed Abstract available

FAN S, Liao Y, Jiang G, Wang L, et al
Efficacy of an inactivated bivalent vaccine for enterovirus 71 and coxsackievirus A16 in mice immunized intradermally.
Vaccine. 2020 Dec 17. pii: S0264-410X(20)31552.
PubMed Abstract available

GRETER H, Ivol S, Oriol Mathieu V, Erismann S, et al
Heterologous vaccine regimen: Stakeholder acceptance and implementation considerations.
Vaccine. 2020 Dec 17. pii: S0264-410X(20)31566.
PubMed Abstract available

BETLACH AM, Fano E, VanderWaal K, Pieters M, et al
Effect of multiple vaccinations on transmission and degree of Mycoplasma hyopneumoniae infection in gilts.
Vaccine. 2020 Dec 17. pii: S0264-410X(20)31443.
PubMed Abstract available

KIM K, Hahn TW
Evaluation of novel recombinant porcine circovirus type 2d (PCV2d) vaccine in pigs naturally infected with PCV2d.
Vaccine. 2020 Dec 17. pii: S0264-410X(20)31580.
PubMed Abstract available

SPARROW E, Wood JG, Chadwick C, Newall AT, et al
Global production capacity of seasonal and pandemic influenza vaccines in 2019.
Vaccine. 2020 Dec 16. pii: S0264-410X(20)31585.
PubMed Abstract available

FULVINI AA, Tuteja A, Le J, Pokorny BA, et al
HA1 (Hemagglutinin) quantitation for influenza A H1N1 and H3N2 high yield reassortant vaccine candidate seed viruses by RP-UPLC.
Vaccine. 2020 Dec 16. pii: S0264-410X(20)31563.
PubMed Abstract available

BORRIELLO A, Master D, Pellegrini A, Rose JM, et al
Preferences for a COVID-19 vaccine in Australia.
Vaccine. 2020 Dec 16. pii: S0264-410X(20)31599.
PubMed Abstract available

BOKEMPER SE, Huber GA, Gerber AS, James EK, et al
Timing of COVID-19 vaccine approval and endorsement by public figures.
Vaccine. 2020 Dec 16. pii: S0264-410X(20)31616.
PubMed Abstract available

MONTGOMERY VA, Lindsey CY, Smith LA, Webb RP, et al
Development of an o-pthalaldehyde (OPA) assay to measure protein content in Ricin Vaccine E. coli (RVEc).
Vaccine. 2020 Dec 15. pii: S0264-410X(20)31573.
PubMed Abstract available

SANFTENBERG L, Kuehne F, Anraad C, Jung-Sievers C, et al
Assessing the impact of shared decision making processes on influenza vaccination rates in adult patients in outpatient care: A systematic review and meta-analysis.
Vaccine. 2020 Dec 14. pii: S0264-410X(20)31581.
PubMed Abstract available

BROOCKMAN D, Kalla J, Guerrero A, Budolfson M, et al
Broad cross-national public support for accelerated COVID-19 vaccine trial designs.
Vaccine. 2020 Dec 14. pii: S0264-410X(20)31555.
PubMed Abstract available

FLORES-VALDEZ MA, Segura-Cerda CA
Preclinical evaluation of tuberculosis vaccine candidates: Is it time to harmonize study design and readouts for prioritizing their development?
Vaccine. 2020 Dec 14. pii: S0264-410X(20)31556.
PubMed

STEVENS VW, Russo EM, Young-Xu Y, Leecaster M, et al
Identification of patients at risk of Clostridioides difficile infection for enrollment in vaccine clinical trials.
Vaccine. 2020 Dec 14. pii: S0264-410X(20)31583.
PubMed Abstract available

BRAVO-GRANDE JL, Asuncion Blanco-Gonzalez M, de la Torre-Robles JM, Asmat-Inostrosa MP, et al
Vaccination adjuvated against hepatitis B in Spanish National Healthcare System (SNS) workers typed as non-responders to conventional vaccines.
Vaccine. 2020 Dec 14. pii: S0264-410X(20)31571.
PubMed Abstract available

CASTANO-ZUBIETA MR, Rossetti CA, Garcia-Gonzalez DG, Maurizio E, et al
Evaluation of the safety profile of the vaccine candidate Brucella melitensis 16MDeltavjbR strain in goats.
Vaccine. 2020 Dec 13. pii: S0264-410X(20)31473.
PubMed Abstract available

BOUCHEZ M, Ward JK, Bocquier A, Benamouzig D, et al
Physicians' decision processes about the HPV vaccine: A qualitative study.
Vaccine. 2020 Dec 13. pii: S0264-410X(20)31586.
PubMed Abstract available

SARINHO E, Goudouris E, Sole D
BCG vaccine: Worrying proposal for COVID-19.
Vaccine. 2020 Dec 13. pii: S0264-410X(20)31593.
PubMed Abstract available

DEGELING C, Williams J, Carter SM, Moss R, et al
Priority allocation of pandemic influenza vaccines in Australia - Recommendations of 3 community juries.
Vaccine. 2020 Dec 11. pii: S0264-410X(20)31577.
PubMed Abstract available

ZACHARIA A, Harberts E, Valencia SM, Myers B, et al
Optimization of RG1-VLP vaccine performance in mice with novel TLR4 agonists.
Vaccine. 2020 Dec 10. pii: S0264-410X(20)31541.
PubMed Abstract available

DE OLIVEIRA EMERICK S, Vieira de Carvalho T, Meirelles Miranda B, Carneiro da Silva A, et al
Lipophosphoglycan-3 protein from Leishmania infantum chagasi plus saponin adjuvant: A new promising vaccine against visceral leishmaniasis.
Vaccine. 2020 Dec 10. pii: S0264-410X(20)31539.
PubMed Abstract available

LIU C, Huang P, Zhao D, Xia M, et al
Effects of rotavirus NSP4 protein on the immune response and protection of the SR69A-VP8* nanoparticle rotavirus vaccine.
Vaccine. 2020 Dec 10. pii: S0264-410X(20)31568.
PubMed Abstract available

HOLM MR, Poland GA
Critical aspects of packaging, storage, preparation, and administration of mRNA and adenovirus-vectored COVID-19 vaccines for optimal efficacy.
Vaccine. 2020 Dec 9. pii: S0264-410X(20)31584.
PubMed

CARIAS C, Pawaskar M, Nyaku M, Conway JH, et al
Potential impact of COVID-19 pandemic on vaccination coverage in children: A case study of measles-containing vaccine administration in the United States (US).
Vaccine. 2020 Dec 9. pii: S0264-410X(20)31557.
PubMed Abstract available

DULIN N, Spanier A, Merino K, Hutter JN, et al
Systematic review of Marburg virus vaccine nonhuman primate studies and human clinical trials.
Vaccine. 2020 Dec 9. pii: S0264-410X(20)31495.
PubMed Abstract available

GHASWALLA PK, Bengtson LGS, Marshall GS, Buikema AR, et al
Meningococcal vaccination in patients with newly diagnosed asplenia in the United States.
Vaccine. 2020 Dec 9. pii: S0264-410X(20)31550.
PubMed Abstract available

RASTEGAR M, Tavana M, Meraj A, Mina H, et al
An inventory-location optimization model for equitable influenza vaccine distribution in developing countries during the COVID-19 pandemic.
Vaccine. 2020 Dec 9. pii: S0264-410X(20)31589.
PubMed Abstract available

WILLIAMS JTB, Robinson K, Abbott E, Rojop N, et al
Adapting and piloting a vaccine hesitancy questionnaire in rural Guatemala.
Vaccine. 2020 Dec 8. pii: S0264-410X(20)31551.
PubMed Abstract available

LUISI MLR
From bad to worse II: Risk amplification of the HPV vaccine on Facebook.
Vaccine. 2020 Dec 7. pii: S0264-410X(20)31540.
PubMed Abstract available

GHIGA I, Richardson S, Alvarez AMR, Kato M, et al
PIPDeploy: Development and implementation of a gamified table top simulation exercise to strengthen national pandemic vaccine preparedness and readiness.
Vaccine. 2020 Dec 5. pii: S0264-410X(20)31500.
PubMed Abstract available

DHAKAL S, Deshpande S, McMahon M, Strohmeier S, et al
Female-biased effects of aging on a chimeric hemagglutinin stalk-based universal influenza virus vaccine in mice.
Vaccine. 2020 Dec 5. pii: S0264-410X(20)31510.
PubMed